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GLOSSARY OF TERMS 
Glossary of terms 
Hospital Data Terms  
Attendance An attendance in this report is a single visit to an emergency or outpatient department. 
Discharge The Hospital In-Patient Enquiry (HIPE) scheme collects activity data at the discharge 
level. A discharge record is created when a patient is discharged from (or dies in) a 
public hospital. At present, in the absence of the rollout of a unique patient identifier, 
it is not possible to follow activity at the patient level (that is, attribute multiple 
discharges to the same patient) across hospitals. 
Day patient A day patient is admitted to hospital for treatment on an elective (rather than an 
emergency) basis and is discharged alive, as scheduled, on the same day. Births are 
excluded. 
In-patient An in-patient is admitted to hospital for treatment or investigation on an elective 
(arranged in advance) or emergency (unforeseen and urgent) basis.  
Elective  
in-patient 
The patient’s condition permits adequate time to schedule the availability of suitable 




The patient requires immediate care and treatment as a result of a severe, life-
threatening or potentially disabling condition. Generally, the patient is admitted 
through the emergency department or acute medical/surgical assessment unit. In this 
report, those admitted to and discharged from the AMAU/ASAU are examined 
separately. 
AMAU/ASAU only The patient is admitted as an emergency to the acute medical/surgical assessment unit 
and is discharged from there. 
Maternity discharges Maternity discharges are those who were admitted in relation to their obstetrical 
experience (from conception to six weeks post-delivery). Maternity discharges capture 
both delivery and non-delivery episodes of care. All delivery episodes of care are 
classified as in-patients and, for maternity discharges, there is no distinction between 
elective and emergency in-patients. 
Public/private status Public or private status relates to whether the hospital patient saw their consultant on 
a private or public basis. It does not relate to the type of bed occupied nor is it an 
indicator of possession of private health insurance. 
In-patient bed day In the analysis of the adult acute psychiatric in-patients, each overnight stay reflects 
one in-patient bed day. 
Other  
GDP GDP measures the total output of the economy in a period i.e. the value of work done 
by employees, companies and self-employed persons.  
GNI* GNI* is designed to be a supplementary measure of the level of the Irish economy and 
excludes globalisation effects related to highly mobile economic activities that 
disproportionately affect the measurement of the size of the Irish economy. 
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FOREWORD 
Foreword 
This report was prepared by researchers at the Economic and Social Research 
Institute (ESRI) for the ESRI Research Programme in Healthcare Reform, which is 
funded by the Department of Health. The report is published as an ESRI Research 
Series Report and is the second report applying the Hippocrates Model of 
healthcare demand and expenditure which has been developed at the ESRI. This 
report analyses expenditure on public acute hospital and psychiatric in-patient 
services and projects expenditure for these services for the years from 2018 to 
2035.  
 
The ESRI Research Programme in Healthcare Reform was agreed between the 
Economic and Social Research Institute (ESRI) and the Department of Health in July 
2014. The broad objectives of the programme are to apply economic analysis to 
explore issues in relation to health services, health expenditure and population 
health, in order to inform the development of health policy and the Government’s 
healthcare reform agenda. The programme is overseen by a Steering Group 
comprising nominees of the ESRI and the Department of Health, which agrees its 
annual work programme. The Steering Group agreed in 2015 that this programme 
would include the development of a projection model of healthcare demand and 
expenditure, and work on developing the model began in that year. The objectives 
of the development of the Hippocrates Model are to supply a tool which will: 
inform health and social service planning in Ireland; inform financial planning for 
the healthcare system; inform planning for capacity, services and staffing; identify 
future demand pressures, and provide a framework in which to analyse the effects 
of potential system changes and reforms.  
 
The ESRI is responsible for the quality of this research, which has undergone 
national and international peer review prior to publication. This report was 
prepared by Dr Conor Keegan, Dr Aoife Brick, Dr Adele Bergin, Dr Maev-Ann Wren, 
Mr Edward Henry, and Mr Richard Whyte and reflects their expertise and views. 
The views expressed in this report are not necessarily those of other ESRI 
researchers, the Minister for Health, Department of Health or organisations 
represented on the Steering Group. 
 
December 2020 




This is the second report to be published applying the Hippocrates projection 
model of Irish healthcare demand and expenditure, developed at the ESRI in a 
programme of research funded by the Department of Health. Previous analyses 
have applied the Hippocrates Model to estimate baseline utilisation of healthcare 
services in Ireland and to provide projections of demand and capacity. This analysis 
extends the Hippocrates Model to provide baseline estimates of expenditure in 
2018 for public acute hospitals and psychiatric in-patient services in Ireland, and to 
project expenditures for these services to 2035.  
 
OBJECTIVES 
The Hippocrates Model has been developed as a tool to: inform health and social 
care capacity and services planning in Ireland, inform financial planning for the 
healthcare system, and identify future demand and expenditure pressures. 
The broad objectives of this report are to: 
− provide comprehensive estimates of current expenditure on public acute 
hospital and adult acute psychiatric in-patient services in Ireland; 
− examine the relative impact of demographic and non-demographic factors on 
projected expenditure; 
− provide a projection framework, and analysis, that considers the impact of 
Covid-19 on projected expenditure in the short and medium term; 
− provide a framework, and analysis, to consider the effects of potential system 
change and reform; and 
− inform hospital service, staffing, and financial planning. 
 
CONTEXT 
The base year for analysis in this report is 2018, with expenditures projected to 
2035. From 2020 onwards, however, the outbreak of the Covid-19 pandemic needs 
to be considered both in terms of the short-term impacts on acute care 
expenditures and the medium-term impact on drivers of expenditure. 
 
Before the onset of Covid-19 the Irish public hospital system was already operating 
under pressure from high population growth and ageing, and as a result of system 
cuts to bed capacity in the preceding decades. The onset of Covid-19 highlighted 
these acute capacity deficits. The immediate budgetary response in 2020 has been 
to increase public healthcare funding dramatically, with priorities given to changes 
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in the model of care delivery in line with the cross-party Sláintecare policy 
objectives, addressing these known capacity deficits, and tackling waiting lists. In 
line with recent policy responses, in this report we consider the impact of these 
short-term expenditure shocks, and develop a framework to examine the potential 
impact of models of care change and improved waiting-list management on acute 
care expenditures over time. 
 
Previous analysis by Wren et al. (2017) showed that Ireland’s rapid projected 
population growth, unusual in a European context, and population ageing will 
increase demand for all forms of health and social care in the coming years. While 
these broad trends are set to continue, using the ESRI’s demographic model we 
adjust assumptions to reflect existing and emerging trends in the data. Most 
notably, assumptions on future net migration, a key driver of overall population 
change in Ireland, are refined over the short term (travel restrictions, uncertainty, 
lower confidence) and medium term (weaker economic conditions) in response to 
the potential disruption of Covid-19. 
 
In recent times Ireland’s healthcare expenditure has been considered as among 
the highest in the OECD. While cross-country comparison of healthcare 
expenditure is challenging, recent analysis has shown that Ireland’s apparent high 
ranking in an international context is driven by relatively high prices for healthcare 
delivery, particularly salaries, rather than due to the volume of care delivered. This 
high cost of healthcare delivery is a function of a high wage/cost economy. 
Importantly, in this analysis we model the projected cost of hospital care delivery 
separately to the demand for care. The evolution of pay and non-pay costs are 
informed by modelling of the Irish economy as it recovers from the impact of Covid-
19, undertaken using the ESRI’s macro-econometric model COSMO. 
 
METHODS 
Hippocrates has been developed as a macro-simulation model. Macro-simulation 
models or cell-based models represent a large and important class of component-
based models, which group individuals into cells according to key attributes such 
as age and sex, and project from that basis. The model is bottom-up in nature, with 
service-level expenditure projections modelled from a demand and cost base in 
2018. We project expenditure for four primary public acute hospital services in this 
report: emergency department attendances, outpatient department attendances, 
and day patient and in-patient discharges. We also project expenditure for public 
acute adult psychiatric in-patient services.  
 
The bottom-up service-level approach to expenditure estimation has also 
facilitated the generation of the most comprehensive age and sex-specific profiles 
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of public acute hospital expenditure in Ireland developed to date. These profiles 
have in turn formed the foundation for a recent Department of Health submission, 
for the first time, of Irish age-cost profiles to the European Commission to inform 
their Ageing Reports. Up until now, Ireland was only one of three countries unable 
to submit age-cost profiles to the European Commission for this purpose. 
 
The first step is to estimate activity rates in 2018 from analysis of current use of 
services by age (single-year-of-age for most services) and sex (see Brick and 
Keegan, 2020a). Demand is projected by multiplying activity rates by projected 
population. Population projections by single-year-of-age and sex to 2035 are 
provided by the ESRI’s demographic model based on assumptions in relation to 
fertility, mortality and net migration. Separately, the unit cost of delivering care in 
2018 is estimated and disaggregated into pay and non-pay components. The ESRI’s 
COSMO model provides government sector earnings and wider inflation 
projections that inform projected trajectories in this analysis of pay and non-pay 
hospital costs. For day and in-patient services, we project the cost of drugs 
separately informed by historic unit cost growth. Importantly, in this regard, the 
report does not forecast expenditure; rather it provides projections of expenditure 
requirements based on clear assumptions in relation to the evolution of these key 
drivers of demand and cost. 
 
Since any projection exercise must address uncertainty, alternative projection 
scenarios are developed for each service analysed, and sensitivity analyses are 
undertaken to test the sensitivity of our projections to changes in key assumptions. 
The alternative expenditure projection scenarios vary assumptions related to 
population change, healthy ageing, and pay and non-pay cost drivers. Assumptions 
are grouped to provide projections of expenditure under low-pressure, central, 
and high-pressure expenditure scenarios. We also define a ‘progress’ scenario 
where we examine the effect on total public acute expenditure of addressing 
important dimensions of the Sláintecare reforms, such as waiting-list management 
and enhanced primary care, which appear subject to a renewed commitment in 
the recent Budget.  
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SUMMARY OVERVIEW OF FINDINGS 
Public acute hospital expenditure 
− Public acute hospital gross expenditure was €5,907m in 2018. 
− In 2018, expenditure per capita is estimated at €1,169 for males and €1,253 for 
females. 
− Reducing current waiting-list backlogs and maintaining waiting times is 
estimated to require an additional €212m on average per annum between 
2021 and 2025. 
− In nominal terms, we project gross expenditure requirements of between 
€10,761m and €14,363m by 2035, or between 3.6 and 5.4 per cent expenditure 
growth on average per annum. 
− When the effect of pay and non-pay cost increases is removed, we project a 
real (or volume) increase in expenditure requirements of between 1.2 and 1.7 
per cent on average per annum. 
− Pay cost is the largest single driver of expenditure growth, projected to account 
for between €2,040m and €4,061m of additional expenditure requirements by 
2035. 
 
Emergency department attendances 
− In 2018, public emergency department expenditure is estimated at €418.6m 
based on 1.4m recorded attendances. 
− In nominal terms, we project gross expenditure requirements of between 
€679m and €876m by 2035. 
− In real (or volume) terms, when the effect of pay and non-pay cost increases is 
removed, we project expenditure requirements of between €468m and €496m 
by 2035. 
 
Outpatient department attendances 
− In 2018, public outpatient expenditure is estimated at €676.4m based on 4.0m 
recorded attendances. 
− In nominal terms, we project gross expenditure requirements of between 
€1,105m and €1,404m by 2035. 
− In real (or volume) terms, when the effect of pay and non-pay cost increases is 
removed, we project expenditure requirements of between €759m and €799m 
by 2035. 
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Day-patient discharges 
− In 2018, expenditure on day-patient discharges from public acute hospitals is 
estimated at €919.5m in 2018, based on 1.0m recorded discharges. 
− In 2018, we estimate 17 per cent of expenditure went on treating private 
discharges.  
− In nominal terms, we project gross expenditure requirements of between 
€1,766m and €2,397m by 2035. 
− In real (or volume) terms, when the effect of pay and non-pay cost increases is 
removed, we project expenditure requirements of between €1,110m and 
€1,201m by 2035. 
 
In-patient discharges 
− In 2018, expenditure on in-patient discharges from public acute hospitals is 
estimated at €3,220.5m based on 0.6m recorded discharges. 
− In 2018, we estimate 18 per cent of expenditure went on treating private 
discharges. 
− In nominal terms, we project gross expenditure requirements of between 
€5,985m and €8,050m by 2035. 
− In real (or volume) terms, when the effect of pay and non-pay cost increases is 
removed, we project expenditure requirements of between €4,029m and 
€4,446m by 2035. 
 
Public acute psychiatric hospital expenditure 
− In 2018, expenditure on in-patient care in adult public acute hospitals/units is 
estimated at €179.3m based on 0.4m recorded bed days. 
− In nominal terms, we project expenditure requirements of between €303m 
and €395m by 2035. 
− In real (or volume) terms, when the effect of pay and non-pay cost increases is 
removed, we project expenditure requirements of between €209m and €223m 
by 2035. 
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POLICY IMPLICATIONS 
The main finding of this report is that, due to a combination of a growing and 
ageing population and increasing costs of care delivery, expenditure on all main 
categories of public acute and psychiatric in-patient services will be required to 
increase substantially by 2035. 
 
The main driver of this increased expenditure is the future expected cost of care 
delivery, particularly pay-related cost. Trends and policy in relation to public-sector 
pay will therefore be an important driver of public hospital expenditure. Policies 
aimed at improving productivity of care delivery such as investment in information 
and communication technology, changes to staff-mix, and better management, 
may be considered as some ways of offsetting these increased costs.  
 
Projected population growth and ageing will also require investment in workforce 
and bed capacity to meet growing demand for public hospital care. In recent times, 
under-investment in acute care capacity has led to a constraint on the volume of 
public acute care delivery. These acknowledged capacity deficits, underscored by 
the effects of the Covid-19 pandemic, have resulted in larger and longer waiting 
lists to access public acute care. Additional expenditure will be required over time 
to address these waiting-list backlogs and sustain lower waiting times into the 
future. However, when considering the sustainability of future expenditure 
requirements, it is important to view these increases in the context of growing 
national income which will contribute to the tax base necessary to finance future 
care needs. 
 
In parallel, however, changes in models of care, as proposed under the cross-party 
Sláintecare report in 2017, may help mitigate some of these increased demand and 
expenditure pressures on the public hospital system. In this analysis we show that 
it is possible to offset the increased expenditure associated with improved waiting-
list management through shifting certain appropriate care, currently delivered in 
public hospitals, to the community over time. The model will be extended to 
consider non-acute expenditure projections, including the effects of models of care 
change, in future work. 
Introduct ion |1  
CHAPTER 1 
Introduction 
Chapter 1 Introduction 
1.1 INTRODUCTION 
In this report we provide healthcare expenditure base year estimates for 2018 and 
projections to 2035 for public acute hospitals and public acute adult psychiatric 
hospitals. These projections have been generated using the Hippocrates Model, 
which was developed at the ESRI in a programme of research funded by the 
Department of Health. Baseline demand profiles underlying these expenditure 
projections have been published separately in the ESRI’s Survey and Statistical 
Reports Series (Brick and Keegan, 2020a). 
 
This report marks the next phase in the development of the Hippocrates projection 
model of Irish healthcare demand and expenditure.1 Previously, the model has 
provided base year estimates and projections of healthcare demand for a wide 
range of Irish health and social care services for the years 2015–2030 (Wren et al., 
2017) and provided projections of hospital bed capacity (Keegan et al., 2018a). 
Future ESRI research will extend the model to develop baseline estimates and 
projections of non-acute healthcare expenditures. 
 
Healthcare projection models have been used in several countries and in a variety 
of ways. Such models assist policymakers to identify future demand pressures and 
to inform financial planning as well as planning for services and staffing. The 
original development of this model to project demand for health and social care 
services was an unprecedented undertaking for Ireland and was ambitious even in 
an international context. While many models project at aggregate levels, 
Hippocrates was developed from a bottom-up perspective, building a service-level 
picture of demand across health and social care services, and incorporating 
measures of unmet need or demand in projecting demand. 
 
The modelling framework has been extended to cost public acute hospital and 
public acute adult psychiatric hospital activity in 2018. This facilitates the 
generation of a service-level picture of expenditure in 2018 and projections of 
these expenditures to 2035, based on identified demographic and non-
demographic drivers. The development of the model required detailed analysis of 
service unit costs in 2018. This is the first time detailed unit costs and baseline 
expenditure profiles for a range of acute services have been published for Ireland.  
 
1  Hippocrates – Greek physician (born c. 460 – died c. 375 BC) regarded as the father of modern medicine. 
 (www.britannica.com/biography/Hippocrates). Also, an acronym of Healthcare in Ireland model of effects of 
Population Projections, Patterns Of CaRe and Ageing Trends on Expenditure and Demand for Services. 
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While the base year for these projections is 2018, the Covid-19 pandemic in 2020 
can be expected to significantly alter trajectories of hospital expenditures over the 
short to medium term. We have adjusted our analysis to reflect these changes 
where possible. In particular, updates were made to key ESRI demographic and 
macroeconomic projections that inform our demand and unit cost projections. We 
also account for the recent impact of Covid-19 when examining the projected 
expenditure implications of clearing large existing backlogs for elective hospital 
care over the next number of years. 
 
The next section outlines the objectives of the model and this report. Section 1.3 
provides an overview of the Irish hospital system while Section 1.4 considers Covid-
19 in the context of this modelling. Section 1.5 gives an overview of the model 
scope and modelling approach. Section 1.6 presents a summary of the report’s 
findings on baseline expenditure for Irish public acute hospitals and public acute 
adult psychiatric hospitals. Section 1.7 outlines this report’s structure. 
 
1.2 OBJECTIVES 
The Hippocrates Model has been developed as a tool to: inform health and social 
capacity and services planning in Ireland; inform financial planning for the 
healthcare system; and identify future demand and expenditure pressures. 
Previous applications of the Hippocrates Model examined questions of demand 
and capacity: how population growth and ageing affect demand for health and 
social care services; what is the extent of unmet need for care; and what are the 
bed capacity implications of projected demand for hospital care (Keegan et al., 
2018a; Wren et al., 2017).  
 
Building on the existing modelling framework, the objectives of this report are to:  
− provide comprehensive estimates of current expenditure on public acute 
hospital and adult acute psychiatric in-patient services in Ireland; 
− examine the relative impact of demographic and non-demographic factors on 
projected expenditure; 
− provide a projection framework, and analysis, that considers the impact of 
Covid-19 on projected expenditure in the short and medium term; 
− provide a framework, and analysis, to consider the effects of potential system 
change and reform; and 
− inform hospital service, staffing, and financial planning. 
 
Future research under the ESRI Research Programme in Healthcare Reform will 
provide base year estimates and projections of non-acute health and social care 
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services. The model is expected to be further extended to develop detailed 
analyses of staffing requirements and to develop demand and expenditure 
projections by region. 
 
1.3 OVERVIEW OF THE IRISH HOSPITAL SYSTEM 
The Irish hospital system is situated within a complex healthcare system, which has 
a mixture of public and private delivery and financing and many eligibility 
categories governing access to care. The Department of Health provides strategic 
leadership for the Irish healthcare system, ensuring that government policies are 
translated into actions and are effectively implemented (Department of Health, 
2016). The Health Service Executive (HSE), established in 2005, manages the 
operation of the Irish health service, replacing the former regionally based health 
boards. The Health Information and Quality Authority (HIQA) is an independent 
authority established in 2007 to promote and monitor quality and safety in Irish 
health and social care services. The National Treatment Purchase Fund (NTPF) was 
established in 2004; its main responsibilities are: to arrange the provision of 
hospital treatment as required; to collect, collate and validate information on 
persons waiting for public hospital treatment; and to agree pricing arrangements 




Hospitals in Ireland may have non-voluntary, voluntary, and private (for profit) 
ownership. Non-voluntary hospitals are owned and directly funded by the HSE. 
Voluntary hospitals, usually established by religious organisations or charities, 
receive large amounts of their funding from the State, while retaining quasi-
independence from the HSE. Many major acute hospitals are owned by voluntary 
organisations. In this report, non-voluntary and voluntary hospitals are collectively 
referred to as public acute hospitals. Privately financed acute care is provided in 
both public and private hospitals. All care in public acute hospitals is considered in 
this report regardless of whether it is publicly or privately financed. 
 
In this report we analyse activity and expenditure in 51 of the 53 public hospitals 
that participated in the Hospital In-Patient Enquiry (HIPE) scheme in 2018.2 Public 
hospitals in Ireland may differ in the care they provide, for example, three 
children’s hospitals offer care to children and younger people only; four standalone 
maternity hospitals offer largely maternity and neonatal care.3 This report presents 
 
2  Two long-term-care hospitals are excluded from the analysis. See Brick and Keegan (2020a) for full list of included 
hospitals.  
3  A small number of hospitals offer specialised services such as for eye and ear conditions, orthopaedic or rehabilitation 
services. Although included in the analysis in this report, some of these hospitals would not be considered ‘acute’ in 
the sense of offering emergency care. However, due to their inclusion for historical reasons in the HIPE dataset and not 
in other service registers, we analyse their activity within the acute hospital grouping. 
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findings for four primary forms of public acute hospital activity: emergency 
department (ED) and outpatient (OPD) attendances, day patient and in-patient 
discharges.  
 
In addition, to the above outlined services the report also presents findings on 
public acute psychiatric hospitals/units. This activity was not included in the 
analysis in Wren et al. (2017) but a subsequent report analysed utilisation of 
mental health services in Ireland in 2018 (Brick et al., 2020a). In this current report 
we focus specifically on in-patient activity and expenditure in the 29 HSE/HSE-
funded public acute adult psychiatric hospitals and co-located units. 
 
1.3.2 Eligibility and access 
Public acute hospitals are funded by a combination of government financing 
allocated through the HSE, by payments from private health insurers for private 
patient care, and by out-of-pocket (OOP) payment of charges. A minority of the 
Irish population qualifies for free public hospital care, receiving medical cards 
which are allocated on grounds of low income, or older age and low income 
combined. Medical cards give access to all forms of care including public hospital 
care without charge, except for a charge for prescribed medications.  
 
The proportion of the population covered by medical cards fluctuates depending 
on the relationships between changing eligibility criteria, income thresholds and 
the income distribution. Between 2010 and 2019, the proportion of the population 
covered by medical cards fluctuated from a high of 40 per cent in 2012 to a low, 
largely due to rising incomes, of 32 per cent in 2019 (Department of Health, 2019a; 
Health Service Executive, 2020a). Non-medical cardholders must pay public 
hospital in-patient bed charges and self-referred ED attendance charges.  
 
Although all residents are eligible for free or subsidised public hospital care, private 
hospital services such as private or semi-private accommodation and consultant-
delivered care (purchased by private fee payment), are available in public and 
private hospitals for those who are willing to pay significant OOP charges, but are 
more typically financed by private health insurance (PHI). In 2019, 46 per cent of 
the population purchased PHI (Health Insurance Authority, 2020), which is largely 
intended to ensure timely access to care, whether in public or private hospitals 
(Wren and Connolly, 2016). 
Although a nominally common waiting system was introduced in 2009, privately 
insured patients’ faster routes of access to initial consultations in hospital 
consultants’ private rooms and to diagnostic tests, ensure that they gain faster 
access to public hospital elective care while public patients can experience long 
waits (Department of Health, 2016; Tussing and Wren, 2006). Additionally, 
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privately insured or paying patients can access the private hospital sector, which 
expanded rapidly in the early 2000s supported by government subsidies (Tussing 
and Wren, 2006). A recent study which examined the impact of insurance status 
on waiting times for hospital-based services found no evidence that the 
introduction of the common waiting list reduced the differential in waiting times 
between those with and without PHI (Whyte et al., 2020). A review group found in 
2019 that, while it was difficult to quantify the extent to which private patients 
might access treatment more quickly in public hospitals, there was anecdotal 
evidence that this was the case at least in some instances (Independent Review 
Group, 2019). 
 
1.3.3 Sláintecare  
In 2016 an all-party parliamentary committee (Houses of the Oireachtas 
Committee on the Future of Healthcare, 2017) was established with the aim of 
achieving a single long-term vision for healthcare and the direction of health policy 
in Ireland. The committee concluded that the health system must be re-orientated 
to ensure equitable access to a universal single-tier system, and that most care 
takes place in primary and social care settings. While promoting a shift away from 
a hospital-centred model of care, the committee recognised that additional 
measures such as significant investment in hospital capacity, hospital waiting-time 
guarantees and a phased elimination of private care in public hospitals would also 
be needed (Houses of the Oireachtas Committee on the Future of Healthcare, 
2017). Although the report received cross-party support and was an important 
milestone in the development of Irish health policy, it lacked clarity on how the 
critical issue of universality should be defined and, although some costings were 
published, they were not comprehensive (Connolly and Wren, 2019).  
 
In January 2019, the Department of Health published a Sláintecare Action Plan 
2019, which stopped short of commitments to introducing universal healthcare by 
progressive expansion of access and changes to eligibility (Department of Health, 
2019b). The plan stated: “Sláintecare proposes providing universal services at no 
or low cost to the patient/service user. We will plan how, when and in what order 
of priority this could be done and make proposals to government for 
consideration” (Department of Health, 2019b: 6). 
 
1.4 CONSIDERING COVID-19 
In this report, 2018 is the base year for analysis of activity and unit costs. Data from 
2018 are used as a basis to project Ireland’s hospital expenditure to 2035. 
However, the outbreak of the Covid-19 pandemic in Ireland has already influenced 
Irish public healthcare expenditure allocations and will likely have longer-term 
implications for drivers of demand and cost. 
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As described in Walsh et al. (2020a), Covid-19 has shone a light on the insufficient 
hospital capacity in Ireland that was evident prior to Covid-19 (Keegan et al., 
2018a). Before the onset of the pandemic, Ireland already had a public bed 
occupancy rate averaging 95 per cent, the highest in the OECD (OECD, 2019a). This 
most recently can be traced back to the 2008 financial crisis, which resulted in large 
reductions in public healthcare expenditure and the stock of public hospital beds 
(Mercille, 2018). Related to this acute capacity shortage, the decision was made in 
the early stages of the pandemic to cancel all but essential elective hospital 
services and to secure additional capacity through effectively nationalising the 
private hospitals temporarily (Walsh et al., 2020a).  
 
While this private hospital capacity was ultimately not fully required to manage the 
additional Covid-19 burden, the numbers waiting for elective treatment have 
continued to grow. In October 2020, there were 613,000 on the OPD waiting list, 
105,000 on the day-patient treatment list, and 24,000 on the in-patient treatment 
list. Almost 42 per cent of those waiting for an OPD appointment had been waiting 
for more than 12 months, while, of those waiting for day and in-patient treatment, 
16 per cent and 30 per cent, respectively, had been waiting for more than 12 
months.4 
 
It was in this context and in preparation for subsequent Covid-19 waves that, in 
September 2020, the HSE announced an ambitious ‘Winter Plan’ plan to increase 
the country’s healthcare capacity and workforce, and to reconfigure care towards 
the community (Health Service Executive, 2020b). Supporting this plan, on 13 
October 2020, the Government announced a record health budget of €22.1 billion 
for 2021, including €1.8 billion in direct Covid-related supports (Government of 
Ireland, 2020). Within the overall funding allocations, and consistent with the 
Winter Plan objectives, it appears that funding priorities relate to changing the 
model of care delivery in line with Sláintecare objectives, addressing known 
capacity deficits, and tackling waiting lists (Government of Ireland, 2020). In this 
report, we adjust our analysis where relevant to consider this expenditure shock 
on projections of gross public acute hospital expenditure. 
 
Longer term, however, future expenditure requirements will be shaped by 
underlying demand and unit-cost drivers. In this context, the Covid-19 pandemic 
may also have implications related to the demand for, and the cost of delivering, 
acute hospital services relevant for modelling trends in expenditures over the 
medium term. To account for these effects, we adjust our projections in several 
ways.  
 
4  Figures for October 2020, personal communication, NTPF, 16 November 2020. 
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Importantly, we have updated and revised our demographic projection scenarios. 
As described in Wren et al. (2017), Ireland’s demographic structure has 
traditionally been somewhat unusual compared to other Western European 
countries, experiencing unusually high population growth5 driven by net inward 
migration. The population has also experienced strong population ageing, albeit 
from a relatively young base. While these broad trends are likely to continue, we 
have adjusted our assumptions to reflect emerging trends. In particular, net 
international migration has been adjusted downwards over the short to medium 
term because of the effects of Covid-19 and the downturn in the macroeconomy. 
In addition, the population estimates for 2020 have been adjusted to take account 
of deaths from Covid-19. 
 
Following Wren et al. (2017), this report also places considerable emphasis on 
measuring and modelling unmet demand (long waiting times) for care in Irish 
public hospitals. In this report, however, we have refined our methods in line with 
an approach developed by Findlay (2017). This approach allows us for the first 
time, to estimate the activity and expenditure required, over the next number of 
years, to achieve and sustain public hospital waiting lists at, or close to, the 
Sláintecare targets of up to 12 weeks. As discussed above, Covid-19 has 
contributed to increasingly larger and longer waiting lists. To ensure that we 
capture this Covid-19 impact, we incorporate into our analysis the most recent 
information on numbers waiting for hospital care as of October 2020. 
 
Recent findings by Wren and Fitzpatrick (2020) have shown that Ireland ranks 
below the EU-15 average in terms of the volume of public health and hospital care 
consumed per capita. However, Ireland ranks relatively high in terms of total 
healthcare expenditure as a proportion of national income. This dichotomy may 
reflect relatively high prices for healthcare delivery in Ireland, characterised by a 
high-wage/high-cost economy. Healthcare salaries, the largest component cost of 
healthcare delivery, are particularly affected by Ireland’s status as a high-wage, 
high-cost economy. When projecting nominal expenditures in the present analysis, 
Hippocrates models pay and non-pay components of costs separately. Trends in 
pay and non-pay (non-drug) costs are informed by the ESRI’s macro-econometric 
model COSMO. These costs are modelled based on two COSMO scenarios for 
economic recovery following the Covid-19 pandemic; a Recovery scenario and a 
Delayed Recovery scenario. Pay is modelled based on assumptions related to 
trends in government sector average earnings growth over the projection horizon, 
linked to pay growth in the wider economy. Non-pay (non-drug) costs growth 
reflects trends in projected inflation (linked to a personal consumption deflator). 
Where applicable, we model the drug cost component of acute care delivery in line 
 
5  For instance, Ireland’s population increased by 31 per cent (1,136m) in the twenty years 1996 to 2016. This compares 
to average population growth in the EU28 of 6 per cent over the same period (Wren et al., 2017). 
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with historic trends, which has seen strong growth in recent years reflecting the 
innovative and high-tech nature of many of these drugs (e.g. oncology). 
 
1.5 MODEL SCOPE AND MODELLING APPROACH  
The Hippocrates Model has been designed to be broad in scope. The Wren et al. 
(2017) report included all health and social care services (acute hospital, primary, 
community and long-term care) and public and private services (including private 
hospitals and privately purchased GP visits, home help hours and other non-acute 
care services). However, scope and data constraints led us to divide the projections 
of healthcare expenditure into separate analyses. This report focuses on the public 
acute care sector due to the greater availability of data on activity and costs with 
which to develop baseline expenditure estimates and projections. Information on 
the unit costs of many non-acute services is currently lacking, and filling this gap 
will require particular attention as part of a non-acute expenditure analysis. The 
acute care system also represents an obvious choice for initial focus given that 
acute care expenditures represent the single largest area of HSE expenditure. In 
2018, acute services accounted for 34 per cent of the HSE’s total gross non-capital 
vote allocation of €16.3 billion (Department of Health, 2019a). As described in 
Section 1.2, future analysis will develop baseline estimates and projections of 
expenditure for non-acute healthcare services. 
 
Hippocrates has been developed as a macro-simulation model. Macro-simulation 
models or cell-based models represent a large and important class of component-
based models, which group individuals into cells according to key attributes such 
as age and sex, and project from that basis. The model is bottom-up in nature; 
expenditure projections are developed from a demand and cost base in 2018. We 
model demand projections primarily based on projected demographic change and 
assumptions on the relationship between life year gains and healthcare use. 
Projected demand for respective services is then costed through modelling, 
assumed trends in pay, drug and other non-pay costs.  
 
Since any projection exercise must address uncertainty, alternative projection 
scenarios are developed for each service analysed, and sensitivity analyses are 
undertaken to test the sensitivity of our projections to changes in key assumptions. 
The alternative expenditure projection scenarios vary assumptions related to 
population change, healthy ageing, and pay and non-pay cost drivers. Assumptions 
are grouped to provide projections of expenditure under low-pressure, central and 
high-pressure expenditure scenarios.  
 
We also define a ‘progress’ scenario where we examine the effect on total public 
acute expenditure of addressing important dimensions of the Sláintecare reforms, 
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such as waiting-list management and enhanced community care, which appear 
subject to a renewed commitment in the recent Budget.  
 
The costs modelled in this analysis reflect the ‘fully absorbed’ costs of treatments 
for specific services. This means they reflect all treatment and care costs (e.g. pay, 
drugs, theatre costs) as well as running costs (e.g. heating and lighting) associated 
with the delivery of care, but exclusive of capital and depreciation. This analysis 
does not consider projections of capital expenditure, which would require separate 
detailed treatment. The report also does not consider baseline expenditure 
estimates and projections of expenditure on acute care in private hospitals. We 
expect this to form the basis of a future report on private hospital expenditure 
projections. Relatedly, the analysis does not consider the impact of the proposed 
removal of private activity from public hospitals on projected expenditures 
(Independent Review Group, 2019). This would require a separate detailed 
examination and specification of assumptions which are outside the scope of this 
analysis. Were the proposals to be implemented, however, it is likely that much of 
the projected private activity and expenditure would remain in the public acute 
hospital system, with funding of this activity becoming the responsibility of the 
Exchequer (Independent Review Group, 2019; Keegan et al., 2018b).  
 
The model is automated using SPSS software, with subsidiary analysis undertaken 
in Microsoft Excel. 
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1.6 EXPENDITURE IN IRISH ACUTE HOSPITALS, 2018 
The development of projections required, first, a detailed picture of the 
expenditure on services provided in Irish public acute hospitals and public acute 
adult psychiatric units in 2018. Figure 1.2 outlines the main expenditure categories 
presented in this report. 
 
Overall, HSE gross expenditure on public acute hospitals was €5,907.1m in 2018.6 
An estimated €4,139.9m of this expenditure related to admitted care, consisting of 
€919.5m on day-patient (incl. maternity) discharges and €3,220.5m on in-patient 
discharges. The vast majority of in-patient expenditure related to emergency care 
(€2,143.5m) followed by elective care (€790.9m), maternity care (€252.9m) and 
those admitted to and discharges from AMAU/ASAUs (€33.1m). Across day-patient 
and in-patient services, most expenditure related to treatment of public (as 
opposed to private) discharges. For instance, 84.0 per cent of in-patient emergency 
expenditure was on public discharges, with similar proportions recorded across the 
other categories of admitted care. 
 




Note: ^ This figure relates to HSE Consolidated Financial Intelligence data on end-year 2018 gross expenditure on Acute Hospitals. 
 ~ In HIPE AMAU/ASAU only discharges are categorised as emergency in-patients. In this analysis we considered them 
separately. 
 * This figure is an estimate provided by the HSE to the CSO as part of the System of Health Accounts submission. 
Source:  Authors’ representation. 
  
 
6  This figure relates to HSE Consolidated Financial Intelligence data on end-year 2018 gross expenditure on Acute 
Hospitals. The data were provided through personal communication with HSE Acute Finance. 
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Expenditure on OPD and ED attendances accounted for an additional €676.4m and 
€418.6m, respectively. Total expenditure on day-patient, in-patient, OPD and ED 
captured a combined €5,234.9m of acute expenditure, or 88.6 per cent of recorded 
gross HSE expenditure on acute hospitals in 2018.7 Finally, expenditure on acute 
adult psychiatric in-patient units/hospitals amounted to €179.3m in 2018.8 This 
service is funded separately through the HSE Mental Health Budget.  
 
1.7 STRUCTURE OF THE REPORT 
The remainder of the report is structured as follows: 
− Chapter 2 reviews the international evidence on the drivers of healthcare 
expenditure, reviews how these drivers have previously been modelled in 
similar projection exercises; and compares Irish health and hospital 
expenditure internationally. 
− Chapter 3 describes the macroeconomic and demographic scenarios that feed 
into the hospital expenditure projection scenarios. 
− Chapter 4 presents the Hippocrates modelling methodology, expenditure 
projection scenarios, and data sources. 
− Chapter 5 to 7 present findings for our baseline analysis of expenditures and 
projections. 
o Chapter 5 – Public acute hospital expenditures by service 
o Chapter 6 – Projected aggregate public acute hospital expenditure 
o Chapter 7 – Public acute adult psychiatric in-patient services expenditure 
− Finally, Chapter 8 concludes by summarising and discussing the findings 
presented in the report. 
 
7  It is difficult to fully reconcile the residual amount of €672.2m not captured by our expenditure categories. However, a 
large proportion (€300m) is related to hospital costs incurred in relation to external services (e.g. hospital laboratory 
testing for primary healthcare providers). We also do not capture approximately €100m in activity related to Minor 
Injury Units (MIU) and other non-casemix hospital activity. We do not capture the cost of services outsourced by 
hospitals as the activity and costs are not captured in HIPE or specialty costing. We are also missing some OPD 
expenditure incurred outside the 40 Activity-based Funding (ABF) hospitals. 
8  This figure is an estimate provided by the HSE to the CSO as part of the System of Health Accounts submission. The data 
were provided through personal communication with the HSE National Finance Division. 
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CHAPTER 2 
Background 
Chapter 2 Background 
2.1 INTRODUCTION 
This chapter provides the background and evidence that informs the development 
of the projection modelling framework described in Chapters 3 and 4. A number of 
strands of literature are reviewed and discussed. As outlined in Chapter 1, 
Hippocrates can be classed as a macro-simulation model, a class of component-
based models, which group individuals into cells according to key attributes such 
as age and sex, and project from that basis. The path of projected expenditure is 
then informed by assumptions related to the drivers of healthcare expenditure. In 
this chapter, we review the literature on the demographic and non-demographic 
drivers of healthcare expenditure as well as the methodological approaches 
adopted to include these drivers in component-based projection models. While 
evidence on the drivers of healthcare expenditure tend to be presented at a system 
or aggregate level, where evidence exists on specific determinants of hospital-
based expenditure, it is highlighted. We also discuss evidence on the 
substitutability of care and avoidable hospitalisations. The chapter concludes by 
considering Irish hospital expenditure in an international context, along with the 
relative contribution of volume and cost to reported expenditure.  
 
2.2 REVIEW OF THE LITERATURE ON THE DRIVERS OF HEALTHCARE 
EXPENDITURE 
Figure 2.1 provides a conceptual breakdown of the drivers of healthcare 
expenditure. Traditionally, these drivers have been disaggregated into 
demographic and non-demographic components. Demographic drivers relate 
broadly to the size and structure of the population along with the relationship of 
health to ageing. Non-demographic drivers capture all other determinants of 
healthcare expenditure. They can broadly be classified into income, relative price 
effects, technological advancements and policy measures (Marino et al., 2017).  
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Sources: Adapted from de la Maisonneuve and Martins Oliveira (2015); Marino et al. (2017) 
 
2.2.1 Demographic drivers 
Population size and structure 
The number of people in a given population will affect total expenditure on 
healthcare goods and services through influencing demand. In a similar way, the 
structure of the population may also drive healthcare expenditure. For instance, 
the demand for healthcare is higher in the first years of life, during maternity years 
for women, and at older ages (European Commission, 2015). A growing population 
will influence total healthcare expenditure but not per capita expenditures, while 
an ageing population may increase overall per capita expenditure as older 
individuals tend to use more care.9  
 
Health and ageing 
While older individuals tend to consume more healthcare resources, the 
relationship between population ageing and healthcare use is complex. Efforts to 
understand this relationship have generated several competing hypotheses. On 
the one hand it has been suggested that, as life expectancy increases, individuals 
spend most of those extra years in bad health. This is referred to as the ‘Expansion 
of Morbidity’ hypothesis (Przywara, 2010). This is often characterised as a ‘failure 
of success’ whereby new treatments prolong life as opposed to improving its 
quality. Other authors have argued the opposite: that, as life expectancy increases, 
morbidity is compressed to older ages – the ‘Compression of Morbidity’ hypothesis 
(Fries, 2002). Under this hypothesis, healthier lifestyles result in a decrease in the 
number of years lived in poor health or with a disability. A final hypothesis put 
forward is that increases in life expectancy are largely spent in good health (total 
life expectancy and healthy life expectancy grow at the same rate). This has been 
referred to as the ‘Dynamic Equilibrium’ hypothesis (Przywara, 2010). While 
healthy ageing hypotheses concern how morbidity may evolve with increasing life 
expectancy, other authors suggest that healthcare expenditure is driven largely, or 
 
9  In this context, it is worth noting that Ireland has experienced accelerated improvements in mortality rates in recent 
years compared to other EU-15 countries. Large reductions in mortality have been observed for diseases of the 
circulatory system and respiratory system, especially among older people (Eighan et al., 2020). 
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even solely, by changing mortality rates (Zweifel et al., 1999). This assumes that 
what is important for healthcare expenditure is not ageing but rather proximity to 
death.10,11 Parallels can be drawn between the Dynamic Equilibrium healthy ageing 
assumption that assumes postponement in morbidity to older ages and the 
Proximity to Death hypothesis (Wren et al., 2017). 
 
An abundance of research has taken place on examining how healthy ageing may 
affect healthcare demand and expenditure, much of it at a sectoral level. In Wren 
et al. (2017), a review of this evidence was conducted. As it relates to acute hospital 
care, studies are broadly in agreement that ‘proximity to death’, rather than age, 
is a key driver of acute care demand and expenditure. For instance, evidence from 
Switzerland (Werblow et al., 2007; Zweifel et al., 1999), the United States (Lubitz 
et al., 2003; Yang et al., 2003), the Netherlands (Polder et al., 2006) and England 
(Seshamani and Gray, 2004) finds that proximity to death can be considered the 
main driver of hospital expenditure. Additionally, where age and proximity to 
death are both captured in healthcare expenditure modelling, age becomes an 
insignificant factor (de Meijer et al., 2011). Importantly, other studies have shown 
that, for less severe chronic conditions (suitable for management in primary care), 
age is still a significant predictor of expenditure. However, for severe conditions 
(such as cancer) closeness to death remains the key driver of expenditure (Wong 
et al., 2011). Most recently, Costa-Font and Vilaplana-Prieto (2020) indicate that 
estimates of the effect of ageing on healthcare utilisation are attenuated (for 
hospital admissions, length of stay, home care and nursing home care) or become 
completely insignificant (outpatient care) when alternative explanations of an 
ageing effect, such as proximity to death and the influence of comorbidities, are 
accounted for. 
 
Overall, however, demographic drivers have been shown to account for relatively 
little of historic increases in healthcare expenditure (de la Maisonneuve and 
Martins Oliveira, 2015). The impact of non-demographic drivers is seen as more 
important in explaining per capita expenditure growth (de la Maisonneuve and 
Martins Oliveira, 2015; Xu et al., 2011). These non-demographic drivers are 
discussed in the next section. 
 
 
10  It is important to note that morbidity and mortality are inter-related concepts in that some disease may result in death 
(Colombier and Weber, 2011). In Wren et al. (2017) parallels were drawn between the Dynamic Equilibrium healthy 
ageing hypothesis, which assumes postponement in morbidity to older ages, and the Proximity to Death hypothesis. 
11  For a detailed review of the healthy ageing hypotheses, see Wren et al. (2017). 
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TABLE 2.1 Hypotheses on gains in longevity and health status 
 
Hypothesis Healthy life expectancy Mechanisms assumed 
Expansion of Morbidity 
(Gruenberg, 1977) 
Gains in longevity accompanied by 
additional years with chronic disease 
Incidence of disease unchanged, medical progress 
will successfully improve survival probabilities for 
several chronic diseases requiring life-long 
treatment, hence increasing the prevalence of 
chronic disease. 
Compression of Morbidity 
(Fries, 1980) 
Both disease and disease-free years 
increasing more than gains in longevity 
Healthier lifestyles will decrease and/or postpone 
the incidence of disease until later ages, while there 
is a defined upper limit for life extension, hence 




Gains in longevity accompanied by 
additional years without disability, not 
necessarily without chronic disease 
but disease with less severe progress 
due to new medical treatments. 
Incidence of disease unchanged, medical progress 
will successfully improve survival probabilities while 
reducing the severity of the disease, hence 
increasing the prevalence of chronic disease but 
decreasing disability. 
 
Source: Lindgren (2016). 
 
2.2.2 Non-demographic drivers 
Income 
National income (usually measured in GDP per capita) has been identified as an 
important factor in explaining differences across countries in the level and growth 
of total healthcare expenditure (Xu et al., 2011). Income growth and healthcare 
expenditure tend to be positively related. As incomes rise, individuals tend to 
demand more, better-quality, healthcare-related goods and services 
(Charlesworth and Johnson, 2018).  
 
The relationship of income to healthcare expenditure is generally understood in 
terms of income elasticity of demand (IED). IED measures the percentage change 
in healthcare spending relative to percentage change in income. Empirically, the 
effect of real income growth on healthcare expenditure has been subject to much 
debate, and the precise value of income elasticity remains uncertain (de la 
Maisonneuve and Martins Oliveira, 2015). Early studies tended to report high 
income elasticities of demand, much greater than unity (Martın et al., 2011). For 
instance, the first seminal work in this area by Joseph Newhouse found income 
elasticities of between 1.15 to 1.31 for 13 OECD countries using data from 1970 
(Newhouse, 1977). Income elasticities above (below) one indicate that healthcare 
is a luxury (necessity) good in which demand increases more (less) than 
proportionately as income rises. However, as longitudinal data became available 
and econometric specifications improved, estimates of income elasticity were 
revised downwards (Baltagi et al., 2017; Martın et al., 2011; Xu et al., 2011). For 
instance, Baltagi et al. (2017) find income elasticity for Western European countries 
to be much lower than one, supporting the idea that healthcare is a necessity as 
opposed to a luxury in these countries. Table 2.2 provides additional recent 
estimates of income elasticities for OECD countries from published literature. 
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TABLE 2.2 Recent income elasticity estimates 
 
Study Time span Income elasticity 
Moscone and Tosetti (2010) 1980-2004 0.36-0.90 
Baltagi and Moscone (2010) 1971-2004 0.44-0.89 
Dormont et al. (2010) 1970-2002 0.75-1.59 
Chakroun (2010) 1975-2003 Below 1 
Acemoglu et al. (2013) 1960-2005 0.7 
 
Source: Adapted from supplementary material provided by Baltagi et al. (2017). 
 
Previous research has focused predominantly on the relationship between income 
and aggregate healthcare expenditure; only a handful of studies have examined 
whether IED differs at a service level. Acemoglu et al. (2013), for example, 
exploiting the variation in oil price shocks, found IED of hospital expenditures to be 
less than one. In contrast, Barati and Fariditavana (2018) found that most 
healthcare services in the United States, including hospital services, reported IEDs 
greater than one.12 Dental care was the only service to report an IED less than unity. 
Further evidence from Iran has indicated that in-patient care is a necessity good 
yet reported income elasticities more than twice that of GP visits and specialist 
visits (Zare et al., 2013). 
 
Despite the relationship between healthcare expenditure and income still being 
subject to some uncertainty, the combination of demographic and income effects 
still fails to account for a large part of total growth in public healthcare expenditure 
across countries in the past (de la Maisonneuve and Martins Oliveira, 2015). 
Relative price effects, technological progress and the underlying health policies 
and institutions are considered the more likely candidates to explain this residual 
growth (de la Maisonneuve and Martins Oliveira, 2015). They are considered in 
turn below.  
 
Relative prices 
Relative price effects relate to the fact that prices for healthcare tend to rise at a 
greater rate than non-medical prices. An explanation of this observed trend is 
contained in Baumol’s theory of cost disease (Hartwig, 2008). This theory posits 
that, because healthcare is labour-intensive, productivity in healthcare tends to be 
lower than in other sectors. However, as wages in low-productivity sectors must 
keep up with wages in high-productivity sectors, prices for health services will tend 
to rise faster than other prices (Baltagi and Moscone, 2010). Baumol’s theory can 
be tested in several ways. For instance, one implication of the theory is that 
variation in the relative price of medical care (vis-à-vis other prices in the economy) 
explains variation in healthcare expenditure. However, early studies that used a 
variable capturing the relative price of medical care as an explanatory variable 
 
12  This includes hospital care, nursing care facilities, home health care, residential and personal care, and public health 
activity. 
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determining healthcare expenditure reported mixed results (Hartwig, 2008; 
Marino et al., 2017). Medical care prices may, however, not be a useful measure 
to test the Baumol effect. For example, medical prices may face an upward bias as 
they do not account for quality adjustments (Hartwig, 2011). Based on such 
concerns, Hartwig (2008) proposed an alternative Baumol variable, which 
measures the ratio of wages in healthcare to productivity gains in the general 
economy (Marino et al., 2017). A coefficient of 1 would indicate that productivity 
gains in the general economy cause a directly proportional increase in wages in the 
healthcare sector. Empirically, studies that have used this variable find evidence in 
favour of Baumol’s theory, with an average effect of 0.6 (Marino et al., 2017). This 
suggests that wages in the healthcare sector rise by about 60 per cent of the 
productivity gains captured in the general economy. 
 
Technological progress 
Technology has been considered an important driver of health expenditure since 
the seminal work by Newhouse (Newhouse, 1992). Technological progress may 
affect healthcare expenditure in several ways. For instance, the positive 
relationship between technological change and health expenditure may be 
understood by the adoption of new technologies broadening the range of 
conditions that are treatable, thereby increasing demand. These new technologies 
(for instance, new oncology drugs, MRI scanners) may, at least initially, be 
considered to increase costs of care. Measuring technologies’ impact on healthcare 
expenditure traditionally proved difficult. Often the impact of technology is 
estimated in a residual manner after other drivers of healthcare expenditure have 
been accounted for (Marino et al., 2017). Previously, measures such as medical 
equipment availability and use (Baker and Wheeler, 1998) and healthcare R&D 
spending (Okunad and Murthy, 2002) have been examined. Previous estimates 
suggest that medical technology has had a large positive effect on healthcare 
expenditure, explaining between 27 and 48 per cent of health expenditure growth 
in the US since 1960 (Smith et al., 2009). 
 
Policy 
One limitation of the residual method is that it captures all unexplained non-
demographic drivers of healthcare expenditure, not just technology (although this 
is assumed to be the largest component). Health system characteristics (including 
health financing, provider payment mechanisms and service provision) are also 
considered important candidates to account for unexplained healthcare 
expenditure growth once other factors have been considered. Some evidence 
exists to show that, in OECD countries, the higher the publicly financed share of 
healthcare expenditure, the lower is per capita healthcare expenditure (Gerdtham, 
1992; Gerdtham et al., 1992a; Gerdtham et al., 1992b). Gerdtham et al. (1992a) 
showed that an increase in the fraction of public financing by 10 per cent was 
associated with 5 per cent lower healthcare expenditure. Greater control of 
18|  Pro ject ions  o f  expenditure for  pub l ic  hos pi ta l s  in  I re land ,  2018 –2035  
healthcare providers in publicly financed systems has been advanced as an 
explanation of these results (Przywara, 2010). Other studies, however, have 
contradicted these findings (Bech et al., 2011; Christiansen et al., 2006; Leu, 1986). 
 
A small number of studies have also examined the role of healthcare financing 
mechanisms as a determinant of healthcare expenditure. Overall healthcare 
expenditure has been observed to be higher in systems with social health 
insurance designs as opposed to tax-financed systems. Gerdtham et al. (1998) 
found that countries that used primary care as a gatekeeping function had 
approximately 18 per cent lower healthcare expenditure than those without 
gatekeeping. However, in an analysis by Barros (1998), the existence of 
gatekeeping was not found to explain health expenditure growth over time and 
across OECD countries. Recently, de la Maisonneuve et al. (2017) showed that, 
while differences in public healthcare expenditure across countries can be largely 
explained by demographic and economic factors (around 71%), cross-country 
variation in measures of the impact of policies and institutions explained most of 
the remaining difference. In summary, health system characteristics do seem to 
play a part in determining healthcare expenditure, but traditionally the literature 
has offered potentially conflicting results regarding the relative importance of 
different characteristics. 
 
2.3 MODELLING METHODS FOR HEALTHCARE EXPENDITURE PROJECTION 
The literature identified on healthcare expenditure projection methodologies 
characterises three broad modelling approaches: macro-level, component-based 
and micro-simulation. Classification is based primarily on the level of data 
disaggregation inherent in the approach.13 Macro-level models, most appropriate 
for short-term forecasting, focus on modelling broad aggregates. On the other 
hand, micro-simulation models focus on individuals as the unit of analysis rather 
than focusing on aggregated values (Przywara, 2010). These data-intensive models 
are used primarily to simulate individual behavioural responses to policies yet to 
be implemented (Zucchelli et al., 2012). 
 
Component-based models, in contrast, represent a large variety of models that 
analyse expenditures by various components (e.g. financing agent, goods and 
services, groups or individuals). An important sub-class of component-based 
models is known as macro-simulation or cell-based models. These involve grouping 
individuals into cells according to key attributes, usually age and sex. Typically, they 
focus on expenditure projection, with each age (a) and sex (s) cell associated with 
an average healthcare expenditure (i.e. healthcare expenditure per capita) for 
goods and services in question. At its most basic level, healthcare expenditure is 
 
13  See Wren et al. (2017) for a detailed review of these alternative modelling methods. 
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then projected by multiplying these average expenditures by the projected 
number of individuals included in each cell in each projection year (t) (Astolfi et al., 
2012) (see Figure 2.2).  
 
Macro-simulation models are flexible, are operational in the face of data 
constraints and, importantly from a stakeholder perspective, provide a transparent 
and intuitive approach to modelling future healthcare demand and expenditure 
(Wren et al., 2017). Macro-simulation modelling is thus a popular modelling 
framework, adopted internationally (Astolfi et al., 2012). 
 




Source: Authors’ representation. 
 
2.3.1 Top-down versus bottom-up projection models 
Many component-based projection models tend to be top-down in nature and 
provide aggregate projections on total or public healthcare expenditure (Astolfi et 
al., 2012). As noted by Charlesworth and Johnson (2018), these models tend to 
project on the main drivers of healthcare expenditure described in the literature 
(see Section 2.2): demographic factors, income effects, and other cost pressures. 
Large econometric analyses often provide parameter estimates for many of these 
drivers which are subsequently incorporated into projections. There are several 
examples of top-down projection model exercises. For instance, the European 
Commission’s biennial EU Ageing Reports model inter alia healthcare expenditure 
projections for each member state (and Norway) using (mostly) country specific 
aggregate age cost profiles (European Commission, 2009a; 2012a; 2015; 2017). 
Colombier and Weber (2011) employ top-down macro-simulation modelling to 
examine the importance of ageing as a driver of future healthcare expenditure 
using Swiss data. Top-down macro-simulation models have also been recently 
employed to examine potential trends in future healthcare expenditure for Spain 
(Blanco-Moreno et al., 2013) and the United Kingdom (Licchetta Mirko and Michal 
Stelmach, 2016).  
 
An alternative approach is to model projected healthcare expenditure from the 
‘bottom up’. Bottom-up models consider many of the same drivers of health 
spending but do so based on detailed information on the components of 
expenditure, demand and cost, for various services and their usage by different 
types of people (Charlesworth and Johnson, 2018). These types of models are less 
common than top-down models, given the greater associated data burden. 
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of applications. Bottom-up models capture differing patterns of demand and 
component cost requirements of service provision that exist across sectors. This 
modelling helps highlight not only areas where expenditure pressures are 
projected to be particularly strong, but also the relative contribution of demand 
and cost in explaining projected expenditure pressures.  
 
Two notable examples of bottom-up healthcare projection modelling are Wanless 
(2002) and Charlesworth and Johnson (2018). Wanless (2002) provided an early 
example of bottom-up sectoral modelling in his review of the long-term trends 
affecting health services in the UK as far as 2022–2023. Most data were 
disaggregated by five-year age groups (births, 0-4, …, 95+) and sex, with activity 
and cost assumptions modelled separately. The review provided a breakdown by 
several activity types, such as in-patient admissions, GP visits, screening, health 
promotion and stays in residential homes. Total health spending was projected to 
increase from 7.7 per cent (2002–2003) to between 10.6 and 12.5 per cent of GDP 
(2022–2023), depending on the modelling scenario. 
 
Updating the Wanless (2002) analysis in 2018, Charlesworth and Johnson (2018) 
reported projections of UK healthcare expenditure to 2033/2034. Similarly to 
Wanless (2002), the report approached projections from a bottom-up perspective, 
modelling demand and cost components separately for a range of UK healthcare 
services. Under the scenarios modelled, UK healthcare expenditure was projected 
to increase as a share of GDP from 7.3 per cent in 2018–19 to 8.9 per cent or 9.9 
per cent in 2033–34. 
 
In an Irish context, the Irish Fiscal Advisory Council has also adopted bottom-up 
methods to health spending projections as part of wider analyses of the 
expenditure pressures facing the public sector over both the short (Irish Fiscal 
Advisory Council, 2018) and longer term (Irish Fiscal Advisory Council, 2020). 
Demand for services changes in line with demographics and income while 
adjustments to prices capture changes in the cost of delivering public services (Irish 
Fiscal Advisory Council, 2020). Under current policies, the Council projects that 
public health spending would rise from 8.3 per cent to 13 per cent of GNI* by 2050. 
Full implementation of Sláintecare would be expected to add 1.1 percentage points 
of GNI* to government spending by 2030, rising, against the background of 
increased cost pressures, to 1.2 percentage points by 2050.14 
 
 
14  Modified GNI (GNI*) is an indicator designed to exclude globalisation effects that disproportionally affect the 
measurement of the size of the Irish economy. GNI is adjusted for ‘retained earnings of firms that have re-domiciled to 
Ireland; the depreciation of foreign-owned intellectual property assets located in Ireland; and the depreciation of 
aircraft owned by aircraft-leasing companies’ (Department of Finance, 2018). 
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2.3.2 Modelling the drivers of healthcare expenditure 
For the most straightforward projections, expenditure profiles can be kept 
constant through the entire projection horizon, implying that all change in 
healthcare expenditure over the projection period is driven solely by changes in 
the size and structure of the population. However, this may represent a somewhat 
unrealistic assumption given that many factors, both demographic and non-
demographic, can influence the projected path of future healthcare expenditure 
(see Section 2.2). This section reviews approaches adopted to incorporate drivers 
of healthcare expenditure, highlighting variations between top-down and bottom-
up approaches where relevant. 
 
Demographic drivers 
Given that uncertainty may exist in terms of the future path of population growth 
and ageing, a standard adjustment to component-based modelling is to examine 
alternative assumptions relating to demographic change (European Commission, 
2011; 2014; 2017). Failure, however, to incorporate effects of improved health 
status as populations age could lead to systematic over-estimation of future 
healthcare demand and expenditure requirements. Therefore, many projection 
models incorporate assumptions related to healthy ageing through the projection 
horizon. A common approach to incorporating healthy ageing effects is that used 
by the European Commission (European Commission, 2008; 2011; 2014; 2017). In 
simple terms, this involves adjusting baseline age and sex-specific per capita 
healthcare expenditure profiles in relation to changes in life expectancy between 
the base year and the projection year. This is under the assumption that per capita 
expenditure profiles act as a proxy for age-related morbidity profiles. The strength 
of the shift specified will determine the healthy ageing hypothesis modelled. This 
healthy ageing approach was also adopted in previous Hippocrates projections 
(Keegan et al., 2018a; Wren et al., 2017)15 and is incorporated in the projection 
analysis in this report (see Chapter 4). 
 
The effects of health and ageing can also be analysed through incorporating death-
related costs into projections. Death-related cost adjustments reflect the fact that 
a large share of total healthcare expenditure is concentrated in the final years of 
an individual’s life (i.e. ‘proximity to death’ effect). In a projection context, as 
mortality rates at relatively younger ages decline and a smaller share of each age 
cohort is in its terminal phase of life, constant expenditure profiles may therefore 
overestimate projections of healthcare expenditure (European Commission, 2015). 
 
Death-related costs are incorporated into macro-simulation projections through 
splitting the population, by age and sex, into survivor and decedent sub-groups in 
the base year. This split is achieved using age and sex-specific mortality rates (i.e. 
 
15  In Wren et al. (2017) and Keegan et al. (2018a), these shifts were applied to demand rather than expenditure profiles.  
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the probability of dying). Each sub-group is then assigned a different expenditure 
profile; that being an adjustment to the ‘normal’ expenditure profile by the ratio 
to which decedent costs differ from survivor costs. Death-related cost projections 
will therefore differ from non-death-related cost projections as age and sex-
specific mortality rates change through the projection horizon (Colombier and 
Weber, 2011; European Commission, 2014).16  
 
It is important to note that the ability to incorporate death-related costs effects 
into projection modelling is heavily influenced by data availability. For instance, the 
European Commission was able to analyse death-related cost projections for only 
a subset of countries that were able to return requisite information on death-
related costs by age (European Commission, 2015; 2018). Similarly, Blanco-Moreno 
et al. (2013), due to the lack of information on decedent and survivor cost profiles, 
estimated death-related costs through incorporating information available on 
palliative care costs. In this current report, data limitations mean it is not possible 
to explicitly incorporate the impact of death-related costs in the analysis. 
 
Non-demographic drivers 
Adjustments to capture the effect of non-demographic drivers of expenditure in 
top-down projection models often involve shifts to expenditure curves to variously 
model the impact of relative prices, income elasticity effects, and technology and 
other residual drivers of expenditure. In many cases, a convergence factor is also 
applied so that the effect of these drivers dissipates as the projection horizon 
approaches. While bottom-up models incorporate many of the same non-




A standard approach in top-down projection exercises is to increase healthcare 
expenditure in line with projected changes to real GDP per capita. For instance, the 
Office for Budget Responsibility in the UK applies an elasticity of 1, which assumes 
that increases in income are accompanied by the same proportionate increase in 
healthcare expenditure (Licchetta Mirko and Stelmach Michal, 2018). In contrast, 
in its last Ageing Report, the European Commission applied an IED of 1.1 in 2016, 
initially assuming healthcare to be a luxury good, but converging towards 1 by 2070 
(European Commission, 2017). Other studies have also applied an IED of 1.1 
(Blanco-Moreno et al., 2013; Colombier and Weber, 2011). Based on the review of 
evidence on income elasticities in OECD countries (see Table 2.2), it may be more 
 
16  Further refinements to this assumption can then take place through changing the age-specific ratio of survivor-to-
decedent expenditures through the projection horizon (known as the k-ratio) (European Commission, 2014). The 
European Commission outlines an approach to link changes in the k-ratio to changes in life expectancy (European 
Commission, 2014; 2017). 
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reasonable to assume an IED less than 1 when modelling healthcare expenditure 
projections. This is the approach adopted by the OECD in recent analyses, primarily 
modelling IED between 0.7 and 0.85 (de la Maisonneuve and Martins Oliveira, 
2015; Lorenzoni et al., 2019). 
 
Bottom-up sectoral healthcare projection models tend not to explicitly model 
income elasticity parameters. This may in part be due to the fact that, at a health 
service level, less empirical evidence exists on the relationship between healthcare 
demand and income, and the evidence that does exist lacks consistency (see 
Section 2.2). Moreover, bottom-up models may inherently account for the impact 
of income on healthcare expenditure in other ways, and to explicitly model IED 
would be to double-count income as a driver of healthcare expenditure. For 
instance, Charlesworth and Johnson (2018) characterise the IED as the underlying 
factor that leads to rising expectations for quality and range of care provided under 
their ‘modernised’ projection scenario. This includes, for example, modelling an 
increase in the numbers of people with a mental health condition who receive NHS 
care and increasing emergency and elective care provision to meet targets and 
reduce backlogs (Charlesworth and Johnson, 2018). 
 
Relative prices 
As described in Section 2.2.2, a theoretical and empirical explanation for rising 
healthcare prices relates to wages in the healthcare sector being tied to 
productivity improvements in the wider economy (i.e. Baumol’s cost disease). 
Reflecting this idea, the European Commission Ageing Reports examine the impact 
on healthcare expenditure of unit costs evolving in line with changes in labour 
productivity (i.e. GDP per hours worked) (European Commission, 2011; 2014; 
2017). Colombier and Weber (2011) and de la Maisonneuve and Martins Oliveira 
(2015) assume that per capita long-term care expenditures rise in line with 
productivity increases in the wider economy (but do not apply these assumptions 
to projections of per capita healthcare expenditure). Recently, Lorenzoni et al. 
(2019), based on panel regression methods, estimated a differential in productivity 
growth between the total economy and the health sector, and used this as a basis 
for incorporating a Baumol effect into health spending projections to 2030 for all 
OECD member countries. 
 
An advantage of bottom-up projection models is that the unit costs of care can be 
modelled directly, including offsetting adjustments for healthcare-specific 
productivity improvements. For instance, Wanless (2002) models increases in 
hospital and community health services’ pay of 4.9 per cent a year in nominal terms 
through the projection horizon. While this pay growth assumption is common 
across all scenarios, offsetting assumed productivity improvements are varied 
between 0.75 and 3 per cent per year. Charlesworth and Johnson (2018) adopt a 
similar approach. Under their ‘status quo’ scenario, real annual wages grow by 
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between 1.7 and 1.9 per cent per annum between 2018 and 2033/34, with 
productivity growth of 0.8 per year assumed, matching historical long-run 
healthcare productivity growth. Under their more optimistic ‘modernised’ 
scenario, wage growth of between 1.9 to 3.0 per cent per year over the period is 
offset with higher assumed productivity growth of between 0.8 and 1.4 per cent 
per year over the period. Comparable methods have also been adopted in bottom-
up modelling of long-term care and dementia (Wittenberg et al., 2018; Wittenberg 
et al., 2020). These analyses assume that the unit costs of care, such as the cost of 
an hour’s home care, rise in line with assumptions for rises in average earnings. 
Specific to Ireland, the Fiscal Council has recently modelled public pay growth to 
rise in line with economy-wide wage growth (between 2.0 and 2.7 per cent per 
annum to 2050) under long-term projections of public finances (including 
healthcare) (Irish Fiscal Advisory Council, 2020). 
 
Modelling other non-demographic drivers 
Residual estimation 
Directly measuring the effect of important non-demographic drivers on healthcare 
can be challenging given that it is often difficult to find reliable proxies to measure 
their impact. In this context, many top-down macro-simulation projection 
exercises estimate a residual coefficient (measured by a time trend) to capture the 
effect of these non-demographic factors and project expenditures based on this 
estimated value (Marino et al., 2017).  
 
For instance, the European Commission examines a ‘non-demographic 
determinants’ scenario whereby the residual approach is adopted to identify the 
aggregate impact of non-demographic factors (including income) on healthcare 
determinants. Country-specific non-demographic cost estimates are defined as the 
excess growth in real per capita healthcare expenditure over the growth in real per 
capita GDP, after controlling for demographic factors. Results are expressed in 
terms of an elasticity, with the weighted median of country-specific estimates (1.4) 
applied to projections in the base year, converging toward 1 by 2070 (European 
Commission, 2017). 
 
However, where income effects are specifically controlled for, much of this 
unexplained residual is assumed to capture the impact of technology. Dybczak and 
Przywara (2010) adopt this residual approach through regressing healthcare 
expenditure on both demography and income and allowing the coefficient on a 
time trend to correspond to the impact of technology and other unexplained non-
demographic factors. Their findings suggest that these factors increase healthcare 
expenditure by an additional 2 percentage points per year on average across 
countries. This estimate is then used as a basis to project forward the impact of 
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technology to 2060 (with the impact of technology linearly converging to zero by 
2060).  
 
A criticism of the residual approach associated with top-down macro-simulation 
projection exercises is that residual estimation for technology, as noted by Marino 
et al. (2017), also takes other effects into account, and thus it has been traditionally 
difficult to provide plausible estimates for the impact of policies and institutions 
which have been identified as a potential important driver of healthcare 
expenditure (see Section 2.2.2). With that in mind, de la Maisonneuve and Martins 
Oliveira (2015) separate out the impact of technology (through a proxy approach) 
and attempt to better quantify the effect that policies and institutions may have 
on healthcare expenditure growth. The authors estimate that 0.8 percentage 
points of residual growth can be explained by the combined impact of relative 
prices and a technology effect (proxied by the relative pace of patent creation in 
the health sector relative to the rest of the economy on average in OECD 
countries). An additional 0.9 percentage points of growth is captured through a 
time trend coefficient which the authors attribute to the impact of changes in 
policies and institutions. The authors then project healthcare expenditure to 2060 
using a combined expenditure growth effect of 1.7 per cent per year (0.8% + 0.9%).  
 
Additional approaches 
As noted, most projection models that incorporate technology as a residual are 
top-down in nature. As a bottom-up sectoral analysis, however, Charlesworth and 
Johnson (2018) adopt a more focused approach to modelling the effect of 
technology. Specifically, technology’s impact on healthcare expenditure is 
measured through a 5.5 per cent real-terms annual increase in hospital drug unit 
costs. This is based on trends in total costs of hospital drug prescribing, removing 
activity growth. The large increase in hospital drug costs is assumed to capture the 
impact of hospitals as the setting for the introduction of newer, more innovative 
technologies (Charlesworth and Johnson, 2018). In an Irish context, a similar 
approach has recently been adopted by the Fiscal Council as part of its long-term 
projections of healthcare spending (among other public services). Under its 
projection approach, prices for medicines and medical devices (included as part of 
non-pay health expenditure) are assumed to rise faster than household consumer 
goods (although the size of this effect is not reported) (Irish Fiscal Advisory Council, 
2020). 
 
Within a health system, a wide range of services can be provided to a population; 
an additional benefit of bottom-up sectoral modelling is that this framework allows 
for greater flexibility in testing scenarios around changing patterns of service 
provision. For instance, Wanless (2002) under his most optimistic scenario, models 
a 2 per cent switch of activity from GPs to pharmacists along with a reduction in 
outpatient (OPD) attendances among 450,000 people using self-care. Additional 
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reductions in demand for hospital and GP services are also modelled to simulate 
changes in health promotion and health behaviour. Charlesworth and Johnson 
(2018) apply their bottom-up model to examine the impact of improved health 
system standards on projected expenditure. As noted previously, this includes 
modelling an increase in mental health treatment prevalence and increasing 
emergency and elective care provision to meet targets and reduce backlogs. For 
instance, following an approach developed by Findlay (2017), planned in-patient 
activity is increased over and above the growth requirements attributable to 
changing population and chronic conditions, to avoid increased waiting times for 
care. Wren et al. (2017) also estimated service-specific measures of unmet need or 
demand across the Irish healthcare system and incorporated them into demand 
projections. This report will refine that approach, in line with the Findlay (2017) 
methodology, to estimate projected costs of removing backlogs, and maintaining 
waiting times for OPD and admitted elective care at manageable levels. 
 
2.4 SUBSTITUTABILITY OF CARE AND AVOIDABLE HOSPITALISATIONS 
As described in Section 2.3.2, a benefit of bottom-up sectoral modelling is that it 
allows greater flexibility for testing scenarios around changing patterns of care 
provision relative to more aggregate approaches. In this regard, a key 
recommendation of Sláintecare (see Chapter 1) is to strengthen the primary care 
system and shift appropriate care away from the acute system. While it can be 
difficult to quantify the impact of this substitution towards the primary care 
system, the change in rate of hospitalisation for conditions where the need for 
secondary care is reduced, by timely and appropriate ambulatory or primary care, 
is regularly employed in the literature to evaluate interventions aimed at improving 
primary care accessibility and quality (Gibson et al., 2013; Rosano et al., 2013; van 
Loenen et al., 2014). These conditions are collectively referred to as ambulatory 
care-sensitive conditions (ACSC) or avoidable hospitalisations. This section reviews 
the evidence in relation to primary care strength and avoidable hospital admissions 
as a basis for modelling in Chapter 4 the potential effect of a better-resourced 
primary care system of acute care spending. 
 
Avoidable hospitalisations are those that, through appropriate preventative health 
interventions as well as early and ongoing disease management, might have been 
prevented (Australian Commission on Safety and Quality in Healthcare, 2017). This 
description notes a key distinction between hospitalisations deemed to be 
‘necessary’ and those designated as ‘unnecessary’. They differ in that avoidable 
hospitalisations incorporate those that could have been treated more 
appropriately in a primary setting (e.g. hypertension) and thus could be classified 
as ‘unnecessary’, in addition to conditions which could have been prevented by 
timely access to primary care but which are ‘necessary’ once the condition has 
progressed (e.g. influenza) (Nolan, 2011). 
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Understanding how primary care design may affect rates of avoidable 
hospitalisation is not straightforward. The research in this area is mainly 
observational in nature, and this relationship is subject to multiple potentially 
confounding factors. Indeed, it has been argued that sociodemographic and health 
characteristics rather than primary care are, in fact, the major drivers of avoidable 
hospitalisation (Falster et al., 2015). That said, several systematic reviews have 
identified an association between primary care design and rates of avoidable 
hospitalisation. For example Rosano et al. (2013) concluded that a majority of 
studies examined reported the expected inverse relationship between avoidable 
hospitalisations and accessibility (measured in terms of physician supply) to 
primary care. Another review, conducted by van Loenen et al. (2014), confirmed 
sufficient primary-care physician supply to be associated with lower risks of 
avoidable hospitalisations across countries, disease and study populations. In 
addition, continuity of relationships between patients and GPs also resulted in 
fewer hospital admissions. However, evidence on the positive effects of other 
organisational aspects to primary care delivery, such as specific disease 
management programmes, is still lacking. 
 
Some Irish-specific evidence also exists regarding the relationship of primary care 
access and rates of avoidable hospitalisation. Nolan (2011), applying quasi-
experimental difference-in-difference analysis, examined the impact of the 
extension of free GP care to those aged 70 and over in 2001 on rates of avoidable 
hospitalisations. Relative to a comparator group (those under 70), no significant 
effect on avoidable hospitalisations was identified.  One explanation offered is that 
other ‘non-financial’ barriers (such as personal mobility, transport and 
information) may be more important barriers to access for older populations. 
 
Sexton and Bedford (2016), considering HIPE discharges related to only chronic 
obstructive pulmonary disease (COPD) and diabetes complications, examined the 
effect of primary care provision (proxied using GP supply) as well as deprivation on 
county-specific age-standardised rates of adult emergency in-patient discharges in 
2011. They reported a national rate of 337.5 per 100,000 for COPD discharges and 
108.1 per 100,000 in relation to diabetes complications. Significant differences in 
rates were observed across counties. The authors also report a negative 
correlation between the rate of discharges for both conditions and the level of GP 
supply. As a practical example, the authors estimate that, if Ireland had a national 
discharge rate for COPD and diabetes similar to Galway (which at the time had 
levels of deprivation and medical-card coverage consistent with national averages, 
but relatively high levels of GP supply) this would translate into approximately 
1,500 fewer COPD discharges and 780 fewer discharges related to diabetes 
complications annually. The authors support the view that improvements in 
primary care resourcing have the potential to reduce avoidable hospitalisation 
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rates but caution that the complex system of entitlements particular to Ireland may 
mediate the effect in unforeseen ways. 
 
Recently, McDarby and Smyth (2019) identified three main conditions accounting 
for a large proportion of potentially avoidable public acute hospital utilisation in 
2016. Just over half of all recorded avoidable hospitalisations related to respiratory 
conditions: vaccine-preventable influenza and pneumonia, and COPD. Vaccine-
preventable Influenza and pneumonia accounted for 39.0 per cent of bed days, and 
COPD for 14.5 per cent of bed days, associated with avoidable hospitalisations, 
respectively. The third most frequently diagnosed condition, pyelonephritis, 
represented 13.8 per cent of bed days associated with avoidable hospitalisation. 
Rates for these conditions were concentrated in older ages. The authors 
recommend prioritisation in primary care investment related to integrated care 
programmes for respiratory avoidable hospitalisations, while there was also 
evidence to support targeting community-based pulmonary rehabilitation, 
including pneumococcal and influenza vaccination programmes, in order to reduce 
the burden of infection and hospitalisations. 
 
2.5 INTERNATIONAL COMPARISON OF ACUTE CARE EXPENDITURE 
The Irish healthcare system is predominantly government-financed (74%), with 
out-of-pocket (OOP) payments contributing 12 per cent to overall financing and 
private health insurance (PHI) contributing 14 per cent in 2018 (Central Statistics 
Office, 2020a). Total public and private current Irish healthcare expenditure was 
€22.5 billion in 2018 (Central Statistics Office, 2020a). The public acute hospital 
sector in Ireland receives the largest component of public healthcare funding, 
accounting for 34 per cent of non-capital HSE expenditure in 2019 (Department of 
Health, 2019a). Analysis of profound pressures on healthcare delivery from recent 
and projected rapid population growth and ageing informed new targets for 
expanded public hospital capacity in the 2018 National Development Plan 
(Government of Ireland, 2018a; PA Consulting, 2018; Wren et al., 2017). 
 
Ranking Irish hospital care expenditure for international comparative purposes has 
been found to be challenging for a number of reasons (Wren and Fitzpatrick, 2020). 
The typical measure used for such comparisons is healthcare as a percentage of 
GDP, but GDP is an over-stated measure of national income in Ireland due to the 
accounting methods of the large multinational sector (Fitzgerald, 2018). Thus, 
Wren and Fitzpatrick (2020) substituted GNI* for GDP in cross-country 
comparisons of public hospital expenditure as a percentage of national income.17 
While healthcare expenditure as a share of national income is a commonly used 
 
17  The GNI* measure was substituted for GDP as the preferred measure of national income for Ireland because GDP 
overstates income remaining with Irish residents due to the effects of multinational activity and globalisation on Irish 
national accounting measures. 
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metric in international comparisons, it includes both price and volume components 
and does not adjust for population size. Wren and Fitzpatrick (2020) therefore 
further examined healthcare expenditure per capita, adjusted for purchasing 
power parity, which is designed as a measure of the volume of healthcare services 
supplied. This change in measure has a substantial effect on the ranking of Irish 
healthcare expenditure (HCE). Irish public HCE as a share of national income, for 
instance, ranked 5th in the EU15 in 2017, whereas Irish public healthcare per capita 
with adjustment for relative prices ranked 9th (Wren and Fitzpatrick, 2020). 
 
A further challenge in comparing hospital care expenditures across countries is that 
definitions and categories of hospital expenditure in OECD Health Statistics, the 
data source for these comparisons, do not align exactly with the definitions 
traditionally used for public hospital programme spending in Ireland. OECD data 
for hospital care are accounted for under the functional categories of Curative and 
Rehabilitative (C&R) Care. In the Irish data returned to the OECD, these two 
functional categories are not accounted for separately. Aggregate C&R 
expenditure does not equate to hospital expenditure, including for instance some 
expenditure on services that are home-based, some provided in residential long-
term care settings, and some provided in the community by primary care 
providers. Thus, it is necessary to analyse OECD data at a quite disaggregated level 
in order to reach an accounting category that equates to expenditure on hospital 
services. At this disaggregated level, however, there is the further limitation that 
hospital expenditure is not separately reported for publicly and privately financed 
services (Wren and Fitzpatrick, 2020). In OECD data, public and private definitions 
refer to the source of financing, whether government (public) or private health 
insurance or out-of-pocket (private). The OECD does not categorise expenditure by 
provider ownership, whereas this report focuses on the provider category of public 
and voluntary hospital services, whether financed by government or privately by 
PHI or OOP. 
 
In relation to hospital care, Wren and Fitzpatrick (2020) found that Irish public 
inpatient C&R expenditure per capita with adjustment for relative prices ranked 
12th in the EU15 in 2017, while private inpatient C&R expenditure per capita ranked 
1st. However, this was not purely a comparison of public expenditure on hospital 
in-patient services since over one-tenth of Irish inpatient C&R expenditure funds 
services provided in residential long-term care settings. When Irish HCE per capita 
on inpatient C&R provided by hospitals is compared, combining publicly and 
privately financed services, Irish expenditure ranked 7th in the EU15 and was 3 per 
cent below the EU15 mean. In contrast, Irish day C&R expenditure on services 
provided by hospitals ranked 1st in the EU15. 
  
30|  Pro ject ions  o f  expenditure for  pub l ic  hos pi ta l s  in  I re land ,  2018 –2035  
Building on the analysis by Wren and Fitzpatrick (2020), in Figure 2.3, we examine 
Irish public inpatient C&R expenditure as a share of national income, which we find 
to rank 10th in the EU15. This compares to the Wren and Fitzpatrick (2020) finding 
that Irish public in-patient C&R expenditure per capita, with adjustment for relative 
prices, ranks 12th in the EU15 (Figure 2.3). Relatively high prices in Ireland inflate 
in-patient expenditure as a share of national income and, when this relative price 
effect is removed, the volume of inpatient C&R services supplied ranks relatively 
lower. 
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2.6 SUMMARY 
This chapter has reviewed and discussed the background and the evidence that 
informs the approach taken to applying the Hippocrates Model to project 
healthcare expenditure in this report. Hippocrates has been developed as a macro-
simulation model. As described in this chapter, macro-simulation models or cell-
based models represent a large and important class of component-based models. 
These models are flexible, are operational in the face of data constraints and, 
importantly from a stakeholder perspective, provide a transparent and intuitive 
approach to healthcare projection modelling. While many component-based 
models are top-down in nature, Hippocrates has been developed from a bottom-
up service-level perspective, modelling demand and cost separately. Bottom-up 
models tend to be less common, given greater data requirements, yet allow for a 
wider range of applications. While top-down and bottom-up projection models 
account for many of the same drivers of healthcare expenditure, the approach to 
incorporating these drivers can differ. As described, demographic and non-
demographic factors both contribute to healthcare expenditure growth over time, 
but, as later chapters will also demonstrate, non-demographic factors tend to 
dominate. As reviewed in this chapter, Ireland’s apparent high healthcare 
expenditure internationally appears to be driven by high prices for healthcare 
delivery in Ireland, particularly salaries, and be influenced by Ireland’s status as a 
high-wage, high-cost economy. 
 
The next chapter describes the generation of key demographic and non-
demographic (macroeconomic) projection scenarios that feed into Hippocrates. 
Chapter 4 then provides detail on the Hippocrates projection methodology, the 
scenarios underlying the expenditure projections, and an overview of data sources. 
 
32|  Pro ject ions  o f  expenditure for  pub l ic  hos pi ta ls  in  I re land,  2018 –2035  
CHAPTER 3 
Macroeconomic and demographic scenarios 
Chapter 3 Macroeconomic and demographic scenarios 
3.1 INTRODUCTION 
This chapter details the macroeconomic and demographic projection scenarios 
developed and applied in this report, which form the basis for understanding 
projected expenditure trends in Chapters 5 to 7. Relative to Wren et al. (2017), the 
demographic projections have been updated and revised in light of the potential 
impact of Covid-19, while two alternative Covid-19 economic recovery scenarios 
form the basis of the macroeconomic projections. We discuss, in turn, the 
assumptions used to develop the macroeconomic and demographic scenarios 
applied in this report. These projections, developed through the ESRI’s COSMO and 
demographic projection models, are later grouped into expenditure scenarios in 
Chapter 4. The macroeconomic scenarios provide a basis for modelling the non-
demographic drivers (e.g. pay) of healthcare expenditure, while the demographic 
scenarios provide a basis for modelling the demographic drivers (e.g. population 
size and ageing), as discussed in Chapter 2. 
 
3.2 MACROECONOMIC PROJECTION SCENARIOS 
This section describes macroeconomic projections from 2018 to 2035 that are used 
in this report to develop healthcare expenditure projections. Future economic 
growth, demographic change and population ageing have important implications 
for healthcare spending and the long-run sustainability of the public finances. The 
projections are generated using the ESRI’s macro-econometric model COSMO 
(COre Structural MOdel of the Irish Economy). Owing to the uncertainty about the 
duration of the economic impact of Covid-19, the economic outlook is highly 
uncertain. As a result, we consider two alternative macroeconomic scenarios 
termed Recovery and Delayed Recovery. Our approach is to simulate the economic 
shock(s) associated with Covid-19 and to model two potential recovery paths for 
the economy. This section briefly outlines the current macroeconomic context, and 
describes the methodology and assumptions underpinning the two scenarios. 
Finally, the scenarios are presented, where an emphasis is placed on the key 
macroeconomic aggregates that are subsequently used as inputs into the 
Hippocrates Model for projecting expenditure. 
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3.2.1 Macroeconomic context 
There is broad consensus that the Irish economy has the capacity to grow at around 
3–3.5 per cent per annum (in real terms) over the medium to long term.18 This, 
referred to as the potential growth rate of the economy, reflects the level of 
growth that is sustainable (without causing inflationary pressures) over the longer 
term. 
 
However, the Covid-19 pandemic has triggered a global and domestic economic 
shock. While the pandemic is a public health shock that is having adverse economic 
impacts, it is not a traditional economic shock. As a result, the path of the economy 
is highly uncertain, especially over the short term. It depends on factors that are 
not easily predictable such as the stringency and duration of existing and new 
public health containment measures, the success of these measures in controlling 
the virus, the effectiveness of treatments and vaccines, and the behavioural 
response of consumers and firms as more normal activity resumes. The severity of 
containment measures has been unprecedented owing to the highly contagious 
nature of the virus, and means that much of the literature on the economic impact 
of pandemics may only provide lower-end estimates. Furthermore, relative to 
other European countries, Ireland had one of the most severe and longest periods 
of lockdown, as measured by the newly developed Oxford Stringency Index (Hale 
et al., 2020).19 At the same time, there has been an unprecedented level of 
government intervention in terms of transfers and income supports, extra 
spending in health and other business and household support programmes. This 
will help dampen the negative economic effects of the public health crisis but will 
also have direct negative implications for the public finances. 
 
The strictest restrictions were in place in Ireland in the second quarter of 2020. 
Many sectors were effectively either closed or activity was severely limited before 
restrictions were eased in June and July. The macroeconomic effects of the virus 
are arguably most noticeable in terms of the labour-market impacts. Figure 3.1 
shows the monthly unemployment rate and the Covid-19 adjusted unemployment 
rate (Pandemic Unemployment Payment recipients are classified as 
unemployed).20 The graph shows that, prior to the pandemic, the unemployment 
rate was around 5 per cent, a rate consistent with full employment (a level of 
employment such that there is no cyclical unemployment). The rate rose sharply 
in March and peaked in April at just over 30 per cent, while it has been falling since 
then as the economy gradually opened up and stood at 14.7 per cent in September. 
 
 
18  See, for example, Bergin et al. (2016) and Department of Finance (2019). 
19  See O'Toole (2020) for a comparison in this index across countries over time. 
20  In addition, over 300,000 workers are being financially supported by the Employment Wage Subsidy Scheme. These 
workers are not classified as unemployed. The scheme is currently scheduled to run until spring 2021. Some of these 
workers may become unemployed. 
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FIGURE 3.1 Monthly unemployment rate, 2005 M01–2020 M07 
 
 
Notes: The unemployment rates are expressed as a percentage of the labour force aged 15–74. 
The Covid-19 adjusted monthly unemployment rate is based on the share of the labour force that were not working due to 
unemployment or were out of work due to Covid-19 and receiving the Pandemic Unemployment Payment (PUP). If all PUP 
recipients were classified as unemployed, the adjusted measure provides an upper bound of the monthly unemployment rate. 
Source: CSO, Monthly Unemployment, available at: 
https://www.cso.ie/en/releasesandpublications/er/mue/monthlyunemploymentseptember2020/ 
 
Most domestic and international analysis, up to roughly the end of August 2020, 
had expected the containment measures to severely affect growth in the short 
term. For example, looking across the short-term projections of the ESRI (May), the 
Central Bank (July) and the Department of Finance (April), real GDP was expected 
to fall in the region of 9 to 20 per cent in 2020. However, recent data reveal that, 
while the economy has suffered a massive domestic shock affecting key aggregates 
such as consumption, significant parts of the traded or export sector have been 
relatively much less affected. As a result, the most recent short-term projections 
are much more benign, and, while real GDP is expected to fall in 2020, the extent 
of the fall is much less than what had been anticipated. In October, the ESRI, 
Central Bank and Department of Finance (Central Bank of Ireland, 2020; 
Department of Finance, 2020; McQuinn et al., 2020) each published new short-
term projections, which show that the fall in GDP is now expected to be in the 
range of 0.4 to 2.5 per cent in 2020. Figure 3.2 shows the change in sectoral GDP 
in the first six months of 2020 relative to the same period last year. What is striking 
from the graph is the uneven performance across sectors, with export-orientated 
sectors such as Manufacturing, Information & Communications and Financial & 
Insurance activities all reporting positive growth over the period, while non-traded 
sectors which are more reliant on domestic demand, and which experienced the 
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FIGURE 3.2 Sectoral GDP: percentage change in 2020 Q1&Q2 relative to 2019 Q1&Q2 
 
 
Notes:  The data are shown by NACE Rev 2 A10 sectors as is the convention in National Accounts. 
The data are in constant basic prices. Overall real GDP growth was 0.3% in the first six months of 2020 compared to the 
same period in 2019. 
Source: CSO Quarterly National Accounts Quarter 2 2020. 
Available at: https://www.cso.ie/en/releasesandpublications/er/na/quarterlynationalaccountsquarter22020/ 
 
Previous research has shown that the export orientation of the Irish economy and 
the sectoral structure of Irish exports, in particular the concentration in pharma-
chem and medical devices, helped to dampen the worst effects of the financial 
crisis and was a significant contributor to the recovery (see, for example, (Barry 
and Bergin, 2019; McQuinn and Varthalitis, 2018)). It appears that these features 
are also playing a key role in alleviating the most negative effects of the Covid-19 
pandemic at a macroeconomic level (O'Toole, 2020). The outlook for 2021 and 
beyond remains uncertain. The timing and speed of any recovery is difficult to 
evaluate because of the extraordinary nature of the shock and the various 
unknown factors mentioned earlier. 
 
3.2.2 Methodology and assumptions 
The macroeconomic scenarios presented in the report are developed using our 
macroeconometric model COSMO. This section provides a brief description of the 
key features of the model, and describes the two scenarios and the main 
underlying assumptions. 
 
A brief description of COSMO 
COSMO is a structural macroeconometric model of the Irish economy which 
models the behaviour of the economy in a small open-economy framework. It has 
a theoretically founded structure with econometrically estimated parameters and 
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dynamics. It is designed to be used for medium-term economic projections and 
policy analysis. 
 
The key mechanisms of the model are summarised below.21 
COSMO initially focuses on the supply-side (output side) of the economy, and then 
examines the expenditure (demand side) and income consequences. A multi- 
sectoral model, it distinguishes between the traded sector, the non-traded sector 
and the government sector.22 The disaggregation reflects the differences between 
firms/agents operating within the three sectors. There is an underlying production 
function for each sector that ultimately drives medium-term growth in the 
economy. Output in the traded sector is driven by global demand for Irish exports 
and cost competitiveness. The non-traded sector is reliant on domestic demand. 
The government sector is policy-driven and includes the treatment of borrowing 
and debt accumulation. 
 
Demand is disaggregated along standard national accounting lines (household 
consumption, public consumption, investment, exports and imports). Households 
make consumption decisions based on the current income and holdings of wealth. 
They also supply labour, with the supply of labour dependent on after-tax wages 
and migration, as well as demographic assumptions. The labour market is open and 
migration is influenced by conditions in alternative labour markets. Firms employ 
labour and make investment decisions, with their factor demands derived from the 
underlying production functions. Wages are determined in a bargaining model and 
influenced by the factors that affect the supply and demand for labour – e.g. prices, 
taxes. The government sector raises taxes, transfers income to households, 
employs labour and invests in capital. Any deficit accumulates onto the 
government debt stock, and interest must be paid on this debt.  
 
Key assumptions underpinning the scenarios 
COSMO has previously been used to develop medium-term projections for the Irish 
economy (Bergin et al., 2016). The exercise here has the same focus but the 
projections for the shorter term are developed by imposing various shocks on the 
model, intended to replicate the initial economic shocks associated with Covid-
19.23  
 
21  This section draws on Bergin et al. (2017), which contains a full description of the mechanisms and behaviour of the 
model.  
22  Sectors are defined based on the Supply and Use Input-Output Tables from the CSO. A sector is defined as traded if at 
least 50 per cent of total final uses (excluding change in stocks) is exported. The aggregate government sector comprises 
those sectors in which at least 50 per cent of total final uses (excluding changes in stocks) is used by the government 
as consumption. The non-traded sector comprises the remaining sectors.  The traded sector comprises Manufacturing, 
Information and Communications, Finance and Insurance activities, and Professional, admin and support services; the 
government sector comprises Public Administration, Education and Health, and the remaining sectors are classified as 
non-traded. 
23  This analysis draws from Bergin et al. (2020). 
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The approach taken is to define the main channels through which the pandemic is 
affecting the economy, to calibrate the size of these shocks using recent data and 
research, and to develop two alternative paths/scenarios over the short and 
medium term. The main channels through which the pandemic and associated 
public health measures are negatively affecting the economy relate to production, 
employment, consumption, investment, and a weaker global environment. At the 
same time, government measures – including income supports, extra spending in 
health, and household and business support measures – should help dampen the 
most negative economic effects of the public health crisis.  
 
CSO data for the first two quarters of 2020 from the Quarterly National Accounts 
is used to calibrate the shocks to consumption and output in the non-traded sector, 
while the Labour Force Survey and Monthly Unemployment are used to calibrate 
the shocks to employment. Recent research from the National Institute of 
Economic and Social Research in the UK (Hurst et al., 2020) on the possible 
international economic impact of the coronavirus, using its global multi-country 
model NiGEM, is used to provide the assumptions relevant for the traded sector. 
Additional shocks to investment are also considered to take account of the 
uncertainty facing firms and the fact that many firms have delayed investment 
decisions. These shocks are implemented into COSMO for the first half of 2020; 
however, the extent and pace of any recovery beyond that time is unclear. Both 
scenarios assume that the most severe macroeconomic impacts will have been in 
the first three quarters of 2020.  
 
The Recovery scenario assumes some rebound in non-traded employment and 
output in the second half of 2020 and then a relatively rapid return to where the 
economy would have been (in the absence of the pandemic) by 2023 Q4. It also 
assumes that there will be a rebound in consumption in the second half of 2020. 
Furthermore, as the export sector has held up reasonably well so far in response 
to the pandemic, the shock to world demand for Irish exports in this scenario is 
scaled back. 
 
The Delayed Recovery scenario assumes that the recovery in non-traded 
employment and output is delayed until the end of 2024. It also assumes that world 
demand for Irish exports remains weak until the end of 2023, and that 
consumption and investment are slower to recover from the initial shocks. This 
scenario also incorporates some scarring effects, whereby some of the losses in 
employment and output in the non-traded sector are considered to be permanent. 
This permanent loss of output and employment is difficult to calibrate; it is thus 
assumed to be 5 per cent. However, depending on the behavioural responses by 
consumers and firms, this loss could be larger. 
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3.2.3 Macroeconomic scenarios 
This section describes the projections for key macroeconomic aggregates from the 
Recovery and Delayed Recovery scenarios. Table 3.1 summarises the 
macroeconomic projections for both scenarios averaged over various time periods 
out to 2035. Projections of the pay component of unit costs in this analysis are 
based on (average) projected government-sector, nominal average wage growth 
from these scenarios. Projections of the non-pay (non-drug) component of unit 
costs in this analysis are based on the projected inflation rate from these scenarios. 
For a full description of how these parameters are incorporated into the 
expenditure modelling, and the variations to growth applied, see Section 4.3. 
 
TABLE 3.1 Summary of macroeconomic projections for the Recovery and Delayed Recovery scenarios 
 
Averaged over: 2019-2020 2021-2025 2026-2030 2031-2035 Overall 
Recovery scenario      
GDP, constant prices, % growth 0.4 5.8 3.4 3.3 3.7 
GNP, constant prices, % growth 0.7 6.8 4.0 4.3 4.5 
GDP, current prices, % growth 3.4 7.5 5.3 5.1 5.7 
GNP, current prices, % growth 1.8 9.1 6.7 6.5 6.8 
Government sector, nominal 
average wage % growth 
2.5 2.5 2.5 2.5 2.5 
Inflation rate, %a 1.8 1.1 2.0 1.6 1.6 
Delayed Recovery scenario      
GDP, constant prices, % growth -0.9 5.8 3.6 3.5 3.7 
GNP, constant prices, % growth -0.3 8.3 4.2 4.3 4.9 
GDP, current prices, % growth 2.2 6.7 5.6 5.4 5.5 
GNP, current prices, % growth 0.5 8.5 7.1 6.8 6.7 
Government sector, nominal 
average wage % growth 
2.2 2.2 2.2 2.2 2.2 
Inflation rate, %a 1.8 0.5 2.0 1.7 1.4 
 
Note: a The inflation rate in COSMO is the deflator on personal consumption and so it is a broader measure of price pressures 
than the traditional consumer price index which considers price changes in a specific basket of goods. Over time the two 
measures tend to track each other quite closely. The GDP deflator is often used as well in these types of analyses. In 
Ireland, as a small open economy, the GDP deflator is influenced by other prices including those for exports, which are 
not directly relevant for the analysis in this report. 
Source:  Projections from COSMO model. 
 
The table shows that growth, measured in terms of gross domestic product (GDP) 
or gross national product (GNP), is severely curtailed in the short term, and this is 
largely driven by the effects of Covid-19 on the economy, with the effects being 
larger in the Delayed Recovery scenario as the economy is expected to recover at 
a slower pace. The largest losses occur in the non-traded sector, driven by the 
severe impact on consumption caused by the public health restrictions and the 
slowdown in investment. As mentioned earlier, the relatively strong performance 
of the traded sector helps mitigate the losses, but not by enough to stop the 
economy from registering negative growth for the 2019–20 period in the Delayed 
Recovery scenario. 
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Over the 2021–25 period, the economy recovers as the effects of the pandemic 
wane. In the Recovery scenario, output returns to baseline (where it otherwise 
would have been, in the absence of the pandemic) by the middle of 2023. In the 
Delayed Recovery scenario, output largely recovers after another two years. 
Despite the size of the initial shock, the economy grows over the medium term, 
even in the more pessimistic scenario. In terms of wage growth, we assume that 
nominal wages in the government sector experience average annual growth of 2.5 
per cent per annum over the period in the Recovery scenario and 2.2 per cent per 
annum in the Delayed Recovery scenario.24 These are policy modelling assumptions 
that reflect the long-run model projection for wages in the sector, which are 
ultimately linked to wage developments in other sectors of the economy. Over the 
short run, wage developments in the sector are difficult to project. For example, 
recent data show that wage growth has held up quite well so far in the pandemic. 
For example, average weekly earnings (seasonally adjusted) grew by 4.7 per cent 
on an annual basis in the first two quarters of 2020 (which includes the period 
when the strictest public health restrictions were in place) and by 3.3 per cent in 
the human health and social work sector.25 The ESRI’s Autumn 2020 Quarterly 
Economic Commentary makes a similar point in its analysis of the public finances, 
which shows that, despite the unprecedented increase in unemployment, income 
tax receipts for the first nine months of the year were only 1.9 per cent below 
where they were in the previous year. However, at some point, the deterioration 
in the public finances may lead to downwards pressure on wages in the 
government sector. As the outlook for the economy is uncertain and because of 
the importance of these projections for aspects of healthcare spending, the report 
also considers a public sector ‘pay freeze’ sensitivity in Section 8.3. 
 
Over the more medium term, there is some internal adjustment in the economy in 
terms of lower price growth to help guide the economy back towards potential 
output. This has a positive effect on competitiveness in the traded sector and more 
generally on labour demand and output in the economy. Beyond 2025, the 
economy grows at or around its potential rate. In the Recovery scenario, the 
improvement in competitiveness helps the economy move above where it 
otherwise would have been (had there been no pandemic); in the Delayed 
Recovery scenario, the economic scarring, caused by factors such as firm closures, 
keeps the economy close to but below where it otherwise would have been (had 
there been no pandemic).  
  
 
24  In COSMO, government-sector wages are modelled at an aggregate level. Although the model does not explicitly 
differentiate between different components of the wage bill, including increments, the projections are consistent with 
long-run historical wage developments in the health sector. For example, Eurostat data show that nominal average
annual wage growth in the health sector was 2.6 per cent between 1995 and 2019. 
25  CSO (2020), Earnings Hours and Employments Costs Survey Q2 2020. 
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3.3 DEMOGRAPHIC PROJECTION SCENARIOS 
This section describes new population projection scenarios which have been 
developed for the latest version of the Hippocrates Model. Three population 
scenarios were examined in Wren et al. (2017). A main Central scenario was based 
on trends in the data and linked to medium-term projections for the Irish economy, 
and, given the uncertainty inherent in any projection exercise, the report also 
considered High Population Growth and Low Population Growth scenarios.  
 
Since the publication of that report, new and revised data are available which have 
been incorporated into this version of the demographic model. Furthermore, some 
of the assumptions have been adjusted to reflect existing and emerging trends in 
the data. In particular, net international migration has been adjusted downwards 
over the short to medium term because of the effects of Covid-19, and the 
population estimates for 2020 have been adjusted to take account of deaths from 
Covid-19. The section below outlines the main assumptions and presents the 
updated population scenarios. It also describes key differences in assumptions and 
in overall scenario projections from those in Wren et al. (2017). 
 
3.3.1 Assumptions 
A cohort component methodology is used to generate population projections. This 
method begins with a base year population26 and projects the population by sex 
and single year of age for each year over the projection horizon according to 
assumptions on the components of population change (fertility, mortality and net 
international migration).27 This section outlines the main assumptions on 
mortality, fertility and migration that are required to generate demographic 
projections, before describing each assumption in more detail. 
 
Table 3.2 outlines the main assumptions for each demographic scenario and 
provides the comparable assumptions for the previous scenarios in Wren et al. 
(2017).28 At a broad level, the main differences between the two sets of scenarios 
are:  
1) Improvements in life expectancy have been more muted than expected in 
recent years. This has contributed to an assumption of continued 
improvements in life expectancy over the projection horizon but at a slightly 
lower rate of improvement than in the previous projections. 
 
26  The base year in the projections is 2016 as this is the latest year for which complete detailed data are available. Census 
data by sex and single year of age are used on the de facto (i.e. all persons present on Census night) population for the 
base population. The base year in Hippocrates has been updated to 2018, so the assumptions guiding each of the 
demographic scenarios only diverge from 2019 on. 
27  See Wren et al. (2017) for a complete description of the methodology. 
28  The projection horizon has been extended to 2035 in the new projections. 
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2) Net immigration has accelerated in recent years in line with the recent strong 
relative performance of the Irish economy, and has been closer to the levels in 
the High Population Growth scenario in Wren et al. (2017). Incorporating this 
data means that population estimates for the most recent years are higher 
than the previous projections. However, the public health crisis is likely to 
reduce net migration below where it otherwise would have been. It is likely 
that travel restrictions, uncertainty about the evolution of the pandemic and 
lower confidence may result in net migration being significantly lower, at least 
in the short term. Medium-term projections for migration have been adjusted 
in line with somewhat lower growth and weaker economic conditions.29 
3) Recent data show a decline in the overall fertility rate compared with the 
previous projections. This will affect both the near-term projections, and has 
led to a downward adjustment in overall fertility rates across the three 
projection scenarios. 
 
TABLE 3.2 Summary of main assumptions for population scenarios and comparison with 2017 projections 
 






Mortality    
Mortality rates assumed to 
decrease with gains in life 
expectancy at birth from 
79.5 years for males and 
83.4 years for females in 
2015 to: 
82.7 years for males and 
85.8 years for females in 
2030 and 83.5 years for 
males and 86.5 years for 
females in 2035 
83.0 years for males and 
86.1 years for females in 
2030 and 83.8 years for 
males and 86.7 years for 
females in 2035 
82.4 years for males and 
85.6 years for females in 
2030 and 83.2 years for 
males and 86.2 years for 
females in 2035 
Migration    
Net immigration over the 
projection horizon: 
Declining from 2019 level 
of +33,700 to +5,000 until 
2022 and then constant at 
+10,000 p.a. thereafter  
Declining from 2019 level 
of +33,700 to between 
+15,000 and +20,000 until 
2022 and then constant at 
+25,000 p.a. thereafter  
Declining from 2019 level 
of +33,700 to between  
–5,000 and zero net 
migration until 2022 and 
then constant at 5,000 p.a. 
thereafter 
Fertility    
Total fertility rate: Unchanged from 2019 rate 
of 1.72 
Rises from 2019 rate of 
1.72 to 1.96 by 2026 and 
remains constant 
thereafter 
Declines from 2019 rate of 
1.72 to 1.62 by 2030 and to 
1.6 by 2035  






Mortality    
Mortality rates assumed to 
decrease with gains in life 
expectancy at birth from 
78.4 years for males and 
82.9 years for females in 
2011 to: 
82.9 years for males and 
86.5 years for females 2030 
83.2 years for males and 
86.8 years for females in 
2030 
82.6 years for males and 
86.3 years for females in 
2030 
Migration    
Net immigration over the 
projection horizon: 
Averaging 9,000 p.a. to 
2021 and 13,000 p.a. 
thereafter 
Averaging 39,000 p.a. to 
2021 and 28,000 p.a. 
thereafter 
Averaging 1,000 p.a. to 
2021 and 12,000 p.a. 
thereafter 
Fertility    
Total fertility rate: Unchanged from 2015 rate 
of 1.94 
Rises to 2.1 by 2021 and 
constant thereafter 
Declines to 1.8 by 2021 and 
to 1.58 by 2030 
 
29   Lower migration in the future could also have implications for migrant labour supply of healthcare workers, which in 
turn could have implications for healthcare expenditure. 
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Life expectancy 
The period expectation of life at birth is the average number of years a newborn 
would live for, based on prevailing mortality rates for that year, and is shown in 
Figure 3.3 for males and females. While the data show continued improvements in 
life expectancy over time, the data for the most recent years reveal a slight 
slowdown in the rate of improvement.  
 
FIGURE 3.3 Period life expectancy at birth, 2020 compared to 2017 projections 
 
 
Sources: Central Statistics Office (2013; 2018b). 
 
This slowdown in the rate of improvement is more pronounced for females than 
for males, and is evident across the age distribution (see Figure 3.4 which shows 
life expectancy for males and females at age 65). It is difficult to assess the reasons 
for the recent slowdown in life expectancy improvements, which have been 
observed generally in the Western world, as changes over time tend to be driven 
by a range of economic, social, institutional and health factors (Preston et al., 2018; 
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FIGURE 3.4 Period life expectancy at age 65, 2020 compared to 2017 projections  
 
 
Sources: Central Statistics Office (2013; 2018b). 
 
The mortality assumptions developed for the recent CSO population projections 
are followed (Central Statistics Office, 2018b) while Wren et al. (2017) adopted the 
mortality assumptions from the previous CSO projections (Central Statistics Office, 
2013). The recent projections (Central Statistics Office, 2018b) show a continued 
improvement in life expectancy, although at a slower pace than in previous 
projections. To generate the projections, a ‘targeting’ method is adopted where it 
is assumed that short-term rates of improvement in mortality (by sex and single 
year of age) will gradually converge to long-term rates of improvement (by sex and 
single year of age) by a target year (assumed to be the 25th year of the 
projections).30 The short-term rates of improvement in mortality rates for males 
and females up to the age of 90 are 2.5 per cent and 2.0 per cent per annum 
respectively. These short-term rates of improvement are assumed to decline 
linearly over a 25-year period to a long-term rate of 1.5 per cent per annum for 
males and females. It is assumed there are no mortality improvements from the 
age of 100 years. For those aged between 90 and 100, the rate of improvement in 
each year is generated by interpolating between the assumed rate of improvement 
at 90 years and 100 years. The key difference with the previous set of projections 
is that the short-term rates of improvement in mortality rates are lower; previously 
they were 3 per cent per annum for males and 2.5 per cent per annum for females 
up to the age of 90 (Central Statistics Office, 2013). Furthermore, for 2020, 
mortality rates have been adjusted to take account of deaths from Covid-19, as this 
would not have been incorporated into the recent projections (Central Statistics 
Office, 2018b). This adjustment is only made for 2020, so implicitly assumes that 
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although the virus may be present for some time, the number of deaths associated 
with COVID-19 will not significantly rise in the coming years.31 
 
Overall, these assumptions imply a projected increase in life expectancy at birth 
for males from 79.3 in 2015 to 83.5 years in 2035 and for females from 83.3 in 2015 
to 86.5 years in 2035. It is the lower rate of improvement in the near-term current 
mortality rates that leads to the slower pace of improvement than in the previous 
projections. Two alternative scenarios for life expectancy are also considered. In 
the High Population Growth scenario, an additional three percentage points are 
added to both the short and long-term rates of mortality improvements for both 
males and females for all ages up to 90. In the Low Population scenario, an 
additional three percentage points is subtracted from both the short and long-term 
rates of mortality improvements for both males and females for all ages up to 90. 
The assumptions for the older ages are generated in the same way as described 
above. Compared to the Central scenario, male (female) life expectancy at birth is 
higher by 0.27 years (0.22 years) in 2035 in the High Population scenario and male 
(female) life expectancy at birth is lower by 0.30 years (0.27 years) in 2035 in the 
Low Population scenario. 
 
Net international migration 
International migration has long played a key role in driving both overall population 
change and the age structure of the population in Ireland. Migrants tend to be of 
prime working age; for example, over the 10-year period ending in 2019 over 80 
per cent of net migration was in the 15 to 44 year-old age group. This helps to lower 
the age structure of the population and to reduce dependency rates. Migration 
flows in and out of Ireland are very volatile, and depend on both domestic and 
international economic conditions. Following the recovery of the Irish economy 
from the Great Recession, net immigration turned positive in 2015 and net inflows 
have been increasing since then. The latest CSO estimates of net international 
migration for 2017, 2018 and 2019 are +19,800, +34,000 and +33,700 respectively 
(Central Statistics Office, 2019). This compares to a twenty-year average of 
approximately +21,400 per annum for the preceding period, showing recent flows 
have been above the historical average. Our assumptions on net migration begin 
in 2020, and migration is distributed by gender and single year of age on the basis 
of historical weights. The overarching assumptions are: 
  
 
31  Specifically, for 2020, the mortality projections by single year of age from CSO (2018) are adjusted downwards to reflect 
the number of laboratory confirmed COVID-19 deaths. This data is from the HPSC CIDR database and was extracted in 
mid-June when there was 1,449 deaths of confirmed cases at that point. The adjustment was made as the starting 
population for 2021 is the population in 2020 and if the projection in the near term is wrong or not adjusted for COVID-
19, this can carry through to the projections over the medium term. 
Macroeconomic and demographic  scenarios  |45  
Central Scenario: Net immigration declines linearly from 2019 level of +33,700 to 
+5,000 until 2022 and to remain constant at 10,000 per annum thereafter. The 
lower projection in the near term reflects the potential impact of Covid-19. While 
the public health crisis has precipitated a massive global and domestic economic 
shock, it may not necessarily affect relative economic conditions between Ireland 
and the international economy. However, the global pandemic may result in 
economic factors being less important in influencing migration flows in the near 
term. The medium-term figure is based on updated projections from the Economic 
Outlook (Bergin et al., 2016) and is consistent with expected economic conditions 
in Ireland and abroad. Over the medium term, net migration is below its long-run 
average as growth rates between Ireland and the international economy begin to 
converge. 
 
High Population Scenario: Net immigration continues at a high rate of 25,000 per 
annum over the long term. In the near term, net migration is assumed to decline 
to between 15,000 to 20,000 until 2022. This scenario is slightly below the 
assumptions from the previous projections and also below the M1 net inward 
migration from the recent CSO projections (CSO, 2018). 
 
Low Population Scenario: Net migration turns negative in the short term (net 
emigration) of between –5,000 and zero until 2022 then remains constant at 5,000 
per annum thereafter. 
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Fertility 
The total fertility rate (TFR) (a measure of the number of children that a 
representative woman will have over her lifetime) has been broadly stable since 
the mid-1990s but has experienced a modest decline since the beginning of the 
last decade (see Figure 3.5).  
 
FIGURE 3.5 Total fertility rate 
 
 
Source: CSO, Vital Statistics and ESRI projections. 
 
For the Central scenario, it is assumed that the TFR will remain unchanged from 
the 2019 rate of 1.72 over the projection horizon. Some differences in fertility rates 
by age are allowed for: a modest increase in fertility rates for women in their 
thirties out to 2026 is assumed, and a further moderate decline for younger women 
out to 2026, while keeping the overall fertility rate unchanged. In the High 
Population scenario, the TFR is assumed to rise to 1.96 by 2026 and remains 
constant thereafter. This is below the replacement rate (the level of fertility at 
which a population exactly replaces itself from one generation to the next) of 2.1 
children per woman, but marginally above the long-run average (over 1991 to 
2018) of 1.94. In the Low Population scenario, the TFR is assumed to continue on 
the slight downwards trajectory observed in recent years, and then declines to 1.68 
in 2026, 1.60 in 2031, and remains constant thereafter. The Central Scenario and 
Low Population Growth scenarios are broadly in line with the F1 and F2 scenarios 
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3.3.2 Population scenarios 
In this section the assumptions on mortality, migration and fertility are brought 
together for the three scenarios to generate the Central, High Population Growth 
and Low Population Growth scenarios. Figure 3.6 shows the total population in 
each of the three scenarios. Each scenario shows relatively strong total population 
growth over the projection horizon. In the Central scenario, between 2018 and 
2035, the population will increase by 528,000, equivalent to average annual 
growth of just over 0.6 per cent, resulting in a total population of 5,403,000 in 
2035. In the High (Low) Population Growth scenario, the total population will grow 
by 1.02 per cent (0.43%) on an average annual basis resulting in a total population 
of 5,795,000 (5,245,000) in the High (Low) Population Growth scenario in 2035. 
 
FIGURE 3.6 Total population – Central, High Population Growth and Low Population Growth scenarios 
 
 
Source: ESRI projections. 
 
Figure 3.7 shows the evolution of the total population under the three scenarios 
out to 2030 with the three scenarios considered in Wren et al. (2017). While the 
two sets of scenarios are broadly consistent, the new projections have a slightly 
narrower range, largely driven by the refinements to the net migration 
assumptions. By 2030, the total population is around 80,000 lower in the Central 
scenario compared to the previous projections and 275,000 lower (12,000 lower) 
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FIGURE 3.7 Total population – new 2020 and previous 2017 projections 
 
 
Source: ESRI projections and Wren et al. (2017). 
 
Table 3.3 shows the absolute change and percentage growth in the male and 
female populations for the Central scenario for the new projections and those from 
the previous scenarios in Wren et al. (2017). To ensure comparability between the 
scenarios, the table shows them over the same period, 2016 to 2030. These age 
cohorts are relevant for different aspects of healthcare services. While the overall 
absolute increase is somewhat smaller than in the previous projections, many of 
the trends for age cohorts are similar across both sets of projections, with the older 
age cohorts expected to experience the fastest growth over the period. The 
number of children (those aged <15) is projected to experience a sharper fall than 
in the previous set of projections. This is driven by a combination of a lower 
assumed overall fertility rate and lower net migration that will result in fewer 
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TABLE 3.3 Comparison between new 2020 and previous 2017 projections of growth in various cohorts 2016–
2030 
 
 Males Females Total 
 % Increase Absolute 
Increase (‘000) 
% Increase Absolute 
Increase (‘000) 
% Increase Absolute 
Increase (‘000) 
 Central Population Growth scenario 2016-2030, 2020 projections 
<15 -13 -68.4 -13 -65.2 -13 -133.6 
15-64 10 153.4 10 155.7 10 309.0 
65+ 54 159.5 50 170.5 78 53.0 
80+ 99 57.9 65 58.3 78 116.2 
85+ 114 26.3 60 26.7 78 115.0 
All Ages 10 244.5 11 260.9 11 505.4 
 Central Population Growth scenario 2015-2030, Wren et al. (2017) 
<15 -3 -13.2 -3 -16.0 -3 -29.1 
15-64 9 133.6 9 149.0 9 282.5 
65+ 53 157.5 52 176.4 90 60.8 
80+ 101 58.8 71 64.1 83 122.8 
85+ 122 28.2 73 32.6 82 120.7 
All Ages 12 277.9 13 309.4 12 587.2 
 
Source: ESRI projections. 
 
In addition to experiencing strong population growth, the age structure of the 
population will continue to change over time. Figure 3.8 shows population 
pyramids (which show the percentage of the population in each year of age) for 
2018 and 2035. From the graph, the ageing of the population is readily apparent; 
20 per cent of the population are over the age of 65 in 2035 compared to just 14 
per cent in 2018. At the same time, the proportion of the population accounted for 
by children (0–14 years old) will become smaller over time as there will be 
relatively fewer women in the key childbearing age groups. In 2018, 21 per cent of 
the population were under the age of 15, while the comparable proportion in 2035 
is 16 per cent. There is also a slight decline in the proportion of the population of 
working age, from 65 per cent in 2018 to 64 per cent in 2035. 
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Source: ESRI projections. 
 
Finally, Table 3.4 summarises both the total numbers and proportions in various 
age groups in 2018 and in 2035 for the three population scenarios. In each 
scenario, despite strong population growth, the ageing of the population is 
observable over time; the proportion of the population over the age of 65 rises 
steadily, while the proportion of the population under the age of 15 falls over time. 
The table also shows the young-age and old-age dependency ratios.32 The old-age 
dependency rate rises from 0.21 in 2018 to 0.32 in 2035 in both the Central and 
Low Population Growth scenarios, while it also increases strongly in the High 
Population Growth scenario, to 0.31 by 2035. 
 
TABLE 3.4 Summary of population scenarios 
 






 N (‘000) % N (‘000) % N (‘000) % N (‘000) % 
0-14 1,007 21 794 15 857 16 1,027 18 
15-64 3,188 65 3,368 64 3,448 64 3,652 63 
65+ 680 14 1,083 21 1,097 20 1,117 19 
Total 4,875 100 5,245 100 5,403 100 5,795 100 
Young-age dependency ratio 0.32 0.24 0.25 0.28 
Old-age dependency ratio 0.21 0.32 0.32 0.31 
 
Source: ESRI Projections. 
 
 
32  The young-age dependency ratio is the ratio of the number of young people at an age when they are normally 
economically inactive (under 15 years old) compared to the working-age population (those aged 15 to 64), while the 
old-age dependency ratio refers to the number of older people at an age when they are generally economically inactive 
(over 65 years old) compared to the working-age population. 
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3.4 SUMMARY 
This chapter has provided a detailed description of the development of the 
macroeconomic and demographic scenarios applied in the remainder of the report 
to project hospital expenditure. Chapter 4 describes the projection methodology 
in detail and draws together the projection scenario assumptions presenting the 
eventual expenditure projection scenarios, while Chapters 5 to 7 present the 
findings from the analyses and projections. 
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CHAPTER 4 
Hippocrates projection methods and data 
Chapter 4 Hippocrates projection methods and data 
4.1 INTRODUCTION 
This chapter presents the methods used to estimate baseline healthcare 
expenditure profiles and describes the Hippocrates projection methodology in 
detail. The expenditure projection scenarios are outlined, and an overview of the 
data sources employed for the analysis is provided. 
 
4.2 PROJECTION METHODOLOGY 
As described in Chapter 2, most component-based models are top-down in nature, 
projecting on aggregate healthcare expenditure. In contrast, Hippocrates belongs 
to a smaller class of models that project from a bottom-up service or sectoral 
perspective; modelling demand and cost separately. While bottom-up models tend 
to be considerably more data-intensive, they allow for more flexibility and a wider 
range of applications. Top-down and bottom-up models consider many of the 
same demographic and non-demographic drivers of healthcare expenditure (these 
drivers were reviewed in details in Chapter 2). The key drivers of expenditure 
considered in this analysis are reported in Table 4.1.  
 
TABLE 4.1 Key drivers of expenditure included in Hippocrates 
 
Demographic drivers  Non-demographic drivers 
Population growth and ageing  Earnings growth 
Healthy ageing  Drug cost growth  
 Productivity  
 
Figure 4.1 outlines the steps involved in developing Hippocrates from a demand 
and cost base to project healthcare expenditures. The following sections describe 
each step of the projection process in detail. 
 
4.2.1 Develop activity rate profiles for 2018 
The first step involved in developing Hippocrates expenditure projections is to 
develop base-year (t) age and sex activity profiles. The base year for this analysis is 
2018. This involves grouping individuals into cohorts capturing age- and sex-
specific activity rates for the service or sector under consideration (e.g. outpatient 
attendances, day-patient discharges). Activity rates are calculated by dividing age- 
and sex-specific activity volumes by corresponding age- and sex-specific 
populations in 2018. 
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Source: Authors’ representation. 
 
Ideally, where the data allow, age cohorts are disaggregated by single-year-of-age 
(SYOA). Where SYOA data are not available we use the most detailed level of age 
disaggregation available (e.g. 5-year age groups). The reasoning behind this is that 
the sensitivity of projections to changes in the age structure of the population 
reduces as the level of data aggregation (i.e. fewer age cohorts) increases. 
Aggregation has the consequence of understating the effect of increasing numbers 
of older people on healthcare demand and leads to understated demand 
projections (see Section 3.3.8, Wren et al. (2017)). 
 
4.2.2 Project activity rates to 2035 
The next step is to project age- and sex-specific activity rate profiles for each year 
(j) of the projection horizon. We adjust age- and sex-specific activity rates 
through the projection horizon in a number of ways, described below. 
 
Adjusting activity rates to account for healthy ageing  
Healthy ageing adjustments are made to account for the fact that, as life 
expectancy increases, not all additional life years may be spent in bad health (Wren 
et al., 2017). To simulate these effects, we shift age- and sex-specific activity curves 
to the right in proportion to projected life-expectancy change. This is based on an 
approach adopted from the European Commission (European Commission, 2011; 
2014; 2017) and previously applied in Wren et al. (2017).33 The strength of the 
activity shift applied describes the healthy ageing effect to be modelled. Several 
healthy-ageing hypotheses are identified in the literature and these are discussed 
in Chapter 2.  
 
33  See Section 3.3.5, Wren et al. (2017) for a technical explanation of these activity rate shifts. 
Base year activity rate (t)
Activity rate adjustment (t+j)
Population projections (t+j)
Projected demand (t+j) 
Base year unit cost (t) 
Projected unit cost (t+j)
Projected expenditure (t+j)
Unit cost indexation (t+j)
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The most pessimistic effect is to assume no healthy ageing, known as the Expansion 
of Morbidity hypothesis. This assumes that all additional life years are spent in bad 
health and is implicitly modelled where activity-rate profiles are kept constant over 
the projection horizon. A more optimistic hypothesis (Dynamic Equilibrium) is to 
assume that, for every one-year increase in life expectancy, the relevant age-
specific activity rate profile shifts back one age year. This assumes, for example, 
that, if life expectancy increases by one year between 2018 and 2035, the care 
demanded by an 80-year-old in 2035 will be the same as that demanded by a 79-
year-old in the base year, 2018. The approach is illustrated graphically in Figure 
4.2. 
 
Any assumption where activity rate shifts exceed gains in life-expectancy models 
the Compression of Morbidity hypothesis. However, the international literature 
offers little guidance on parameter values to assign when modelling Compression 
of Morbidity. In this report we follow the approach adopted in Wren et al. (2017) 
and model Compression of Morbidity as gains in health (as proxied by activity rate 
shifts) exceeding gains in life expectancy by 150 per cent. As in Wren et al. (2017) 
we also introduce an additional Moderate Healthy Ageing assumption so that gains 
in health are set at 50 per cent of the gain in life expectancy.  
 




Source: Authors’ representation. 
 
As with the approach adopted in Wren et al. (2017) activity rate shifts are only 
applied where activity rates, proxying morbidity, are increasing through the age 
distribution. Additionally, activity rates shifts are not applied to the entire age 
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variation in morbidity (Blanco-Moreno et al., 2013). Activity rate shifts are 
therefore limited to those aged 35 and over (Figure 4.2).  
 
Adjusting activity rates to account for avoidable hospitalisations 
Avoidable hospitalisations relate to conditions for which hospitalisation can be 
considered avoidable through timely and effective utilisation of non-acute care. 
These rates are often used as a marker of primary care quality (Gibson et al., 2013; 
Rosano et al., 2013). This assumption reduces the rate of avoidable hospitalisations 
through the projection horizon to simulate the impact of improved access to and 
use of more appropriate non-acute care. 
 
In this analysis, avoidable hospitalisations are defined in accordance with 
Australia’s National Healthcare Agreement indicator PI 18-Selected potentially 
preventable hospitalisations (Australian Institute on Health and Welfare, 2020) and 
refined in line with McDarby and Smyth (2019), who recently conducted a 
population-based analysis of avoidable hospitalisations tailored to the Irish 
setting.34 In total, 21 avoidable hospitalisation conditions are identified. Cases are 
identified based on the presence of a principal diagnosis or, for some conditions, 
any diagnoses of the relevant conditions in the HIPE discharge record. Diagnoses 
are classified based on the ICD-10-AM, 8th edition, coding classification. In line with 
previous analyses, only emergency in-patient discharges from public hospitals are 
considered (Ansari et al., 2012; Sheridan et al., 2012). 
 
In this analysis, we then adjust our baseline age‐specific and sex‐specific 
complexity-adjusted activity rates in 2018 by removing the identified hospital 
activity related to the three most frequent emergency in-patient (excl. maternity) 
avoidable hospitalisations (see Appendix A). These relate to vaccine-preventable 
influenza and pneumonia, Chronic Obstructive Pulmonary Disorder (COPD), and 
urinary tract infections (including pyelonephritis), which together account for 54.2 
per cent of unweighted and 70.7 per cent of complexity-weighted avoidable 
hospitalisations recorded in 2018 (Figure 4.3). These are also the most frequent 
avoidable hospitalisations identified by McDarby and Smyth (2019). While these 
conditions account for the majority of avoidable hospitalisations recorded, there is 
also an established evidence base for treatment or prevention (in the case of 
influenza and pneumonia) outside of the acute hospital setting (McDarby and 
Smyth, 2019; OECD, 2019a). 
 
 
34  See Appendix A for a list of the ICD-10-AM diagnosis codes employed in this analysis. 
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FIGURE 4.3 Avoidable hospitalisations: unweighted and complexity-weighted emergency in-patient discharges 




Source: HIPE, 2018. 
 
A parameter in the model specifies the extent to which the avoidable 
hospitalisation rate is reduced. Setting this parameter to zero models no reduction 
in the rate of avoidable hospitalisations while setting the parameter to one would 
remove all hospitalisations classified as avoidable. Setting the parameter to one is 
not a reasonable assumption as all countries, regardless of the relative strength of 
their primary care systems, will record some level of avoidable hospitalisations 
(OECD, 2019a). As described in Chapter 2, the relationship between primary care 
strength and rate of avoidable hospitalisations is mixed, with causation and effect 
sizes difficult to identify. With that review in mind, for the main analysis, we 
assume this model parameter to linearly converge to a value of 0.33 by 2035. This 
implies that by 2035 improved investment in, and access to, effective primary care 
treatment will have reduced the overall rate of avoidable hospitalisations by 33 per 
cent relative to 2018.35 This is a refinement of methods previously developed and 
described in Keegan et al. (2018a), The approach is illustrated graphically in Figure 
4.4 (β represents the parameter under consideration). 
 
 
35  For context, a 33 per cent reduction would reduce Ireland’s relatively high rate of COPD hospital admissions from 288 
per 100,000 to 193 per 100,000, moving Ireland’s relative ranking (all else equal) from 5th to 15th highest among 37 
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FIGURE 4.4 Illustrative example of the impact of avoidable hospital rate reductions, for various values of β, on 




Source: Authors’ representation. 
 
We apply the convergence of this model parameter to 0.33 to all three selected 
conditions and across all age and sex groups. However, given the uncertainty 
around this choice of parameter, sensitivity analysis presented in Chapter 8 
considers the effect of alternative parameter assumptions on healthcare 
expenditure projections. Appendix A provides an analysis of the level and 
distribution of avoidable hospitalisations in Ireland and further detail on the three 
selected conditions in 2018. 
 
Adjusting activity rates to account for waiting-list management 
The methodology employed to account for public acute hospital waiting lists in the 
model has changed since Wren et al. (2017).36 It is based on a method developed 
for NHS waiting times analysis (Findlay, 2017) and applied by the Institute for Fiscal 
Studies and the Health Foundation (Charlesworth and Johnson, 2018) and the 
Health Foundation (Charlesworth et al., 2020). A non-recurring backlog of cases at 
a point in time is estimated along with an estimation of the recurring additional 
activity required to keep pace with demand and maintain waiting times at a 
manageable level (12 weeks). The estimated non-recurring backlog is assumed to 
be removed across five years of the projection horizon (2021–2025) along with the 
recurring additional activity required to keep waiting times to 12 weeks. These 
volumes are converted to rates to adjust activity in Hippocrates. This method is 
described in detail elsewhere (Brick and Keegan, 2020b). 
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4.2.3 Project demand to 2035 
Demand for care is then projected by multiplying yearly age- and sex-specific 
activity rate profiles with yearly age- and sex-specific projected population 
volumes. Age- and sex-specific population volumes for all years of analysis (2018–
2035) are developed by the ESRI’s in-house cohort component model. A detailed 
description of the assumptions underlying the Low, Central and High Population 
Projection scenarios is provided in Chapter 3. 
 
4.2.4 Develop unit costs for 2018 
To develop base-year and projected healthcare expenditure, it is necessary to 
estimate the unit cost of the (projected) activity under consideration. A unit cost 
refers to the cost of delivering one unit of a particular service (e.g. OPD 
attendance). From the perspective of projection modelling it is important to also 
know the relative component shares of cost in the base year to allow for 
differential modelling of the growth rates of these components through the 
projection horizon. 
 
For this analysis, we focus on two main components of unit costs: pay costs and 
non-pay costs. Pay costs relate to medical, nursing, and non-clinical staff costs 
required to deliver acute care. Non-pay costs are varied, and relate to elements 
such as drugs, laboratory equipment, and overheads. For projection purposes, 
where appropriate, non-pay costs for selected services are disaggregated into drug 
costs and ‘other’. This approach is discussed in more detail in Section 4.2.5. Such 
separation of unit costs for the purposes of projecting expenditure is similar to 
approaches adopted elsewhere (Barrett and Bergin, 2005; Charlesworth and 
Johnson, 2018; Irish Fiscal Advisory Council, 2018; 2020; Wanless, 2002; 
Wittenberg et al., 2018). 
 
There is no internationally accepted gold standard for unit-cost estimation. 
Different approaches can influence the unit costs estimated (Mayer et al., 2020). 
In this analysis, where possible, we use a data-intensive bottom-up approach to 
cost estimation. Bottom-up unit costing identifies the different resources 
associated with the delivery of a service (e.g. salary costs, drug costs, other non-
pay costs) and assigns a value to each (Curtis and Burns, 2019). For the majority of 
acute services under consideration in this report, detailed bottom-up costs exist, 
provided by the HPO. However, for certain services where bottom-up costing data 
are unavailable (i.e. specialist in-patient psychiatric services), we follow a top-down 
costing approach. Top-down costing involves calculating an overall unit cost of care 
by dividing total expenditure by units of activity (i.e. bed day).37 Where such top-
 
37  This approach does have benefits also, requiring less information than bottom-up costing, and it provides a 
straightforward way to aggregate back up to total recorded expenditures for a given service in a base year. 
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down costing is required, pay and non-pay shares are then applied to this total 
rather than estimated directly from the underlying data. 
 
4.2.5 Project unit costs to 2035 
The next step discusses the assumptions adopted in projecting unit costs of care 
through the projection horizon.   
 
Pay costs 
As described in Chapter 2, increases in healthcare expenditure are often explained 
by supply-side effects whereby remuneration in labour-intensive healthcare 
sectors (and less productive sectors more broadly) needs to keep pace with 
remuneration in the broader economy to support recruitment and retain workers. 
As described in Section 3.2, assumed pay cost trends in this analysis are based on 
projections of government-sector average wage growth, which is in turn linked to 
wages in other sectors of the economy. Over the period 2019 to 2035, nominal 
average annual government-sector wage growth is 2.5 per cent under the 
Recovery scenario and 2.2 per cent under the Delayed Recovery scenario.  
 
Non-pay drug costs 
We also pay special attention to the drug component of non-pay costs. 
Traditionally, the cost of providing drugs and medicines in public hospitals has 
increased at a faster rate than other non-pay cost components (Department of 
Health, 2017) and may be expected to do so into the future (Connors, 2017). As 
noted by Connors (2017), the number of new hospital drugs coming on stream over 
the coming years is expected to increase substantially, particularly in the area of 
oncology. Cancer is the therapeutic area expected to experience the largest 
expenditure growth of which approval for costly new drugs will be an important 
component. Table 4.2 shows trends in day and in-patient expenditure on drugs and 
medicines compared to spending on other non-pay costs in ABF hospitals between 
2015 and 2018.  
 
TABLE 4.2 Breakdown of HSE acute care clinical expenditures, 2015–2018 
 
 Expenditure (‘000) Unit Cost 












Drugs and medicines  297,883 324,463 335,545 357,070 19.9 6.2 5.2 
Other non-pay  980,132 1,001,187 1,063,598 1,109,119 13.2 4.2 3.2 
 
Source: HPO Specialty Costing 
 
60|  Pro ject ions  o f  expenditure for  pub l ic  hos pi ta ls  in  I re land ,  2018 –2035  
The overall growth rate for drugs and medicines over the 2015–2018 period 
(19.9%) exceeded the growth rate of other non-pay costs (13.2%). This translates 
into a compound annual growth rate for drugs and medicines of 6.2 per cent 
compared to 4.2 per cent for other non-pay costs. Adjusting for the change in 
activity over the period, the increase in the unit cost of drugs and medicines was 
5.2 per cent per year. These higher unit-cost increases attributable to drugs and 
medicines are likely to have been driven by the new-technology attributes of many 
of these hospital drugs (Charlesworth and Johnson, 2018). Simulating this 
technology effect on future expenditures, and assuming the hospital cost of drugs 
and medicines rises in line with this recent experience, we assume that growth in 
drug unit costs will vary between 4.2 and 6.2 per cent per annum across scenarios 
(see Table 4.3). This represents a similar approach to that adopted by Charlesworth 
and Johnson (2018).38 In contrast to the residual approach often applied in top-
down projection exercises (see Chapter 2), this approach offers a direct way to 
simulate the supply-side effects of technology on hospital expenditure.  
 
Other non-pay costs 
We assume that all other non-pay costs will follow the trend in prices in the 
broader economy. This is a similar approach to that adopted in previous Irish 
healthcare expenditure projection analyses (Barrett and Bergin, 2005; Irish Fiscal 
Advisory Council, 2018). Over the period 2019 to 2035, the average annual inflation 
rate is expected to be 1.6 per cent under the Recovery scenario and 1.4 per cent 
under the Delayed Recovery scenario (see Chapter 3, Table 3.1). We add between 
0.5 (low-pressure) and 1.0 (central and high-pressure) percentage points to these 
rates across scenarios to reflect assumed higher cost growth for elements of non-
pay hospital cost (e.g. medical and surgical supplies, laboratory equipment, 
overheads) over the projection horizon. 
 
4.2.6 Develop expenditure profiles for 2018 and project to 2035 
For the base year 2018, we then combine activity profiles (Section 4.2.1) with unit 
costs (Section 4.2.4) to develop base year age- and sex-specific expenditure 
profiles. These base-year expenditure profiles are presented throughout Chapters 
5 to 8. To project expenditure for each year, we multiply annual projections of 
demand (Section 4.2.3) by annual projections of unit costs (Section 4.2.5). For 
major categories of acute expenditure, we also decompose expenditure growth 
into its constituent drivers, applying methods described elsewhere (Ha et al., 2014; 
Wren et al., 2017).  
 
 
38  Charlesworth and Johnson (2018) project a 5.5 per cent real-terms annual increase in hospital drug unit costs based on 
historical expenditure data, removing activity growth. 
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4.2.7 Sensitivity analysis and productivity effects 
In addition to examining a range of projection scenarios, we conduct a sensitivity 
analysis in Chapter 8 to demonstrate the sensitivity of projections to changes in 
our key assumptions. Additionally, as part of this analysis we examine the potential 
impact of improved productivity on projected expenditures. Productivity measures 
the relationship between input and outputs (Bojke et al., 2017). More productive 
systems can achieve a greater level of output (e.g. activity) with the same input 
(e.g. staff) or alternatively the same output for less input (Charlesworth and 
Johnson, 2018). As described in Chapter 2, healthcare tends to be less productive 
than other sectors, and the gap between pay growth and productivity growth is 
considered a key driver of healthcare expenditure. Future healthcare expenditure 
will be sensitive, therefore, to the trajectory of future productivity. The ability to 
increase productivity could play an important role in offsetting increases in the cost 
of delivering care. 
 
Analysis by Burke et al. (2014) has suggested improved productivity between 2008 
and 2012, with evidence of public hospitals doing ‘more with less’ despite less staff 
and funding (Whyte et al., 2020) in response to the economic crisis at the time. 
Burke et al. (2014) report poor hospital productivity growth from 2013 to 2014, 
while more recent analysis by Lawless (2018) and the Department of Health (2017) 
offer somewhat contradictory findings. These studies, however, do not measure 
productivity change directly, and no index currently exists in Ireland that captures 
in isolation acute or even healthcare system productivity trends over time. The CSO 
produces a productivity index related to Health and Human and Social Work 
(Central Statistics Office, 2020b).39 However, as this index includes residential care 
and social work activity, it is unlikely to be representative of trends in acute care 
productivity. 
 
Considering this weak evidence base on which to project acute care productivity, 
we test the effect of productivity on projected expenditure growth as part of our 
sensitivity analysis rather than incorporating it into our set of projection scenarios. 
We test this productivity effect by modelling a 1.0 and 1.5 per cent per annum 
downward adjustment to unit costs of care. This approach, and the modelled rate 
of productivity growth, is in line with previous analyses in the UK (Charlesworth 
and Johnson, 2018; Wanless, 2002). 
  
 
39  This is based on an aggregation of European Industrial Activity Classification (NACE) codes 86 (Human Health Activities), 
87 (Residential Care Activities) and 88 (Social Work Activities without Accommodation). It was not possible to receive 
a more detailed breakdown from the CSO. 
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4.3 EXPENDITURE PROJECTION SCENARIOS 
For the main analysis, rather than projecting the effect of each driver in isolation, 
we follow the approach taken in Wren et al. (2017) and many other healthcare 
projection exercises (Blanco-Moreno et al., 2013; Charlesworth and Johnson, 2018; 
de la Maisonneuve and Martins Oliveira, 2015; Lorenzoni et al., 2019; Wanless, 
2002) of developing a range of projection scenarios that group drivers together in 
a consistent manner. Given the uncertainty inherent in any projection exercise 
such as this, this provides a basis for developing a projection range charting the 
likely course of future expenditures.   
 
Projection scenarios used in this report are presented in Table 4.3. For all services 
we apply a set of low, central, and high expenditure scenarios. These scenarios vary 
in relation to assumptions on the future evolution of demand and cost of care. 
Variation in projected demand across these scenarios is influenced by assumptions 
in relation to population growth and ageing, and healthy ageing. Three alternative 
population projection scenarios are available to Hippocrates (low, central, and 
high) to examine how alternative assumptions on demographic change may affect 
projected demand. As described in Chapter 3, since the publication of Wren et al. 
(2017), new and revised data are available which are incorporated into this version 
of our demographic model. Furthermore, we have adjusted some of our 
assumptions to reflect existing and emerging trends in the data. In particular, we 
have adjusted downwards net international migration over the short to medium 
term because of the effects of Covid-19, and we have adjusted our population 
estimates for 2020 to take account of deaths from Covid-19. Additionally, in light 
of the Covid-19 pandemic we now place more weight on the low and central 
population projections. Previously, in Wren et al. (2017), projected economic 
circumstances favoured a focus on the central and high population projections. 
 
Macroeconomic projections generated using the ESRI’s macroeconometric model 
COSMO (described in detail in Chapter 3), provide a basis for modelling pay and 
non-pay (non-drug) costs in this analysis. Owing to the uncertainty about the 
duration of the economic impact of Covid-19, the economic outlook is highly 
uncertain. Therefore, two alternative macroeconomic scenarios, termed Recovery 
and Delayed Recovery, are considered. The Recovery scenario assumes some 
rebound in the second half of 2020 and a relatively rapid return to where the 
economy would have been (in the absence of the pandemic) by late 2023. The 
Delayed Recovery scenario assumes a delayed recovery until the end of 2024, with 
some permanent losses in employment and output. In this analysis, pay growth is 
linked to government-sector average wage growth (linked to wages in other 
sectors of the economy). Non-pay (non-drug) cost trends are informed by 
projected trends in inflation. More detail on the generation of these COSMO 
scenarios and the assumptions underlying them are described in Chapter 3. Drug 
cost trends are modelled in line with historical trends (see Section 4.2.5). 
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Central scenario 
Under our central scenario, demand evolves in line with our central population 
growth scenario combined with moderate healthy ageing. Pay costs evolve in line 
with government-sector average wage growth from COSMO’s Recovery scenario. 
Non-pay costs are indexed to a projected inflation rate from COSMO’s Recovery 
scenario plus one percentage point per annum to reflect assumed higher growth 
of non-pay (non-drug) hospital costs above general inflation. Drug unit costs evolve 
in line with an historical annual growth rate of 5.2 per cent (see Section 4.2.5).  
 
Low- and high-pressure scenarios 
We then model what we term ‘low’ and ‘high’-pressure projection scenarios. Given 
uncertainty in relation to the expected course of expenditure drivers, these 
scenarios examine trajectories where demand and cost drivers place relatively 
lesser or greater pressures on projected expenditures. Under the low-pressure 
scenario, demand evolves in line with lower projected population growth (defined 
by lower fertility rates and inward migration, and greater mortality) and more 
optimistic healthy ageing effects (Dynamic Equilibrium). Pay costs evolve in line 
with government-sector average wage growth from COSMO’s Delayed Recovery 
scenario. Non-pay costs evolve in line with inflation from COSMO’s Delayed 
Recovery scenario plus 0.5 percentage points per annum. Drug costs growth is 
assumed to be one percentage point per annum lower than under the central 
scenario.  
 
In our high-pressure scenario, for public acute hospital care, we revert to our 
Central population growth assumption40 and assume a pessimistic relationship 
between life-expectancy increase and acute care demand (i.e. expansion of 
morbidity hypothesis, which assumed all additional life years gained are spent in 
bad health). For psychiatric in-patient, we apply a high population growth 
assumption to provide more nuance to demand projections for this particular 
service as we consider that the application of healthy ageing effects are not 
appropriate for this service. For all acute and psychiatric services, pay and drug 
costs are assumed one percentage point per annum higher relative to the Central 
scenario. Non-pay costs evolve in line with inflation from COSMO’s Recovery 
scenario plus one percentage point per annum. 
 
Progress scenario 
Finally, we also specify an additional scenario that examines the potential acute 
care expenditure implications of realising important dimensions of the original 
Sláintecare proposals (see Chapter 2) related to reorientation of care to the 
community (through reducing the rate of avoidable hospitalisation) and improved 
 
40  Sensitivity analysis in Chapter 8 analyses the effect of projected high population growth on all main services. 
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management of acute waiting lists. We term this our Progress scenario. All other 
assumptions on demand and cost reflect those specified under the central 
scenario, discussed above. The progress scenario applies to projections of 
aggregate public hospital expenditure only (see Chapter 6). 
 
TABLE 4.3 Projection scenario assumptions 
 
 Low pressure Central High pressure Progress 
Public Acute Hospital     
Demand assumptions     
Population growth and 
age structure 
Low Central Central Central 
Healthy ageing Dynamic Equilibrium Moderate Healthy 
Ageing 




- - - Linearly reduce rate of 
avoidable 
hospitalisations each 
year, converging to 
33% reduction by 2035 
Waiting-list 
management 
- - - Model additional non-
recurring activity to 
reduce current backlog 
between 2021–2025; 
additional recurring 
activity to sustain 12-
week waiting times 
Cost assumptions     
Pay COSMO Delayed 
Recovery – projected 
government-sector 
wage growth (2.2% 
p.a.) 
COSMO Recovery – 
projected 
government-sector 
wage growth (2.5% 
p.a.) 




+1 pct point p.a. 
(3.5% p.a.) 
COSMO Recovery – 
projected 
government-sector 
wage growth (2.5% 
p.a.) 
Non-pay     
Drug cost 4.2% increase p.a. 5.2% increase p.a. 6.2% increase p.a. 5.2% increase p.a. 
Other COSMO Delayed 
Recovery – indexed 
to projected 
inflation rate + 0.5 
pct point p.a. 
COSMO Recovery – 
indexed to projected 
inflation rate + 1 pct 
point p.a. 
COSMO Recovery – 
indexed to projected 
inflation rate + 1 pct 
point p.a. 
COSMO Recovery – 
indexed to projected 
inflation rate + 1 pct 
point p.a. 
Psychiatric In-patient      
Demand assumptions     
Population growth 
and age structure 
Low Central  - 
Healthy ageing - -  - 
Cost assumptions     
Pay COSMO Delayed 
Recovery – projected 
government-sector 
wage growth (2.2% 
p.a.) 
COSMO Recovery – 
projected 
government-sector 
wage growth (2.5% 
p.a.) 




+1 pct point p.a. 
- 
Non-pay COSMO Delayed 
Recovery – indexed 
to projected 
inflation rate + 0.5 
pct point p.a. 
COSMO Recovery – 
indexed to projected 
inflation rate + 1 pct 
point p.a. 
COSMO Recovery – 
indexed to projected 




Source: Authors’ representation. 
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4.4 OVERVIEW OF DATA SOURCES 
In Wren et al. (2017), where possible disaggregated administrative data on service 
utilisation were applied in the analyses. As described in Wren et al. (2017), 
administrative data are collected by organisations, including government bodies, 
for administrative purposes (e.g. Hospital In-Patient Enquiry – HIPE). While these 
data are not primarily collected for research purposes, which can create 
challenges, their use is becoming more common. For the purposes of projecting 
healthcare demand and expenditure, access to administrative data is especially 
useful as the data are routinely collected; do not depend on self-reporting; and are 
often stringently audited. Additionally, they usually provide information on the full 
population of service users.41  
 
Granular administrative data on public acute hospital services are available for this 
analysis. For example, in modelling projected demand for public acute hospital day 
and in-patient services, detailed discharge data collected by the Healthcare Pricing 
Office (HPO) in the HIPE scheme are used.42 Furthermore, specialty costing data 
collected by the HPO provided an estimate of total activity levels for emergency 
department (ED) and OPD attendances.43,44 
 
Data provided by the National Treatment Purchase Fund (NTPF) have allowed a 
detailed analysis of public patient waiting lists for OPD appointments, and day 
patient and in-patient treatment (Brick and Keegan, 2020b). The data have enabled 
the estimation of the activity and expenditure (excluding any associated capital 
costs) required to achieve a 12-week waiting time. 
 
Data provided by the Health Research Board (HRB) National Psychiatric In-Patient 
Reporting System (NPIRS) enable the generation of specialist public acute in-
patient psychiatric profiles for inclusion in the model.45,46 There is no overlap in the 
activity reported in HIPE and the activity reported in NPIRS. These psychiatric 
hospitals/units do not report their activity to HIPE and are not currently part of the 
ABF process, even when co-located. The expenditure data environment has proved 
very challenging in this area. There are currently no patient-level cost data 
available on acute public in-patient psychiatric episodes. In addition, the data 
 
41 In Wren et al. (2017), where administrative data were not available, use was made of survey data. Application of survey 
data was particularly necessary for modelling non-acute healthcare demand where no appropriate administrative data 
on healthcare use were available. 
42  HIPE is a health information system designed to collect clinical and administrative data on discharges from, and deaths 
in, public acute hospitals in Ireland. 
43  For a detailed explanation of the data and methods used to generate the baseline utilisation profiles see Brick and 
Keegan (2020a). 
44  We do not capture a small amount of OPD activity that takes place in non-Activity-based Funding (ABF) hospitals. 
45  For a detailed explanation of the data and methods used to generate the baseline utilisation profiles see Brick et al. 
(2020a).  
46  Unlike acute public hospitals, there are no waiting-list data available for acute adult in-patient psychiatric services see 
Brick et al. (2020a). 
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collected by the NPIRS, unlike HIPE data, have no complexity weighting. This meant 
that we had to estimate an average unit cost per bed day for 2018 using a top-
down method. Data provided by the HSE as part of the annual System of Health 
Accounts submission are used to ascertain the total expenditure on acute HSE and 
HSE-funded adult psychiatric in-patient units.47,48,49,50 A cost per 2018 bed day is 
achieved by dividing the total expenditure in 2018 by the total number of bed days 
in 2018. 
 
With the exception of in-patient psychiatric services, cost data for this analysis are 
sourced from speciality costing data captured by the HPO. Speciality cost returns 
are submitted by all hospitals funded through ABF (40 hospitals).51 Speciality costs 
refer to the costs associated with all patients of a consultant in a particular 
specialty (e.g., ‘all costs associated with the patients of cardiologist(s) should be 
allocated to the cardiology specialty’) (Healthcare Pricing Office, 2019b). In this 
process, costs are matched to the service that generates them (e.g. day patients) 
and are allocated to cost centres such as wards and departments. This process 
provides detailed breakdowns of pay, non-pay and overhead costs for each 
hospital through time. For the purposes of this analysis, HPO provided speciality 
costing returns aggregated across all hospitals for each year 2015, 2016, 2017, and 
2018.  
 
While the HPO specialty costing files have very detailed categories of costs 
(Healthcare Pricing Office, 2019b), for the purpose of the projections, and in 
consultation with the HPO, we aggregated these to three categories: pay, non-pay 
drugs and non-pay other. 
1) Pay52 – includes pay for medical and dental, nursing and allied health 
professionals, administration, para-medical, catering, housekeeping, all other 
support services, and any pay overheads. Pay overheads include the 
proportion of the overhead from services such as radiology, pharmacy, 
laboratories etc., as determined by the HPO, attributable to pay. 
 
47  These are defined as acute adult in-patient units with a 24-hour medical presence and classified as approved centres 
by the Mental Health Commission under the Mental Health Act 2001. 
48  A list of the 29 included units can be found in Appendix B. These units account for 80 per cent of total acute psychiatric 
in-patient expenditure and 89 per cent of acute psychiatric in-patient bed days in 2018. 
49  For baseline utilisation profiles and projections of demand for the aggregated public acute adult psychiatric in-patient 
episodes included in the expenditure analysis, see Appendix B. 
50  HSE National Finance advised that the HSE’s current financial reporting system is aligned to Annual Financial Statements 
(i.e., Nursing pay, Drugs and Medicines etc.) and does not align to the services and sub-services in operation. To obtain 
a service view of Mental Health expenditure through the System of Health Accounts, high-level assumptions and 
allocations were required to be included in a manual calculation of this service breakdown. The Future Health Report 
(Department of Health, 2012) identified the financial and service information systems of the Health Service as not fit 
for purpose. To address this, over 200 legacy financial systems will be moved to a Single Integrated Financial and 
Procurement Management System (IFMS). This process is now underway, the IFMS project is currently in the detailed 
design phase. When the IFMS system is fully implemented, Mental Health will be able to report on a more accurate 
basis in relation to expenditure by service category. Personal communication, HSE National Finance, 8 October 2020. 
51  See Brick and Keegan (2020a) for baseline utilisation profiles and a list of the hospitals included in the analysis. 
52  Specialty costing does not include superannuation. 
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2) Non-pay drugs – captures costs of drugs and medicines. 
3) Non-pay other – includes all other costs outside of pay and non-pay drugs. This 
includes such items as medical and surgical supplies, office equipment, 
transport, and maintenance. Non-pay overheads include the proportion of the 
overhead from services such as radiology, pharmacy, laboratories etc., as 
determined by the HPO, attributable to non-pay. 
 
Table 4.4 lists the principal data sources employed in the baseline demand and 
expenditure analysis and in the analysis of waiting lists. Where possible, data have 
been analysed at the level of SYOA and sex, with the most disaggregated age 
breakdowns included where SYOA data are not available. The base year for this 
report is 2018. Where data from 2018 are not available or unsuitable, particularly 
in light of Covid-19, data from other time periods are used to supplement the 
analysis (this is clearly indicated in the report).  
 
TABLE 4.4 Principal data sources for baseline expenditure analysis – summary 
 
Service Data Provider Year 
Public acute hospitals  HPO 2018 
ED HPO Specialty Costing HPO 2015–2018 
OPD HPO Specialty Costing HPO 2015–2018 
Day patient HIPE HPO 2015–2018 
In-patient HIPE HPO 2015–2018 









In-patient psychiatric  
(public acute adult) 
NPIRS 





Note: See Brick and Keegan (2020a) for full description of the data used to establish baseline utilisation. 
 
4.5 SUMMARY 
This chapter provided a detailed description of the projection methods, applied in 
the analysis in this report. The development of projection methods was informed 
by a detailed review of the evidence on the drivers of healthcare expenditure and 
their application to component-based modelling, reviewed in Chapter 2. The 
chapter also outlined the final expenditure projection scenarios to be applied in 
Chapters 5 to 7 and provided an overview of the data sources employed for the 
analysis. Chapters 5 to 7 present the findings from the analyses and projections. 
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CHAPTER 5 
Findings: Public acute hospital expenditure by service 
Chapter 5 Findings: Public acute hospital expenditures by service 
5.1 INTRODUCTION 
This chapter presents findings for projected public acute hospital expenditure at 
the service level to 2035. The services examined are public acute hospital 
outpatient (OPD) attendances, emergency department (ED) attendances, and day-
patient and in-patient discharges. Maternity services are presented separately 
throughout. Expenditures are projected for three scenarios: low-pressure, central, 
and high-pressure. The three scenarios incorporate assumptions that place varying 
expenditure pressures on acute services to 2035. (Chapter 4 provided a detailed 
discussion on the development of, and assumptions underlying, these projection 
scenarios.) 
 
Age- and sex-specific expenditure profiles for each service in 2018 provide the basis 
for projections in this chapter. These expenditure profiles, in turn, are generated 
from underlying age- and sex- specific activity rate profiles for 2018, combined with 
the average unit cost of delivering care. Underlying age- and sex- specific activity 
profiles for 2018 are reported and analysed separately in Brick and Keegan (2020a). 
The starting point for this chapter is an analysis of unit costs of care for each 
service. These unit costs reflect all the treatment and care costs as well as running 
costs associated with the delivery of care, but are exclusive of capital and 
depreciation. Baseline expenditures and projections presented in this chapter 
therefore relate to current expenditure. As described in Chapter 1, both public and 
private patients are treated in public acute hospitals. Baseline expenditures and 
projections for day-patient and in-patient expenditure in this chapter, unless 
stated, include both publicly and privately financed activity.  
 
Section 5.2 presents an analysis of trends in unit costs of care between 2015 and 
2018. Section 5.3 presents findings on baseline expenditure for public hospital ED 
and OPD attendances. Section 5.4 presents findings on baseline expenditure for 
public hospital day-patient and in-patient discharges. Section 5.5 presents findings 
for projected expenditure to 2035 for categories of care analysed in Section 5.3 
and 5.4. Section 5.6 discusses and concludes. 
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5.2 FINDINGS – UNIT COSTS 
Table 5.1 summarises the unit costs of services in public acute hospitals between 
2015 and 2018.53 The unit costs, provided by the HPO, have increased year-on-year 
for each service over the period. The average annual compound growth rate 
ranged from 3.1 per cent for an in-patient to 6.5 per cent for a day patient.  
 












  € € € € 
2015 263 142 733 4,555 
2016 270 156 754 4,602 
2017 294 163 836 4,794 
2018 298 171 885 4,985 
Average annual growth 2015–2018 4.2% 6.2% 6.5% 3.1% 
 
Source: HPO Specialty Costing, 2015-2018; HIPE, 2015-2018. 
 
Data from the HPO allows for the unit cost of each service to be disaggregated into 
pay, non-pay drugs, and non-pay other components. Figure 5.1 shows, for 2018, 
the proportion of the unit cost for each service accounted for by each of pay, non-
pay drugs, and non-pay other. Pay accounts for the highest proportion of the unit 
cost across all services, between 49.2 per cent for day-patient discharges and 76.3 
per cent for ED attendances. Across all services, non-pay drugs contributed the 
highest proportion to the cost of a day-patient discharge in 2018 (23.6%). 
 
 
53 The unit cost of a day and in-patient discharge captures the overall average cost (across all patient types) of treating a 
single weighted unit of activity. The unit cost of treating a private patient will largely reflect the unit cost of treating a 
public patient, as the same staff and non-staff resources are applied in delivering care to both categories of patients. 
The only exception to this relates to the salaried consultant component of the unit cost which is part of the cost of 
providing public but not private care. The data available does not allow us to disentangle this cost component from our 
overall average base cost. Therefore, the private expenditure reported in this analysis is a closer reflection of the overall 
cost of treating private patients, which has a consultant pay component, rather than the direct cost to the hospital 
which for private patients does not include the consultant fee. 
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Source: HPO Specialty Costing 2018; HIPE 2018. 
 
Figure 5.2 outlines the proportionate contribution of each component to the 
change in the unit cost of each service between 2015 and 2018. The biggest 
contributor to the change in the unit cost for each service between 2015 and 2018 
was pay; contributing 80 per cent to the increase in the unit cost of an ED 
attendance, 73.4 per cent to in-patient discharge cost, 57.5 per cent to OPD 
attendance cost, and 45.6 per cent to day-patient discharge cost. Non-pay made a 
similar contribution across all services. Non-pay drugs only affected OPD and day 
patient unit costs, with one -quarter and one -third of the increase attributed to 
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Source: HPO Specialty Costing 2018; HIPE 2015-2018. 
 
The HPO specialty costing data further disaggregate the pay category by medical 
and dental, nursing, and other (Figure 5.3).54 Medical and dental contribute 
approximately one-quarter to the total pay cost of the four services, slightly less 
for day-patient discharges. Nursing contributes 47.5 per cent to the pay 
component of an in-patient discharge compared to 21.9 per cent for an OPD 
attendance. Other pay contributes 54.4 per cent to the pay component of an OPD 
attendance compared to 30.3 per for an in-patient discharge. Some of the areas 
contributing most to the other pay costs were, radiology for ED and OPD 
attendances, and anaesthetics for day and in-patient discharges. 
 
 
54 Other includes administration, para-medical, catering, housekeeping, maintenance, porters, and other support 
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Note: Other includes administration, para-medical, catering, housekeeping, maintenance, porters, and other support services.  
It also includes pay components of services such as radiology, laboratories, pharmacy, allied clinics etc. 
Source: HPO Specialty Costing 2018; HIPE, 2018. 
 
5.3 FINDINGS – BASELINE EXPENDITURE – ATTENDANCES 
The following sections outline baseline expenditure profiles for ED and OPD 
attendances, and day and in-patient discharges in 2018.55  
 
5.3.1 Emergency department 
Expenditure on ED attendances in public acute hospitals amounted to €418.6m in 
2018. Figure 5.4 shows that age-specific expenditure was highest at the youngest 
ages (<4 years) and oldest ages (75 years and older), with similar patterns for males 
and females. Notably, while total expenditure decreases from 70 years, per capita 
expenditure continues to increase. 
 
 


























Find ings :  Publ ic  acute hospita l  expend iture  by s erv ice |73  




Source: HPO Specialty Costing, 2018; HSE Patient Experience Time, 2018; ESRI population data, 2018. 
 
5.3.2 Outpatient department 
Total expenditure on OPD attendances in 2018 was €676.3m. Figure 5.5 shows the 
estimated age- and sex-specific OPD expenditure for non-maternity (€584.3m) and 
maternity (€92m) in 2018.56 With the exception of those under 15 years, 
expenditure is higher for females (excl. maternity) than males at all ages. There is 
a particularly high differential between 30 and 65 years. Total expenditure (excl. 
maternity) is highest for females at 45–49 years while for males it is highest at 65–
69 years. Per capita expenditure is highest for males and females at 75–79 years. 
Estimated maternity OPD expenditure accounts for 13.6 per cent of total OPD 
expenditure. Both total and per capita expenditure peak at 30–34 years. 
 
 
56 See Brick and Keegan (2020a) for a full description of the methods for how age- and sex-specific profiles for OPD 
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FIGURE 5.5 OPD – age- and sex-specific expenditure and expenditure per capita, 2018 
 















































































































Female  (excl. mat)
- per capita











































Find ings :  Publ ic  acute hospita l  expend iture  by s erv ice |75  
5.4 FINDINGS – BASELINE EXPENDITURE – DISCHARGES 
5.4.1 Day patients 
Public acute hospital expenditure on day-patient (excl. maternity) discharges57 
amounted to €909.9m in 2018. Figure 5.6 shows the age- and sex-specific 
distribution of expenditure and expenditure per capita.58 In 2018, 50.9 per cent of 
expenditure related to female discharges (€462.8m) and 49.1 per cent to male 
discharges (€447.1m). Expenditure peaked at 68 years for males and 69 years for 
females. While male expenditure is greater than female at the youngest and oldest 
ages, the opposite is the case for discharges aged 25–59 years, where female 
expenditure is substantially greater than male. Expenditure per capita follows a 
similar pattern but peaks at older ages (80 years for males and 76 years for 
females). 
 
FIGURE 5.6 Day patients (excl. maternity) – age- and sex-specific complexity-weighted expenditure and 




Source: HIPE, 2018; HPO Specialty Costing, 2018; ESRI population data, 2018. 
 
When total expenditure is disaggregated by the public/private status59 of the 
patient, we see, as expected, that expenditure on public day-patient discharges 
(€753.1m – 82.8%) far exceeds that on private discharges (€156.9m – 17.2%) 
 
57  ‘Each HIPE discharge record represents one episode of care. Patients may be admitted to hospital more than once in 
any given time period with the same or different diagnoses. In the absence of a unique health identifier, therefore, the 
data reported to HIPE facilitate analysis of hospital discharge activity but do not permit analysis of certain parameters, 
such as the number of hospital encounters per patient; or estimate the incidence or prevalence of a particular disease’ 
(Healthcare Pricing Office, 2019a, pg 7). 
58  Day patient profiles are complexity-weighted to account for relative intensity of resource use across the age distribution 
(Brick and Keegan, 2020a). 
59  ‘Public/private status refers to whether the patient saw the consultant on a private or public basis. It does not relate 
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(Figure 5.7). While the age-specific expenditure peaks at similar ages for public (70 
years) and private (68 years) discharges, expenditure increases with age at a faster 
rate for public discharges. Per capita expenditure peaks at 81 years for public 
patients and 75 years for private patients. 
 
FIGURE 5.7 Day patients (excl. maternity) – age-specific complexity-weighted expenditure and expenditure per 




Source: HIPE, 2018; HPO Specialty Costing, 2018. 
 
5.4.2 In-patients 
Total public acute hospital expenditure on in-patient (excl. maternity) discharges 
amounted to €2,967.5m in 2018. Figure 5.8 shows the age- and sex-specific 
distribution of expenditure and expenditure per capita.60 In 2018, 53.2 per cent of 
expenditure related to males (€1,578.4m) and 46.8 per cent to females 
(€1,389.2m), with expenditure for both highest at youngest ages, particularly on 
those <1 year old.61 From one year to 30 years expenditure is relatively stable but 
from 30 years onwards expenditure increases with age. There is a second peak for 
males at 71 years and at 90+ years for females at which points expenditure 
decreases with age.  
 
 
60  In-patient profiles are complexity-weighted to account for relative intensity of resource use across the age distribution 
(see Brick and Keegan (2020a)). 
61  This is related to both the relatively high volume and complexity of discharges in this age category. A large proportion 
of these in-patients are categorised as ‘newborn’ (51.2% of total in-patients and 54.3% of emergency in-patients). These 
are emergency in-patients aged between 0–27 days who are categorised as in-patients following delivery due to 
conditions such as being preterm, respiratory issues, neonatal jaundice, or observation for infection. Well newborn 
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There is little difference in expenditure between male and female discharges at 
younger ages until approximately 55 years when expenditure on males becomes 
substantially greater than that on females. This remains the case until 80+ years, 
at which point female expenditure exceeds male expenditure. Expenditure per 
capita follows a similar pattern but, rather than decreasing in later years, it 
continues to increase. 
 
FIGURE 5.8 In-patients (excl. maternity) – age- and sex-specific complexity-weighted expenditure and 
expenditure per capita, 2018 
 
 
Source: HIPE, 2018; HPO Specialty Costing, 2018; ESRI population data, 2018. 
 
In-patient (excl. maternity) expenditure is disaggregated by public/private status 
in Figure 5.9. Expenditure on public in-patients comprises 82.0 per cent 
(€2,433.1m) of total in-patient expenditure, with the remaining 18.0 per cent 
(€534.4m) on private in-patients. The age distribution of expenditure is similar for 
public and private patients, with the highest expenditure at the youngest and 
oldest ages. Expenditure per capita increases with age for both public and private 
in-patients but the differential between them increases substantially from 
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FIGURE 5.9 In-patients (excl. maternity) – age-specific complexity-weighted expenditure and expenditure per 
capita by public/private status, 2018 
 
 
Source:  HIPE, 2018; HPO Specialty Costing, 2018; ESRI population data, 2018. 
 
Elective and emergency in-patient 
Figure 5.10 disaggregates expenditure by admission type,62, elective and 
emergency in-patient. Of total in-patient (excl. maternity and acute 
medical/surgical assessment units (AMAU/ASAU) only63) expenditure, elective in-
patient expenditure accounts for 26.7 per cent (€790.9m) and emergency in-
patient expenditure for 72.2 per cent (€2,143.5m). For elective discharges, 
expenditure peaks at 71 years while for emergency discharges it peaks at <1 year. 
Expenditure per capita increases considerably more with age for emergency than 
elective discharges. 
 
62  See Brick and Keegan (2020a) for a full description of the admission type disaggregation used in this analysis. 
63  Discharges from the ‘AMAU/ASAU only’ are recorded as emergency in-patients in HIPE. They are admitted as an 
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FIGURE 5.10 Elective and emergency in-patients (excl. maternity) – age-specific complexity-weighted 
expenditure and expenditure per capita by admission type, 2018 
 
 
Source: HIPE, 2018; HPO Specialty Costing, 2018; ESRI population data, 2018. 
 
Figure 5.11 shows age-specific in-patient (excl. maternity) expenditure 
disaggregated by admission status (elective and emergency) and public/private 
status. The pattern of expenditure across the age distribution is similar for public 
and private discharges.  
 
FIGURE 5.11 Elective and emergency in-patients (excl. maternity) – age-specific complexity-weighted 
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AMAU/ASAU in-patient 
Expenditure on AMAU/ASAU only in-patient discharges amounted to €33.1m in 
2018 or 1.1 per cent of total in-patient expenditure. Most units do not treat 
children, which explains the age distribution of expenditure. Expenditure increases 
with age to approximately 70 years old at which point it begins to decrease, while 
expenditure per capita increases with age (Figure 5.12). 
 
FIGURE 5.12 AMAU/ASAU only (excl. maternity) – age- and sex-specific complexity-weighted expenditure and 
expenditure per capita, 2018 
 
 
Source: HIPE, 2018; HPO Specialty Costing, 2018; ESRI population data, 2018. 
 
5.4.3 Maternity 
Expenditure on maternity discharges accounted for €262.4m in 2018, 3.6 per cent 
of which relates to maternity day patients. The age-specific distribution of 
expenditure is presented in Figure 5.13. Expenditure increases with age until 
approximately 35 years at which point it begins to decrease. Expenditure on private 
maternity patients accounts for 20.3 per cent of day-patient maternity expenditure 
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FIGURE 5.13 Maternity patients – age-specific complexity-weighted expenditure and expenditure per capita 







Notes: Expenditure per capita is calculated from ESRI population estimates of the female population aged 14–51 years. 
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5.5 FINDINGS – EXPENDITURE PROJECTIONS 
In the following section, we present service-level findings of three projection 
scenarios: low-pressure, central and high-pressure. These scenarios group 
together assumptions on demand (population growth and ageing, healthy ageing) 
and cost (pay cost, drug cost, ‘other’ non-pay cost growth).64 The low- and high-
pressure scenarios incorporate assumptions that would place lesser or greater 
expenditure pressures on acute services relative to the central scenario. Table 5.2 
summarises the assumptions applied in each of the projection scenarios (a more 
detailed description of these assumption and scenarios is provided in Chapter 4). 
Expenditure projections are presented in both real and nominal terms between 
2018 and 2035.65 Real projections hold costs constant at 2018 values, thus enabling 
analysis of projected volumes of care as if the cost of care had not changed. 
Nominal projections capture both demand and cost effects.  
 
TABLE 5.2 Projection scenario assumptions 
 
 Low pressure Central High pressure 
Demand assumptions    
Population growth 
and ageing 
Low Central Central 
Healthy ageinga Dynamic equilibrium Moderate healthy ageing None 
Cost assumptions    
Pay COSMO Delayed Recovery – 
projected government-sector 
wage growth (2.2% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth (2.5% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth + 1 pct point p.a. 
(3.5% p.a.) 
Non-pay    
Drug costb 4.2% increase p.a.  5.2% increase p.a.  6.2% increase p.a.  
Otherc COSMO Delayed Recovery – 
indexed to projected inflation 
rates + 0.5 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates + 1 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates + 1 pct point p.a. 
 
Notes: a No healthy ageing shifts applied to maternity care. 
 b Applied to day-patient and in-patient projections only. 




Table 5.3 presents real and nominal projected expenditure growth for public ED 
care from 2018 to 2035 based on our three projection scenarios. In real terms, ED 
attendance expenditure is projected to increase by 11.7 per cent, 16.7 per cent and 
18.5 per cent across our low-pressure, central, and high-pressure scenarios, 
respectively between 2018 and 2035. This equates to projected real ED 
expenditure in 2035 of between €467.5m and €496.0m. In nominal terms, ED 
expenditure is projected to increase by 62.2 per cent, 78.2 per cent and 109.2 per 
cent across our low-pressure, central, and high-pressure scenarios, respectively 
 
64 The drug cost assumption applies to the day and in-patient projections only. 
65  Appendix D reports projected expenditures for the services analysed in this report in terms of average annual growth 
rates. 
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between 2018 and 2035. This equates to projected nominal ED expenditure 
requirements in 2035 of between €679.0m and €876.0m.  
 




Projected HCE growth 2018–2035 (%) 
Reala Nominal 
Activity Expenditure (€m) Low Central High Low Central High 
Male 715,411 213.0 11.2 16.5 18.3 61.4 77.8 109.0 
Female 690,416 205.6 12.2 17.0 18.6 63.0 78.6 109.5 
Total 1,405,828 418.6 11.7 16.7 18.5 62.2 78.2 109.2 
 
Notes: a Real projections hold base costs constant at their 2018 values. 
Source:  HPO Specialty Costing, 2018; HSE Patient Experience Time, 2018; ESRI population data, 2018, authors’ calculations. 
 
Nominal projections presented in Table 5.3 point towards cost (which is held 
constant at 2018 values under real projections) rather than demand pressures as 
the major driver of projected ED expenditure. This is illustrated in more detail in 
Figure 5.14 which, for each scenario, decomposes projected ED expenditure. 
Under the central scenario, for example, population growth (€45.3m) and changes 
to the population age structure (€24.8m) account for a combined additional 
€70.1m of expenditure by 2035. In contrast, pay (€194.1m) and non-pay (€63.2m) 
drivers account for a combined €257.2m of additional expenditure by 2035. Pay 
cost places the largest pressure on projected expenditure and reflects the fact that 
the vast majority (76.3%) of the unit cost of delivery of care in EDs is pay-related 
(Figure 5.1). 
 
The relative contribution of demand and cost drivers also varies consistently across 
our low- and high-pressure scenarios. For instance, relative to the central scenario, 
combined demand pressures are lower under the low-pressure scenario (€48.9m), 
due to the combined effect of lower population growth and more optimistic 
healthy ageing. Similarly, combined demand pressures are greater under the high-
pressure scenario (€77.4m), where no healthy ageing is assumed. However, similar 
to the central scenario, pay is the dominant driver across low- and high-pressure 
projection scenarios. This is particularly true of the high-pressure scenario whereby 
pay (€300.2m) accounts for 65.6 per cent of all additional projected expenditure 
by 2035. 
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Notes: * Adjusted for healthy ageing in the low and central scenarios 
Source:  HPO Specialty Costing, 2018; HSE Patient Experience Time, 2018; ESRI population data, 2018, authors’ calculations. 
 
Figure 5.15 illustrates baseline 2018 public ED attendances, by age, and projections 
for 2035 for each of the projection scenarios. As the activity rate distributions 
underlying our demand projections differ by age, but unit costs do not, the shape 
of these projected age-specific curves will be influenced by demographic factors. 
Increases in expenditure are most notable for younger adults and those aged 45 
years and over. Relative to other services, the ED activity rate is uniform across 
much of the age distribution (Brick and Keegan, 2020a). Population growth (driven 
by net inward migration of younger adults over the medium term) plays a more 
important role than the population age structure in driving increased expenditure. 
  
2018 2035 2035 2035
 Low  Central  High
Population growth 31.7 45.3 45.3
Population age structure* 17.2 24.8 32.1
Pay 155.3 194.1 300.2
Non-pay other 56.2 63.2 79.7
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Source: HPO Specialty Costing, 2018; HSE Patient Experience Time, 2018; ESRI population data, 2018; authors’ calculations. 
 
Outpatient department 
Table 5.4 presents real and nominal projected expenditure growth for public OPD 
care from 2018 to 2035, based on our three projection scenarios. In real terms, 
OPD care expenditure (incl. maternity) is projected to increase by 12.1 per cent, 
16.4 per cent and 18.1 per cent across our low-pressure, central and high-pressure 
scenarios, respectively, between 2018 and 2035. This equates to overall projected 
real OPD expenditure in 2035 of between €758.5m and €798.6m. Notably, either 
flat (0.3%) or slightly negative (-3.3%) real expenditure growth is observed for 
maternity OPD across scenarios. This is heavily influenced by the projected decline 
in absolute numbers in the population of those aged 30–39 by 2035, the age cohort 
in which use of these services is most intensive (Figure 5.5). 
 
In nominal terms, OPD expenditure is projected to increase by 63.4 per cent, 77.8 
per cent and 107.6 per cent across our low-pressure, central and high-pressure 
scenarios, respectively, between 2018 and 2035. This equates to projected OPD 
expenditure requirements in 2035 of between €1,105.2m and €1,404.2m. While 
projected maternity OPD expenditure was noted to be relatively flat in real terms, 
nominal increases of 40.8 per cent, 53.2 per cent and 76.3 per cent are observed 
across the low-pressure, central and high-pressure scenarios by 2035, respectively. 
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Projected HCE growth 2018–2035 (%) 
Reala Nominal 
Activity Expenditure (€m) Low  Central High Low Central High 
Male 1,525,348 260.2 14.1 19.3 21.9 66.3 82.2 114.3 
Female         
Excl. maternity 1,900,075 324.1 15.0 18.6 20.1 67.5 81.3 111.2 
Maternityb 539,880 92.1 -3.3 0.3 0.3 40.8 53.2 76.3 
Total 3,965,303 676.4 12.1 16.4 18.1 63.4 77.8 107.6 
 
Notes: a Real projections hold base costs constant at their 2018 values. 
 b We assume no healthy ageing effects for maternity care. 
Sources:  HPO Specialty Costing, 2018; National Treatment Purchase Fund, 2018; NHS 2018-2019; ESRI population data, 2018; authors’ 
calculations. 
 
Figure 5.16 takes a closer look at the relative contribution of demand and cost 
drivers, through decomposing nominal OPD expenditure projections by scenario. 
Under the central projection scenario, population growth (€73.9m) and changes to 
the population age structure (€36.9m) account for a combined additional €110.8m 
of expenditure by 2035. In contrast, pay (€285.1m) and non-pay (€130.5m) drivers 
account for a combined €415.6m of additional expenditure by 2035. Similar to ED, 
pay cost places the largest pressure on projected expenditure and reflects the fact 
that the majority (69.6%) of the unit cost of treating an OPD attendance is pay-
related (Figure 5.2.). 
 
As with ED care, pay remains the most significant driver of projected expenditure 
growth across all scenarios; the large projected expenditure increases under the 
high-pressure scenario are particularly sensitive to the assumed evolution of pay. 
Under the high-pressure scenario, pay (€440.9m) accounts for 60.6 per cent of all 
additional projected nominal expenditure by 2035. 
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Notes: * Adjusted for healthy ageing in the low pressure and central scenarios 
We assume no healthy ageing effects for maternity care. 
Sources:  HPO Specialty Costing, 2018; National Treatment Purchase Fund, 2018; NHS 2018-2019, ESRI population data, 2018; authors’ 
calculations. 
 
Figure 5.17 illustrates the projected change in OPD expenditure between 2018 and 
2035 across the age distribution for all scenarios. Across all scenarios, there are 
two peaks apparent in OPD expenditure growth, one around 25–34 years and the 
other at older ages. This reflects differences in underlying age-related activity 
profiles (Brick and Keegan, 2020a). In particular, maternity activity is largely driving 
the peak at 25–34 years. At older ages, assumed healthy ageing effects 
incorporated in the low-pressure and central scenarios reduce expenditure relative 
to what they otherwise would be. 
  
88|  Pro ject ions  o f  expenditure for  pub l ic  hos pi ta ls  in  I re land ,  2018 –2035  








Table 5.5 reports real and nominal projected expenditure growth for public day-
patient and in-patient care (incl. maternity) from 2018 to 2035 based on our three 
projection scenarios. In real terms, total day-patient expenditure is projected to 
increase by 20.7 per cent, 26.6 per cent and 30.7 per cent across our low-pressure, 
central and high-pressure scenarios, respectively, between 2018 and 2035. This 
equates to projected total real day-patient expenditure requirements in 2035 of 
between €1,109.8m and €1,201.5m.  
 
Projected real growth rates for in-patient care are noticeably higher across 
scenarios, reflecting a higher concentration of (complexity-weighted) in-patient 
per capita expenditure at older ages in 2018 relative to day patients. Between 2018 
and 2035, total real in-patient expenditure is projected to increase by 25.1 per 
cent, 32.8 per cent and 38.0 per cent across our low-pressure, central and high-
pressure scenarios, respectively. This equates to projected total real in-patient 
expenditure requirements in 2035 of between €4,029.4 and €4,445.6m. For both 
day-patient and in-patient care, projected growth in real public expenditure is 
moderately greater than projected growth in real private expenditure to 2035. 
 
Notably, real expenditure on maternity care is set to decline for both day patients 
(between -4.6% and -8.3%) and in-patients (between -2.5% and -6.2%) by 2035. 
The decline in the absolute numbers in the 30 to 39 age cohort over time leads to 
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private maternity care, reflecting the older profile of women who use private 
services. 
 
While total in-patient expenditure growth is set to outstrip day-patient 
expenditure growth in real terms, the opposite is the case for nominal expenditure 
growth. In nominal terms, total day-patient expenditure is projected to increase by 
92.0 per cent, 118.7 per cent and 160.7 per cent, across our low-pressure, central 
and high-pressure scenarios, respectively, between 2018 and 2035. This equates 
to projected total nominal day-patient expenditure requirements in 2035 of 
between €1,765.8m and €2,396.9m.  
 
In contrast, by 2035 nominal in-patient expenditure is expected to increase by 85.9 
per cent, 108.6 per cent and 150.0 per cent across our low-pressure, central and 
high-pressure scenarios. This equates to projected total nominal in-patient 
expenditure requirements in 2035 of between €5,985.3m and €8,050.0m. The 
larger nominal expenditure growth for day patients is driven by the large projected 
increase in the cost of drugs (Figure 5.17), which represent a much larger 
proportion of the cost of delivering day-patient relative to in-patient care (see 
Figure 5.1). As with real expenditure, for both day-patient and in-patient care, 
projected growth in nominal public expenditure is moderately greater than 
projected growth in real private expenditure to 2035.  
 
While real expenditure on day and in-patient maternity care is set to fall by 2035 
due to lower projected volumes of care, nominal expenditure is set to increase as 
a result of projected increases in the cost of delivery of a unit of service. In nominal 
terms, total day-patient maternity expenditure is set to increase by between 45.9 
and 90.4 per cent, while total in-patient maternity expenditure is set to increase 
by between 39.3 and 76.6 per cent, between 2018 and 2035. 
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TABLE 5.5 Day patient and in-patient – projected real and nominal expenditure growth by public/private status 











Low Central High Low Central High 
Day patients         
Total 1,038,825 919.5 20.7 26.6 30.7 92.0 118.7 160.7 
Male 505,172 447.1 21.7 28.8 33.8 93.7 122.4 166.9 
Female 533,653 472.3 19.7 24.6 27.7 90.5 115.2 154.8 
Excl. maternityb 522,937 462.9 20.3 25.2 28.4 91.4 116.2 156.1 
Maternity 10,715 9.5 -8.3 -4.6 -4.6 45.9 64.8 90.4 
Public 859,387 760.6 20.8 26.9 31.1 92.3 119.2 161.6 
Male 423,141 374.5 21.9 29.1 34.2 94.0 122.9 167.8 
Female 436,245 386.1 19.8 24.8 28.1 90.6 115.6 155.6 
Excl. maternityb 427,703 378.6 20.3 25.4 28.7 91.4 116.5 156.9 
Maternity 8,542 7.6 -6.2 -2.5 -2.5 49.2 68.4 94.5 
Private 179,438 158.8 17.0 23.6 28.4 86.2 113.4 156.1 
Male 82,030 72.6 18.0 25.6 31.3 87.8 117.0 162.0 
Female 97,407 86.2 16.2 21.8 25.9 84.8 110.3 151.2 
Excl. maternity 95,234 84.3 16.9 22.6 26.8 86.0 111.7 153.0 
Maternity 2,173 1.9 -16.3 -12.6 -12.6 33.1 50.9 74.3 
In-patients         
Total 646,077 3,220.5 25.1 32.8 38.0 85.9 108.6 150.0 
Male 316,645 1,578.4 27.8 36.6 42.8 89.9 114.5 158.5 
Female 329,433 1,642.1 22.5 29.2 33.5 82.0 103.0 141.8 
Excl. maternity 278,695 1,389.2 27.7 35.0 40.1 89.7 112.1 153.6 
Maternity 50,738 252.9 -6.2 -2.5 -2.5 39.3 53.2 76.6 
Public 530,083 2,642.3 25.0 32.8 38.2 85.6 108.7 150.2 
Male 260,351 1,297.8 27.3 36.2 42.5 89.1 113.9 158.0 
Female 269,732 1,344.5 22.7 29.6 34.0 82.3 103.6 142.7 
Excl. maternity 227,780 1,135.4 27.7 35.1 40.3 89.6 112.3 154.1 
Maternity 41,951 209.1 -4.0 -0.3 -0.3 42.6 56.6 80.5 
Private 115,995 578.2 23.3 31.6 37.4 83.1 106.8 148.8 
Male 56,294 280.6 27.8 37.2 44.0 89.8 115.5 160.8 
Female 59,701 297.6 19.1 26.4 31.2 76.9 98.5 137.5 
Excl. maternity 50,915 253.8 25.2 33.2 38.8 86.0 109.2 151.3 
Maternity 8,786 43.8 -16.7 -12.9 -12.9 23.7 36.8 57.7 
 
Notes: a Real projections hold base costs constant at their 2018 values. 
 b We assume no healthy ageing effects for maternity care. 
Source:  HIPE, 2018; ESRI population data, 2018; authors’ calculations. 
 
Table 5.6 reports real and nominal projected expenditure growth for in-patient 
elective and emergency care from 2018 to 2035 based on our three projection 
scenarios. In real terms, total elective in-patient expenditure is projected to grow 
by 22.4 per cent, 29.3 per cent and 34.2 per cent, across our low-pressure, central 
and high-pressure scenarios, respectively, between 2018 and 2035. This equates 
to projected real elective in-patient expenditure requirements of between 
€967.7m and €1,061.3m by 2035. Larger projected real expenditure increases are 
observed for emergency in-patient care, reflecting the steep per capita age 
gradient associated with this care (see Figure 5.10). Total real emergency in-patient 
expenditure is projected to increase by 29.0 per cent, 37.9 per cent and 44.3 per 
cent across our low-pressure, central and high-pressure scenarios, respectively, by 
2035. This equates to projected real emergency in-patient expenditure 
requirements of between €2,764.7m and €3,093.4m by 2035. For both elective and 
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emergency in-patient care, there is little variation in projected growth rates when 
split in terms of whether the care was public or privately financed. 
 
In nominal terms, total elective in-patient expenditure is projected to grow by 81.7 
per cent, 103.1 per cent and 143.0 per cent across our low-pressure, central and 
high-pressure scenarios, respectively, between 2018 and 2035. This equates to 
projected nominal elective in-patient expenditure requirements of between 
€1,437.4m and €1,921.7 by 2035. By 2035, total nominal emergency in-patient 
expenditure is projected to grow by 91.6 per cent, 116.6 per cent and 161.3 per 
cent across our three scenarios, respectively. Spending requirements for this care 
type are therefore projected to be between €4,106.8m and €5,601.4m by 2035. 
 
TABLE 5.6 Elective and emergency in-patients (excl. maternity) – projected real and nominal expenditure 











Central Low High Central Low High 
In-patients – elective         
Total 158,669 790.9 22.4 29.3 34.2 81.7 103.1 143.0 
Male 82,190 409.7 22.1 29.9 35.6 81.3 104.1 145.6 
Female (excl. maternity) 76,479 381.2 22.7 28.6 32.7 82.2 102.0 140.2 
Public 120,957 602.9 21.8 29.0 34.0 81.0 102.7 142.6 
Male 62,718 312.6 21.5 29.4 35.1 80.5 103.3 144.5 
Female (excl. maternity) 58,239 290.3 22.2 28.6 32.9 81.5 101.9 140.6 
Private 37,712 188.0 19.9 28.2 34.8 78.1 101.4 144.1 
Male 19,472 97.1 20.3 29.9 37.4 78.7 104.0 148.9 
Female 18,240 90.9 19.4 26.4 32.0 77.4 98.6 139.0 
In-patients – emergency         
Total 430,019 2,143.5 29.0 37.9 44.3 91.6 116.6 161.3 
Male 231,449 1,153.7 28.8 38.4 45.4 91.3 117.4 163.3 
Female (excl. maternity) 198,569 989.8 29.2 37.3 43.1 91.9 115.6 159.1 
Public 361,005 1,799.5 28.4 37.5 44.1 90.7 116.0 161.0 
Male 194,837 971.2 28.1 37.8 45.0 90.3 116.5 162.5 
Female (excl. maternity) 166,169 828.3 28.8 37.1 43.1 91.3 115.4 159.2 
Private 69,014 344.0 26.8 37.3 45.3 88.4 115.7 163.0 
Male 36,613 182.5 28.4 39.3 47.6 90.8 118.9 167.2 
Female (excl. maternity) 32,401 161.5 25.0 35.0 42.7 85.7 112.1 158.3 
 
Notes: a Real projections hold base costs constant at their 2018 values 
Source:  HIPE, 2018; ESRI population data, 2018; authors’ calculations. 
 
Figure 5.18 presents a decomposition of nominal day-patient expenditure growth 
between 2018 and 2035. Similarly to other services examined, cost rather than 
demand is the major driver of nominal expenditure projections. Under the central 
scenario, for instance, population growth (€99.6m) and changes to the population 
age structure (€145.1m) account for a combined additional €244.8m of required 
expenditure by 2035. The proportionately greater impact of ageing, not observed 
for OPD and ED, is again reflective of the steeper per capita expenditure age 
gradient associated with admitted care. Pay (€298.1m) and drugs (€375.7m) and 
other non-pay (€172.7m) cost drivers, in contrast, account for a combined €846.4m 
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of additional expenditure by 2035. As noted previously, projected drug cost growth 
is expected to be the largest driver of future day-patient expenditure 
requirements. 
 
Relative to the central scenario, combined demand pressures on expenditure are 
lower under the low-pressure scenario (€190.4m), due to the combined effect of 
lower population growth and more optimistic healthy ageing. Similarly, combined 
demand pressures are greater under the high-pressure scenario (€282.0m) where 
no healthy ageing is assumed. However, as in the central scenario, pay and drugs 
are the dominant drivers across the low- and high-pressure projection scenarios. 
This is particularly true of the high-pressure scenario whereby pay (€468.9m) and 
drug (€504.8m) cost pressures account for 65.9 per cent of all additional projected 
expenditure by 2035. 
 




Notes: * Adjusted for healthy ageing in the low- pressure and central scenarios. 
We assume no healthy ageing effects for maternity care. 
Source:  HIPE, 2018; ESRI population data, 2018; authors’ calculations. 
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Figure 5.19 presents a decomposition of nominal in-patient expenditure growth 
between 2018 and 2035. Similar to other services, cost drivers dominate demand 
drivers. Consistent with underlying per capita expenditure profiles, changes to the 
population age structure have a proportionately large effect as a demographic 
driver of expenditure, and are estimated to account for €707.8m of the €1,056.7m 
combined demographic effect under the central scenario. This concentration of 
expenditure at older ages is enhanced through complexity-weighting (see Brick and 
Keegan, 2020a). Pay is the dominant cost driver, accounting for €1,472.1m of 
projected additional expenditure. Compared with day patients, drug costs are a 
less significant driver of in-patient expenditure growth. This reflects the much 
lower proportion of in-patient care delivery attributable to drug costs (Figure 5.1). 
 
As with the other services examined, stronger assumed healthy ageing and lower 
population growth reduce additional demographic pressures (€808.9m) under the 
low-pressure scenario, while no assumed healthy ageing under the high-pressure 
scenario leads to increased demographic pressures (€1,225.2m), relative to the 
central scenario. However, modelled pay cost pressures (an additional €2,332.4m) 
under the high-pressure scenario is the most significant differentiating factor in 
terms of overall projected growth across scenarios. 
 




Notes: * Adjusted for healthy ageing in the low pressure and central scenarios. 
We assume no healthy ageing effects for maternity care. 
Source:  HIPE, 2018; ESRI population data, 2018; authors’ calculations. 
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Figure 5.20 presents the projected change in both day patient and in-patient 
nominal expenditure between 2018 and 2035 across the age distribution for all 
scenarios. For both day and in-patient care, growth in expenditure between 2018 
and 2035 takes place predominantly at the older end of the age distribution. This 
is consistent with the relatively large impact of ageing as a demographic driver for 
these services (even under assumed healthy ageing effects in the low-pressure and 
central scenarios) illustrated in Figures 5.18 and 5.19. 
 








































































































































































Find ings :  Publ ic  acute hospita l  expend iture  by s erv ice |95  
5.6 SUMMARY 
This chapter provided baseline estimates and expenditure projections for care in 
Irish public acute hospitals. Its focus was on comprehensively capturing baseline 
expenditure for the main public hospital services and types of care, and projecting 
that expenditure to 2035 under a range of alternative projection scenarios. 
Baseline expenditure and projections capture all non-capital expenditure 
associated with the delivery of care. For admitted public acute hospital patients, 
this expenditure can be financed by a combination of public and private (largely 
private health insurance) sources.  
 
5.6.1 Baseline expenditure, 2018 
Estimating baseline expenditure profiles required development of detailed 2018 
base-year activity rate profiles66 and unit costs of care. The baseline expenditure 
analysis alone provides a detailed and more comprehensive analysis of 
expenditure on public acute hospital services than has previously been available 
for Ireland.  
 
The baseline analysis highlights variation in expenditure profiles and the level and 
composition of unit costs of care across services. The cost of delivering a unit of 
service varied widely, from €171 on average for an OPD attendance to €4,985 for 
an in-patient hospital stay, in 2018. The major component of all unit costs was pay, 
although this varied by service from over three-quarters of the total unit cost for 
ED care (76.3%) to just under half for day-patient care (49.2%). Nearly a quarter of 
the unit cost (23.6%) of delivering day-patient care was attributable to drug costs, 
a far higher proportion than for other services. This is consistent with the 
substantial drug-related requirements for delivery of much of the care in day-
patient settings. For example, chemotherapy and radiotherapy combined 
accounted for 21.0 per cent of total day-patient discharges in 2018. 
 
The baseline analysis also found that, while expenditure on services tended to 
increase with age, there was large variation in the underlying per capita 
expenditure profiles. Per capita expenditure profiles express the distribution of 
underlying activity rates in expenditure terms, and many of the findings in this 
regard reflect previous insights reported in Wren et al. (2017). For instance, the 
emergency in-patient (excl. maternity) profile shows expenditure per capita peaks 
twice, at older ages and also in the youngest ages (<1 year) as any newborns 
requiring treatment are admitted as emergency in-patients.  
 
 
66  See Brick and Keegan (2020a) for a detailed analysis of these activity profiles. 
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ED and OPD care show less concentration of expenditure in older ages compared 
with admitted day-patient and in-patient care. While older individuals tend to use 
in-patient services more frequently, they also tend to use them more intensively. 
It was possible to account for both these factors through complexity-weighting 
these expenditure profiles. These complexity-weighted profiles are not something 
that have been published in detail previously. 
 
5.6.2 Expenditure projections, 2018 to 2035 
Variation in the shape of baseline expenditure per capita profiles (reflecting 
underlying activity rate profiles) and the composition of unit costs of care form the 
basis for variation in projected growth in expenditure on services. The impact of 
demographic factors can be most readily seen when considering real expenditure 
projections. Under the three scenarios examined, projected percentage increases 
in expenditure on ED (11.7% to 18.5%) and OPD (12.1% to 18.1%) are lower than 
for day-patient (20.7% to 30.7%) and in-patient care (25.1% to 38.0%). In line with 
evidence on the relationship between acute care expenditure and ageing (see 
Chapter 2), we model healthy ageing effects as part of the low-pressure and central 
scenarios, but not under an assumed high-pressure scenario, which represents the 
upper range of projected expenditure growth. 
 
While demographic pressures drive expenditure through the projected volumes of 
services to be delivered, analysis from this chapter suggests that it is the projected 
cost of delivering these services that will be the more dominant driver of nominal 
expenditure to 2035. These findings align with previous projections of Irish 
healthcare expenditure that have also reported on the relative importance of cost 
over demographics (Irish Fiscal Advisory Council, 2018).  
 
Given the labour-intensive nature of healthcare delivery, pay represents the 
largest single driver of increases in nominal expenditure for ED, OPD and in-patient 
care. In addition to pay, the large percentage increases in day-patient expenditure 
reported are also predominantly driven by projected drug cost pressures. As noted, 
drugs accounted for a large component of the unit cost of day-patient care in 2018. 
The innovative and high-tech nature of hospital drugs suggests that historical 
patterns of large increases in costs could continue over the medium term, leading 
to strong pressure on projected day-patient care expenditure. 
 
Reflecting these cost considerations, and the varying impact of demographics 
across services already discussed, under the three scenarios examined nominal ED 
expenditure and OPD expenditure are projected to increase by between 62.2 per 
cent and 109.2 per cent and 63.4 and 107.6 per cent, respectively, by 2035. In 
contrast, day-patient and in-patient expenditure are projected to increase by 
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between 92.0 and 160.7 per cent and 85.9 and 150.0 per cent, respectively, by 
2035.  
 
Finally, this chapter did not take account of any assumed productivity 
improvements that could be expected to offset some of the cost increases 
modelled in this analysis. Nor did we consider any models of care change that may 
affect projected acute expenditure trajectories. Modelling assumptions in relation 
to acute care productivity improvements is challenging given that no historical 
acute care (or broader healthcare) productivity index has been developed for 
Ireland. Analyses, however, suggest recent challenges in delivering productivity 
improvements in Irish hospitals (Burke et al., 2014; Lawless, 2018). That said, we 
consider the potential impact of productivity effects on projected expenditure 
growth under sensitivity analysis in Chapter 8. Chapter 6 uses the age- and sex-
specific expenditure profiles developed as part of this chapter to develop a 
comprehensive age- and sex-specific aggregate expenditure profile for public acute 
hospitals in 2018. As part of that analysis, we also introduce an additional 
projection scenario (progress scenario) that considers the impact of improved 
waiting-list management and reduced rates of avoidable hospitalisation on 
projected total public acute expenditure. 
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CHAPTER 6 
Findings: Projected aggregate public acute hospital expenditure 
Chapter 6 Findings: Projected aggregate public acute hospital expenditure 
6.1 INTRODUCTION 
This chapter presents findings for baseline public acute hospital gross expenditure 
in 2018 and projections of expenditure to 2035. These estimates include gross 
expenditure required to care for both public and private patients in public 
hospitals. In this way, we record and project total gross expenditure on public 
acute hospital services , even if not financed by public sources. Gross expenditure 
on acute hospital services is estimated through aggregating (by age and sex) our 
baseline profiles (developed in Chapter 5) for public emergency department (ED), 
outpatient department (OPD), day-patient and in-patient care. Data limitations 
have meant that Ireland has traditionally struggled to develop age- and sex-specific 
expenditure profiles for healthcare services. Ireland, as a consequence, has been 
one of only three countries unable to submit age-cost profiles to the European 
Commission to inform their Ageing Reports (European Commission, 2009b; 2012b; 
2015; 2018). Findings in this chapter, therefore, represent a significant step 
forward as for the first time a comprehensive age- and sex-specific expenditure 
profile is developed for public acute hospital services in Ireland. We then aggregate 
these age- and sex-specific expenditure profiles, which account for just under 90 
per cent of HSE-recorded acute hospital gross expenditure in 2018. Following 
adjustment for the unexplained residual expenditure, we project from this basis to 
2035. 
 
In addition to the low-pressure, central and high-pressure projection scenarios 
examined in Chapter 5, this chapter introduces an additional progress scenario. 
The motivation behind this additional scenario is to examine the potential impact 
on projected acute expenditure of progressing two important dimensions of 
healthcare reform (Houses of the Oireachtas Committee on the Future of 
Healthcare, 2017).  
 
First, we project the additional activity and related cost required to reduce waiting 
list backlogs for OPD appointments and elective day patient and in-patient 
treatment (augmented by Covid-19-related cancellation of non-urgent elective 
care) and to sustain future waiting times below 12 weeks. This is based on a 
method developed in the UK (Findlay, 2017) and recently applied as part of NHS 
expenditure projections (Charlesworth and Johnson, 2018).  
 
Second, we examine the potential impact on acute hospital expenditure of 
improved investment in, and access to, primary healthcare services. We simulate 
this by reducing the rate of hospitalisation in relation to (vaccine-preventable) 
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influenza and pneumonia, urinary tract infections (including pyelonephritis) and 
COPD. These conditions can be classified as ‘avoidable hospitalisations’ and relate 
to conditions for which hospitalisation can be considered avoidable through timely 
and effective utilisation of primary care. Moreover, rates of avoidable 
hospitalisation are often used as a marker of primary care quality (Gibson et al., 
2013; Rosano et al., 2013). The conditions described above are the three most 
resource-intensive avoidable hospitalisations recorded in Irish public hospitals and 
have been identified as a priority for targeted primary care investment (McDarby 
and Smyth, 2019). In 2018, these three conditions together accounted for 70.7 per 
cent of total (complexity-weighted) avoidable hospitalisations identified (see 
Appendix A). More detail on these assumptions is provided in Chapter 4.  
 
In examining how projected growth rates may differ through the course of the 
projection horizon in this chapter, we also adjust our projections to consider the 
impact, over the short and longer term, of large Covid-19-related shocks to 
healthcare expenditure growth in the period 2020–2022. More detail on this 
approach is also provided in Appendix C. 
 
Section 6.2 describes findings in relation to baseline acute public hospital gross 
expenditures. Section 6.3 presents findings in relation to projections of total acute 
public hospital gross expenditures. Section 6.4 discusses and concludes. 
 
6.2 FINDINGS – AGGREGATE GROSS EXPENDITURE 
Table 6.1 provides a summary of total public acute hospital gross expenditure for 
2018 by main service category and overall. Gross expenditure captures all 
expenditure on delivering public acute hospital care prior to any income 
deductions (for example, in relation to treatment of private patients). Combining 
the main service categories of expenditure examined in Chapter 5 yields a total 
gross expenditure of €5,234.9m on these services in 2018. Most of this expenditure 
relates to in-patient care (61.5%), followed by day-patient care (17.6%), OPD care 
(12.9%) and ED (8.0%). For comparison, HSE gross expenditure on public acute 
hospitals in 2018 was €5,907.1m.67,68 By aggregating our service-level profiles, we 
therefore capture just under 90 per cent of public acute hospital gross expenditure 
as recorded by the HSE in 2018.69  
 
67  The final expenditure figure of €5,907.1m was provided by HSE Finance, personal communication, 7 October 2020.  
68  The corresponding net expenditure figure (after income adjustment) was €5,064,4m (HSE Finance, personal 
communication, 7 October, 2020). 
69  It is difficult to fully reconcile the residual amount of €672.2m not captured by our expenditure categories. However, a 
large proportion (€300m) is related to hospital costs incurred in relation to external services (e.g. hospital laboratory 
testing for primary healthcare providers). We also do not capture approximately €100m in activity related to Minor 
Injury Units (MIU) and other non-casemix hospital activity. We are also missing some OPD expenditure incurred outside 
the 40 Activity-Based-Funding (ABF) hospitals. 
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TABLE 6.1 Public acute hospital gross expenditure, 2018 
 
  Expenditures 
  €m % 
ED attendances 418.6 7.1 
OPD attendances (incl. maternity) 676.4 11.4 
Day-patient discharges (incl. maternity) 919.5 15.6 
In-patient discharges (incl. maternity) 3,220.5 54.5 
Combined services total 5,234.9 88.6 
Residual 672.2 11.4 
Total HSE gross expenditure  5,907.1 100 
 
Source: HPO Specialty Costing, 2018; HIPE, 2018. 
 
Figure 6.1 reports the distribution of public acute hospital gross expenditure and 
gross expenditure per capita by age and sex. This figure aggregates expenditure on 
ED, OPD, day-patient and in-patient activity, and distributes the residual 
component of gross expenditure identified above (€672.2m) in line with the overall 
age and sex distribution of service use. 
 
In 2018, 52.3 per cent of expenditure related to females (€3,087.6m) and 47.7 per 
cent to males (€2,819.6m). Expenditures peak at two points for females: at ages 
35–39 (€241.8m) and 70–74 (€242.1m). Expenditures peak at age 70–74 for males 
(€288.4m). While expenditure on males is greater than on females at the youngest 
and older ages (apart from the oldest age groups), the reverse is the case between 
the ages of 15–19 to 50–54, largely coinciding with maternity years for females.  
 
Overall expenditure per capita is estimated at €1,169 for males and €1,253 for 
females.70,71 Expenditure per capita follows a similar pattern to overall expenditure 
volumes but peaks at older ages (90+ years for males and 85–89 years for females). 
Of note, sex-specific expenditure per capita profiles widen at older ages while at 
very old ages expenditure per capita plateaus for females approaching end-of-life 
while it continues to rise for males. This reflects a similar pattern in acute 
healthcare utilisation, observed in Wren et al. (2017), and may be associated with 
higher rates of residential long-term care use by females at end of life, which can 
act as a substitute to more costly public acute care (Jakobsson et al., 2006). 
 
 
70  Combined total expenditure per capita is estimated at €1,212. 
71  Substantial expenditure and expenditure per capita for those <5 years mainly relates to expenditure on emergency in-
patient discharges of <1 years old (males €2,819; females €2,353). 
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Source: Authors’ calculation. 
 
6.3 FINDINGS – AGGREGATE GROSS EXPENDITURE PROJECTIONS 
In the following section we present public acute hospital gross expenditure 
projections, applying the three main projection scenarios examined in Chapter 5 
(low-pressure, central and high-pressure) as well as an additional ‘progress’ 
scenario. The assumptions underlying the progress scenario are outlined in Table 
6.2 (a more detailed description is provided in Chapter 4). In addition to the 
standard demand and cost drivers employed and described in projections in 
Chapter 5, in the progress scenario we introduce additional assumptions in relation 
to improved waiting-list management and a reduction in the rate of avoidable 
hospitalisations through improvement in primary care delivery. It is important that 
these assumptions are modelled jointly as it would be unrealistic to assume that 
beds and other acute resources made available through shifting care to the 
community would not be then directed towards those waiting to access hospital 
care. 
 
The waiting-list management assumption applies and refines methods developed 
in the UK (Findlay, 2017) to estimate the non-recurring activity (and associated 
expenditure) required to reduce waiting-list backlogs and the recurring activity 
(and associated expenditure) to maintain waiting times at target levels (Brick and 
Keegan (2020b), and Appendix D). The avoidable hospitalisation assumption seeks 
to model the potential effect of improved access and investment in primary care 
on hospital expenditure. This is achieved through reducing the rate of ED 
attendance and emergency in-patient (excl. maternity) hospitalisation for activity 
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influenza and pneumonia, Chronic Obstructive Pulmonary Disorder (COPD), and 
urinary tract infections (including pyelonephritis) (see Appendix A). In this chapter 
we linearly reduce the rate of these avoidable hospitalisations (and associated ED 
attendances) each year, converging to a 33 per cent reduction in avoidable 
hospitalisations in 2035. A sensitivity analysis (reported in Chapter 8) examines the 
effect on projected expenditure of varying assumptions in relation to avoidable 
hospitalisation reduction and improved waiting-list management (as well as other 
drivers of demand and cost).  
 
Expenditure projections in this section are presented in both real and nominal 
terms. Real projections hold costs constant at 2018 values, thus enabling analysis 
of projected volumes of care as if the cost of care had not changed. Nominal 
projections capture both demand and cost effects. Projections are run for each 
service area individually and then summed for each projection year. The residual 
component of total HSE acute gross expenditure is projected in line with the yearly 
growth rate of the combined service projections.  
 
TABLE 6.2 Progress projection scenario – assumptions 
  
OPD ED Day patient and in-patient  
Demand assumptions    
Population growth  
and ageing 
Central Central Central 
Healthy ageinga Moderate healthy ageing. Moderate healthy ageing. Moderate healthy ageing. 
Waiting list  
management 
Additional non-recurring 
activity to reduce current 
backlog between 2021–2025. 
Additional recurring activity 
to sustain 12 week waiting 
times. 
N.A. Additional non-recurring 
activity to reduce current 
backlog between 2021–2025. 
Additional recurring activity 




N.A. Linearly reduce ED 
attendances in line with in-
patient avoidable 
hospitalisations each year. 
Linearly reduce rate of 
avoidable hospitalisations 
each year, converging to 33% 
reduction by 2035.  
Cost assumptions    
Pay COSMO Recovery –  
projected government-sector 
wage growth (2.5% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth (2.5% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth (2.5% p.a.) 
Non-pay    
Drug costb N.A. N.A. 5.2% increase p.a. 
Otherc COSMO Recovery – 
indexed to projected inflation 
rates + 0.5 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates + 1 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates + 1 pct point p.a. 
 
Notes: a We do not apply healthy ageing shifts to maternity care. 
 b Applied to day-patient and in-patient projections only. 
 c Based on personal consumption deflator. 
Source:  Authors’ representation. 
 
Table 6.3 presents real and nominal projected gross expenditure growth for public 
acute hospital care between 2018 and 2035, based on our four main scenarios 
outlined above. In real terms, total public hospital gross expenditure is projected 
to increase by 28.3 per cent under the central scenario between 2018 and 2035. 
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This falls to 21.6 per cent under our low-pressure scenario and increases to 32.6 
per cent under our high-pressure scenario. In nominal terms, expenditure is 
expected to more than double by 2035 under our central scenario (104.0%). This 
falls to 82.2 per cent under our low-pressure scenario and increases to 143.2 per 
cent under our high-pressure scenario. Under the assumptions specified, our 
progress scenario suggests a projected expenditure increase of 24.9 per cent in real 
terms and 98.7 per cent in nominal terms. In both instances, these projected 
increases are below those recorded under our central scenario but higher than 
under our low-pressure scenario. Across all scenarios, by 2035 we project acute 
public gross expenditure requirements of between €7,183.2.5m and €7,834.1m in 
real terms and between €10,760.6m and €14,363.3m in nominal terms. 
 
The variation in projected expenditure growth between the central and progress 
scenarios is driven by greater non-recurring activity taking place to clear the OPD, 
day-patient and in-patient backlogs (2021–2025), greater recurring activity to 
maintain target waiting times (2021–2035), and reduced ED and emergency in-
patient activity in line with a reduction in the rate of avoidable hospitalisation 
(2021–2035). Over the entire projection horizon, the assumed reduction in the rate 
of avoidable hospitalisation (linearly converging to a 33% reduction by 2035) 
outweighs the additional activity required to manage waiting lists and therefore 
has the effect of reducing overall projected expenditure relative to the central 
scenario.  
 






Projected HCE growth 2018–2035 (%) 
Real Nominal 
Low Central High Progress Low Central High Progress 
Male 2,831.2 23.9 31.6 36.9 27.8 85.7 109.4 151.2 103.4 
Female 3,075.9 19.5 25.3 22.3 22.3 78.9 99.0 135.8 94.4 
Total 5,907.1 21.6 28.3 32.6 24.9 82.2 104.0 143.2 98.7 
 
Notes: Real projections hold base costs constant at their 2018 values. 
Source: Authors’ calculations. 
 
Table 6.4 presents nominal projected public acute hospital gross expenditure 
average annual growth rates by scenario and projection period. Over the entire 
projection period, nominal growth rates vary between 3.6 and 5.4 per cent. For 
comparison, growth in HSE acute hospitals’ gross nominal expenditure between 
2013 and 2018 was 4.5 per cent on an average annual basis.  
 
Some noticeable variation in growth rates is also observable in the defined early 
projection period, 2018–2025. Included in the assessment of this variation is an 
additional scenario, modelled on our central projection scenario, that makes 
adjustments to 2020, 2021, and 2022 projections to factor in the effect on growth 
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rates of Covid-19-related expenditures in these years. Specifically, we assume a 10 
per cent increase in expenditure in 2020, a 15 per cent increase in 2021 and static 
2022 expenditure, before the model returns to projected growth paths. (More 
details and analysis underlying these assumptions are provided in Appendix C). As 
expected, the assumed effects are most noticeable to 2025 where the average 
annual growth under this scenario is projected at 6.0 per cent, higher than under 
the other scenarios. The effect of this shock recedes over the period 2018–2035 as 
the average annual growth rates, and projected expenditures, for the central-
adjusted scenario fall within the bounds of our main projection scenarios.  
 
Under the progress scenario, we also project higher annual growth rates in the 
period 2018–2025. This largely reflects the assumption that significant additional 
activity will take place in the period 2021–2025 to reduce waiting-list backlogs.72 
Once these backlogs are addressed, in later years a smaller amount of activity and 
expenditure will be needed to sustain waiting times at target levels (see Appendix 
E). Expenditure requirements under the progress scenario are further reduced in 
later years due to the progressive reduction in the rate of avoidable 
hospitalisations.  
 
Over the entire period, expenditure growth rates are lower than they otherwise 
might have been due to refined population growth assumptions linked to weaker 
economic conditions and lower subsequent medium-term net migration. Over the 
short term, however, we also model lower net migration due to uncertainty about 
the evolution of the pandemic, lower confidence and travel restrictions (see Table 
3.2). In the period 2018–2025 this effect, along with lower assumed inflation, can 
be most clearly observed across our low, central and high projection scenarios. 
 
TABLE 6.4 Public acute hospital gross expenditure – nominal average annual growth rates by projection scenario, 
2013–2035 
 
  Nominal expenditure growth (average annual) 
2013-2018 4.5 
 Low Central High Progress Central – adjusted 
2018-2025 3.3 4.1 5.3 4.5 6.0 
2026-2030 3.8 4.4 5.5 4.2 4.4 
2031-2035 3.8 4.3 5.4 4.1 4.3 
2018-2035 3.6 4.3 5.4 4.1 5.1 
 
Source: 2013–2018 – HSE Management Data Reports, December 
2018–2035 – authors’ calculations.  
  
 
72  Projected expenditure estimates to clear waiting-list backlogs and manage waiting times into the future, as with all 
projected expenditure estimates in this report, exclude any associated capital costs. 
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Figure 6.2 illustrates the proportional contribution of each service area to total 
public acute hospital gross expenditures.73 In 2018, ED, OPD, day-patient and in-
patient expenditure accounted for 8.0 per cent, 12.9 per cent, 17.6 per cent and 
61.5 per cent of combined expenditures respectively. Under all projection 
scenarios, the proportionate contribution of day-patient and in-patient care to 
total combined expenditures increases by 2035, while the proportionate 
contribution of ED and OPD falls. This is consistent with the higher projected 
relative expenditure increases for day-patient and in-patient care observed in 
Chapter 5. As discussed in Chapter 5, these higher projected expenditures on day-
patient and in-patient care are driven by high rates of activity in older ages and the 
separate modelling of drug cost trends for these services. 
 
Under the progress scenario, however, the proportionate increase in in-patient 
expenditure by 2035 is marginal (61.5% to 61.6%). Again, this reflects the impact 
of assumed reductions in the rate of avoidable hospitalisation over the projection 
period in reducing in-patient projected expenditures relative to what they 
otherwise would have been. 
 





Note: Excludes the residual component of expenditure. 
Source: Authors’ calculations. 
  
 
73  For ease of presentation, these totals exclude the small residual proportion of expenditures used to scale up to baseline 
and projected HSE public acute hospital gross expenditure. 
61.5% 62.8% 62.9% 63.3% 61.6%
17.6% 18.5% 18.8%
18.8% 19.6%
12.9% 11.6% 11.3% 11.0% 11.7%
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Figure 6.3 presents the relative contribution of demand and cost drivers by 
decomposing public acute hospital gross expenditure projections by scenario. 
Consistent with analyses of component services in Chapter 5, cost is expected to 
be a larger driver of projected expenditures than demand. Under the central 
scenario, for example, population growth (€651.1m) and changes to the 
population age structure (€1,048.9m) are estimated to account for €1,700.0m of 
projected additional expenditure by 2035. In contrast, pay (€2,579.7m), in-patient 
and day-patient non-pay drugs (€675.0m) and other non-pay costs (€1,188.8m) are 
estimated to account for a combined €4,443.5m. Pay costs are expected to account 
for 42.0 per cent of the projected additional public acute gross expenditure 
between 2018 and 2035. 
 
Relative to the central scenario, combined demand pressures on expenditure 
amount to €1,293.7m under the low-pressure scenario, due to the combined effect 
of lower population growth and more optimistic healthy ageing. Combined 
demand pressures on expenditure are highest under the high-pressure scenario, 
accounting for €1,956.8m where no healthy ageing is assumed. However, as in the 
central scenario, pay is the dominant driver across the low- and high-pressure 
projection scenarios. This is particularly true of the high-pressure scenario whereby 
pay (€4,061.2m) accounts for 48.0 per cent of all additional projected expenditure 
by 2035. 
 
Our progress scenario projects an acute expenditure saving effect in 2035 of 
€313.4m. This suggests that, by 2035, the increased acute expenditure associated 
with clearing OPD and elective waiting-list backlogs and sustaining waiting-time 
targets into the future can be offset through preventing certain hospitalisations for 
conditions more appropriately treated in the community. As shown in Appendix E, 
the bulk of expenditure required to manage waiting lists is required from 2021–
2025 (€212m on average per year), with lower levels of recurring additional 
expenditure required from 2026 onwards.74 
 
 
74  Waiting-list expenditure estimates exclude any associated capital costs. 
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Notes: * Adjusted for healthy ageing in the low and high scenarios 
Source: Authors’ calculations. 
  
2018 2035 2035 2035 2035 2035
 Low  Central  High  Progress
Progress 313.4
Population growth 456.5 651.1 650.9 651.1
Population age structure* 837.3 1,048.9 1,305.9 1,048.9
Pay 2,040.3 2,579.7 4,061.2 2,579.7
Non-pay drugs 474.0 675.0 909.9 675.0
Non-pay other 1,045.4 1,188.8 1,528.2 1,188.8
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Figure 6.4 illustrates the projected change in gross acute public hospital 
expenditure between 2018 and 2035 across the age distribution for all scenarios. 
Reflecting changes in the size and structure of the population, a large proportion 
of expenditure growth takes place at relatively older ages. This is related to the 
shape of the profiles of per capita age- and sex-specific expenditure presented in 
Figure 6.1. Expenditure per capita increases sharply with age, and when combined 
with a projected ageing population, this results in large increases in expenditure in 
older age cohorts. The impact of this population ageing effect, however, is reduced 
under the low-pressure and central projection scenarios that assume healthy 
ageing effects. 
 





Source: Authors’ calculations. 
 
6.4 SUMMARY 
Building on the age- and sex- specific expenditure profiles developed for public 
OPD, ED, day-patient and in-patient care in Chapter 5, this chapter developed an 
aggregate age- and sex- specific gross expenditure profile for public acute hospitals 
in Ireland for 2018, and projected that expenditure to 2035 under a range of 
projection scenarios. 
 
6.4.1 Public acute hospital gross expenditure, 2018 
The 2018 acute hospital expenditure profile developed in this chapter represents 
the most comprehensive age- and sex specific profile of acute hospital 
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cent of recorded gross expenditure. This represents a substantial contribution to 
understanding the age-cost profile of Ireland’s healthcare expenditure. As 
described in Chapter 1, Ireland has struggled noticeably in this regard relative to 
peer countries (Parliamentary Budget Office, 2019). 
 
The findings highlight significant variation in acute expenditure profiles by age and 
sex in 2018. In volume terms, the distribution of female expenditure is trimodal in 
nature, with peaks in expenditure observed for the very young (< 1 years), those 
aged 35 to 39, and those aged 70 to 74. In contrast, male expenditures peak for 
the very young (<1 years) and for those aged 70 to 74. Scaled in per capita terms, 
this shows marginally higher expenditures for females on average (€1,253) relative 
to males (€1,169). While per capita spending for both males and females increases 
strongly with age, female per capita expenditure outstrips male expenditure at 
younger ages, and this trend reverses at older ages. At very old ages, this per capita 
differential is considerable. It may reflect higher rates of residential long-term care 
use by females at the end of life, which can act as a substitute to more costly public 
acute care (Jakobsson et al., 2006). 
 
6.4.2 Public acute hospital gross expenditure projections, 2018 to 2035 
In real terms, total public acute hospital gross expenditure is projected to increase 
by between 21.6 and 32.6 per cent across our scenarios, respectively, between 
2018 and 2035. Including projected changes to the cost of delivering this care, this 
equates to a projected growth rate of between 82.2 and 143.2 per cent in nominal 
terms. These growth rates explicitly capture the assumed impact of Covid-19 on 
acute expenditures over the horizon as both underlying demographic and 
macroeconomic assumptions have been adjusted from 2020 onwards to capture 
the assumed short- and medium-term impacts of the pandemic (see Chapter 3).  
 
Both day-patient and in-patient care are expected to increase their relative shares 
of total public acute hospital gross expenditure by 2035, while shares attributable 
to OPD and ED care are set to fall. This reflects findings from Chapter 5 that day-
patient and in-patient care are likely to be subject to both greater demographic 
and cost pressures over the medium term. 
 
As overall growth rates are a function of the length of the projection horizon, it is 
useful to also consider projected expenditure growth in terms of average annual 
rates. Findings from this chapter suggest that, over the entire projection period, 
average annual nominal growth rates vary between 3.6 and 5.4 per cent. This range 
appears consistent with recent historic expenditure growth in gross public acute 
hospital expenditure. Additionally, we project variation in average annual growth 
rates for different projection periods. As described in Chapter 1, public acute 
110|  P roject ions  o f  expend iture for  pub l ic  hosp ita ls  in  I reland ,  2018 –2035  
hospital expenditure in 2020 and 2021 is likely to be very large. This raises 
projected public acute hospital expenditure above trend in the short term but does 
not materially affect our projected expenditure range over the medium term. 
 
Additionally, under the progress scenario, we calculate the expenditure, excluding 
any associated capital costs, required to clear existing OPD and elective backlogs, 
beginning in 2021, to amount to  €212m on average per year in nominal terms over 
five years (Brick and Keegan (2020b) Appendix E). While this expenditure would be 
relatively substantial over this period, the additional expenditure required to 
sustain waiting-time targets at 12 weeks from 2026 onwards is less, even following 
adjustment for future demographic and cost pressures. For instance, we estimate 
this total expenditure at €70.5m per year on average between 2031 and 2035. 
 
While improved waiting-list management increases acute expenditure 
requirements under the progress scenario, these increases could be offset over 
time through appropriate management of care in the community. Specifically, we 
modelled the effect of a reduction in the rate of emergency in-patient 
hospitalisation and associated ED attendance for (vaccine-preventable) influenza 
and pneumonia, urinary tract infections (including pyelonephritis) and COPD by 
2035.  
 
While this analysis did not consider the expenditure implications of additional 
staffing and other resources required to facilitate greater levels of care in the 
community, the three conditions examined in this chapter represent the most 
resource-intensive of all avoidable hospitalisations identified in 2018 (see 
Appendix A) and, importantly, there is an evidence base for cost-effective 
treatment or prevention of these conditions at primary care level (McDarby and 
Smyth, 2019; OECD, 2019a).  
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CHAPTER 7 
Findings: Public acute psychiatric in-patient services expenditure 
Chapter 7 Findings: Public acute psychiatric in-patient services expenditure 
7.1 INTRODUCTION 
This chapter presents findings on expenditure on public acute psychiatric in-patient 
services for adults in 2018.75 The estimated cost for a public psychiatric in-patient 
adult bed day is presented, as well as baseline age- and sex-specific expenditure 
profiles. In addition to these profiles, the chapter presents three (low-pressure, 
central and high-pressure) projection scenarios. The scenarios incorporate 
assumptions that place varying pressures on acute adult in-patient psychiatric 
services to 2035. The results for this service are presented separately to those in 
Chapters 5 and 6 as the expenditure relates to specialist mental health services and 
not acute hospital services. 
 
7.2 FINDINGS – BED DAY COST 
Figure 7.1 presents the estimated unit cost for a public acute adult psychiatric in-
patient bed day between 2015–2018. Using the top-down method described in 
Chapter 4, we estimate the unit cost of an in-patient bed day in 2018 to be €453, 
with an average annual compound growth rate of 11 per cent between 2015 and 
2018. The HSE reports that pay contributes 80 per cent to total gross expenditure 
in these units per annum. 
 




Notes: Author calculations based on HSE CSO System of Health Accounts returns. 
Source: HSE, 2015–2018 and HRB National Psychiatric In-Patient Reporting Scheme (NPIRS), 2015–2018. 
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7.3 FINDINGS – BASELINE EXPENDITURE 
Expenditure on public acute psychiatric in-patient services for adults amounted to 
€179.3m in 2018. Figure 7.2 shows the estimated age- and sex-specific expenditure 
profile for 2018. We estimate that 54 per cent of expenditure related to male bed 
days (€96.7m) and 46 per cent to female bed days (€82.6m). Given the distribution 
of bed days, the distribution of expenditure is quite different for males compared 
with females. Expenditure for males peaks at 35–39 years (€11.0m) while for 
females it does not peak until 50–54 years (€8.1m).76 Male expenditure is higher 
than female in younger age groups, while from 50 years onwards, except for 75–
84 years, female expenditure is higher. Per capita expenditure is highest for males 
aged 30–34 years (€64.8) and highest for females aged 70–74 years (€64.6). 
 




Notes: Author calculations based on HSE CSO System of Health Accounts returns. 
Per capita expenditure is calculated using ESRI population estimates for 2018, 18 years and older. 
There was a small number of episodes/bed days in adult units relating to children aged less than 18 years. 
Source: HSE, 2018 and HRB NPIRS, 2018. 
  
 
76  This is due to differing diagnoses between males and females in these age groups. There is a high number of males with 
a diagnosis of ‘F20-F29 Schizophrenia, schizotypal and delusional disorders’, which is associated with a relatively high 































































































Male - per capita
Female - per capita
Find ings :  Publ ic  acute psychiatr ic  in -pat ient  s erv ices  expend iture |113  
7.4 FINDINGS – EXPENDITURE PROJECTIONS 
In the following section we present findings from the three expenditure projection 
scenarios as applied to psychiatric in-patient care. Table 7.1 summarises the 
demand and cost assumptions.77 Of note in terms of the assumptions applied here 
are the use of the high population projection in the high-pressure scenario; no 
healthy ageing is assumed; and, due to limitations in the expenditure data, no 
assumptions on changes in drug costs are possible. As in Chapters 5 and 6, 
expenditure projections are presented in both real and nominal terms. 
 
TABLE 7.1 Projection scenario assumptions 
 
 Low pressure Central High pressure 
Demand assumptions    
Population growth 
and ageing 
Low Central High 
Healthy ageinga None None None 
Cost assumptions    
Pay COSMO Delayed Recovery –  
projected government-sector 
wage growth (2.2% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth (2.5% p.a.) 
COSMO Recovery –  
projected government-sector 
wage growth + 1 pct point p.a. 
(3.5% p.a.) 
Non-pay    
Drug cost None None None 
Otherb COSMO Delayed Recovery – 
indexed to projected inflation 
rates + 0.5 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates+ 1 pct point p.a. 
COSMO Recovery – 
indexed to projected inflation 
rates + 1 pct point p.a. 
 
Notes: a We assume no healthy ageing effects for in-patient psychiatric care. 
 b Based on personal consumption deflator. 
 
Table 7.2 presents real and nominal projected expenditure growth for public acute 
psychiatric in-patient care from 2018 to 2035, based on our three projection 
scenarios (Table 7.1). In real terms, expenditure is projected to increase by 16.4 
per cent, 18.8 per cent and 24.5 per cent across our low, central and high-pressure 
scenarios, respectively, between 2018 and 2035. This equates to overall projected 
real expenditures in 2035 of between €208.8m and €223.3m. 
 
In nominal terms, expenditure is projected to increase by 68.8 per cent, 81.3 per 
cent and 120.4 per cent across our low, central and high-pressure scenarios, 
respectively, between 2018 and 2035. This equates to projected expenditure 
requirements in 2035 of between €302.7m and €395.2m. This again highlights the 
strong influence of cost on projected expenditures. 
  
 
77  A detailed description of the assumptions underlying the scenarios is provided in Chapter 3. 
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Projected HCE growth 2018-2035 (%) 
Reala Nominal 
Bed days Expenditure (€m) Low Central High Low Central High 
Male 213,760 96.7 14.5 17.1 23.4 66.0 78.7 118.4 
Female 182,434 82.6 18.7 20.8 25.9 72.1 84.3 122.8 
Total 396,194 179.3 16.4 18.8 24.5 68.8 81.3 120.4 
 
Notes: a Real projections hold base costs constant at their 2018 values. 
 b We assume no healthy ageing effects for psychiatric in-patient care. 
Source:  Authors’ calculations. 
 
Figure 7.3 examines the relative contribution of demand and cost drivers, through 
decomposing nominal expenditures projections by scenario. Under the central 
projection scenario, population growth (€33.2m) and changes to the population 
age structure (€0.6m) account for a combined additional €33.8m of expenditure by 
2035. Cost drivers, pay at €88.3m and non-pay at €23.7m account for a combined 
€112.0m of additional expenditure by 2035. These place the largest pressure on 
projected expenditure and reflect the fact that most (79.6% in 2018) of the average 
cost of a psychiatric in-patient bed day is pay-related (Figure 7.1). 
 
FIGURE 7.3 Psychiatric in-patient – decomposition of projected nominal expenditure growth, 2018-2035, by 




Notes: We assume no healthy ageing effects for psychiatric in-patient care. 
Source: Authors’ calculations. 
 
2018 2035 2035 2035
 Low  Central  High
Population growth - 28.7 33.2 43.8
Population age structure - 0.8 0.6 0.2
Pay - 72.4 88.3 141.1
Non-pay other - 21.6 23.7 30.9
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Pay is the largest driver of expenditure growth across all scenarios. The pay 
component of nominal expenditure growth over the period ranges from €72.4m 
(58.6%) in the low-pressure scenario to €141.1m (65.3%) in the high-pressure 
scenario. 
 
Figure 7.4 illustrates the projected change in expenditure between 2018 and 2035 
across the age distribution for all scenarios. Across all scenarios, large proportions 
of growth in nominal expenditure take place at younger (20–29 years) and older 
ages (50 years and older). Lower proportionate expenditure growth is projected 
for the 30–49 age groups, which reflects decreasing projected demand for bed days 
in the underlying age-related activity profiles (Appendix, Figure B.3). This in turn 
reflects a projected fall in the population aged 30-49 between 2018 and 2035 as 
the end of the baby-boom generation is not replaced (see Figure 3.8). 
 





Notes: We assume no healthy ageing effects for psychiatric in-patient care. 
Source: Authors’ calculations. 
 
7.5 SUMMARY 
This chapter has provided baseline estimates and expenditure projections for care 
in public (HSE and HSE-funded) acute adult psychiatric in-patient units. To our 
knowledge, this is the first time an age- and sex-specific expenditure profile has 
been estimated for public acute adult psychiatric in-patient care in Ireland. The 
baseline expenditure profiled here accounts for the 29 public acute adult 
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total public in-patient psychiatric gross expenditure78 and 89 per cent of in-patient 
bed days in 2018.79 
 
To estimate an expenditure profile, we have calculated a unit cost per in-patient 
bed day in 2018 using aggregated expenditure data from the HSE and HRB NPIRS. 
This unit cost was then applied to the age- and sex-specific distribution of 2018 bed 
days. As with the services reported on in Chapter 5, pay was the major component 
of the unit cost of a psychiatric in-patient bed day (79.6%). The expenditure profiles 
show that expenditure increases with age to 39 years for males and 49 years for 
females, and decreases with age thereafter. 
 
For acute adult psychiatric in-patient services, growth in nominal expenditure of 
between 68.8 and 120.4 per cent, or between €100m and €200m, is projected by 
2035. As in the analysis in Chapter 5, it is the impact of projected cost, particularly 
pay, that is the dominant driver of nominal expenditure growth over the projection 
horizon.  
 
78  As reported by the HSE to the CSO as part of the System of Health Accounts submission. 
79  Public children’s units and the forensic hospitals account for the remaining expenditure and bed days. It is hoped to 
extend the analysis to cover these units in future iterations of Hippocrates. 
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CHAPTER 8 
Summary and conclusion 
Chapter 8 Summary and conclusion 
8.1 INTRODUCTION 
This is the second report to be published applying the Hippocrates projection 
model of Irish healthcare demand and expenditure developed at the ESRI in a 
programme of research funded by the Department of Health. Previous analyses 
have applied the Hippocrates Model to estimate baseline utilisation of healthcare 
services in Ireland and to provide projections of demand and capacity. This analysis 
extends the Hippocrates Model to provide baseline estimates of expenditure for 
public acute hospitals and psychiatric in-patient services in Ireland in 2018 and to 
project expenditures for these services to 2035. This required a detailed analysis 
of service-level unit costs of care and development of assumptions on how 
components of these costs may evolve through the projection horizon. The analysis 
provides age- and sex-specific aggregate expenditure profiles, which  up to now 
have not been available for Ireland. This chapter summarises these analyses, 
providing an overview of gross expenditure on Irish public acute hospitals and 
psychiatric in-patient services, and analyses projected expenditure and the 
underlying drivers. 
 
The model is bottom-up in nature, with expenditure projections developed from a 
demand and cost base in 2018. To inform this, a detailed review of the 
demographic and non-demographic drivers of healthcare expenditures and 
associated modelling frameworks was undertaken in Chapter 2. We modelled 
demand projections primarily based on projected demographic change and 
assumptions on the relationship between life year gains and healthcare use. 
Projected demand for respective services was then costed through modelling 
assumed trends in pay, drug and other non-pay costs. Additional modelling 
assumptions were  incorporated to examine the acute expenditure implications of 
improved waiting-list management and of improved access to and investment in 
primary care.  
 
The outbreak of Covid-19 in 2020 resulted in short-term shocks to acute hospital 
utilisation and expenditure. While hospital beds were occupied to treat Covid-19 
cases, there was a corresponding initial sharp drop in non-Covid attendances at 
public hospital emergency departments (EDs) (Brick et al., 2020b), and cancellation 
of all but the most urgent elective services. In response to the ongoing threat of 
Covid-19 and acknowledged hospital capacity deficits, the HSE announced an 
ambitious ‘Winter Plan’ plan in September 2020. This was followed by an 
announced record health budget of €22.1 billion for 2021 (October 2020), including 
€1.8 billion in direct Covid-related supports. Funding priorities relate to changing 
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the model of care delivery in line with Sláintecare objectives, addressing known 
capacity deficits, and tackling waiting lists. We adjusted our analysis where 
relevant to consider this expenditure shock on projections of gross public acute 
hospital expenditure. 
 
The Covid-19 pandemic may also have longer-lasting impacts on the demand for, 
and the cost of delivering, acute services – relevant for modelling trends in 
expenditures over the medium term. To account for these effects, we adjusted our 
projections in several ways. The demographic projection scenarios were updated 
and revised in light of the potential impact of Covid-19. This incorporated 
adjustments to 2020 mortality rates and downward revisions to projected trends 
in international migration. Additionally, the pay and non-pay price trends that 
informed the projected trajectory of healthcare costs were drawn from two 
alternative Covid-19 economic recovery scenarios, generated through the ESRI 
macro-econometric model, COSMO. In costing improved waiting-list management, 
we also accounted for the spike in waiting-list numbers attributable to cancellation 
of elective treatments due to Covid-19.80 
 
In recognition of the uncertainty surrounding the key assumptions relating to 
drivers of demand and cost, alternative expenditure projection scenarios were also 
developed in this report. (These expenditure projection scenarios are discussed in 
detail in Chapter 4, and the underlying macroeconomic and demographic scenarios 
are discussed in Chapter 3.) The alternative expenditure projection scenarios vary 
assumptions related to population change, healthy ageing, and pay and non-pay 
cost drivers. Assumptions were grouped to provide projections of expenditure 
under low-pressure, central and high-pressure expenditure scenarios. For instance, 
under our low-pressure scenario we combined assumptions on low population 
growth, optimistic healthy ageing, and relatively low projected pay and non-pay 
cost pressures. We also defined a ‘progress’ scenario where we examined the 
effect on total public acute hospital expenditure of improved waiting-list 
management and reorientation of appropriate care to the community through a 
reduction in avoidable hospitalisations. These reflect important dimensions of the 
Sláintecare reforms (Houses of the Oireachtas Committee on the Future of 
Healthcare, 2017). Waiting-list management assumptions consider how much 
increased activity and associated expenditure would be required to clear existing 
OPD and elective waiting-list backlogs and sustain shorter waiting times into the 
future. Simultaneously, we asked how much public acute hospital expenditure 
growth could be mitigated if there were a reduction in the rates of the three most 
 
80  The analysis does not account for any potential longer-term Covid-related effects on acute healthcare expenditure (e.g. 
‘long’ Covid, the health effects of postponed or cancelled screening or treatment, the effects on mental health). It may 
be possible to factor these longer-term effects into subsequent analyses as the evidence emerges. 
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common and resource-intensive avoidable hospitalisations in Ireland through a 
shift in care to the community.81 
 
Also, in this chapter, additional analyses are presented which demonstrate the 
sensitivity of our projections to changes in key assumptions. As part of the 
sensitivity analysis, we also examine the effects on projected expenditures of 
assumed improvements in productivity. The current Irish evidence-base in relation 
to trends in acute hospital productivity was considered too weak to model 
assumptions as part of our main scenario analysis. However, as described in 
Chapter 2, productivity improvements can play an important role in offsetting 
increases in the cost of delivering care. Therefore, as part of our sensitivity analysis 
we subjected projections to varying rates of annual productivity improvement to 
examine the effect on public acute hospital expenditure growth. Additionally, we 
considered the impact of more pessimistic pay growth assumptions. Particularly 
considering the recent increased expenditure burdens on the Irish State in 
response to Covid-19, we modelled the effect of a public pay freeze in 2021 and 
2022 in addition to lower assumed wage growth over the remainder of the 
projection horizon.  
 
In considering the findings in this and previous chapters, it is important to note that 
we model projections, not forecasts, of acute expenditures. Over the short term, 
expenditures may vary from year to year due to unanticipated shocks, of which the 
Covid-19 pandemic is a salient example. In addition, spending decisions are 
ultimately political in nature and based on government priorities. Budgetary 
constraints often create trade-offs in terms of pay, volumes of services delivered 
and level of unmet demand. However, informed by the anticipated evolution of 
key drivers of expenditures, the modelling approaches adopted are considered to 
provide a reasonably reliable guide to the future over the medium term 
(Charlesworth and Johnson, 2018). 
 
Section 8.2 summarises and discusses this report’s main findings on baseline and 
projected expenditure from Chapters 5 to 7. Section 8.3 discusses the sensitivity of 
our projection scenarios to alternative assumptions on the drivers of demand and 
cost. Section 8.4 discusses the limitations of the analysis. Section 8.5 examines the 
implications of our demand projections for policy, reflects, and concludes. 
 
 
81  Vaccine-preventable influenza and pneumonia, urinary tract infections (including pyelonephritis), and COPD. See 
Appendix A for more details on the activity and expenditure on these conditions in 2018.  
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8.2 SUMMARY AND DISCUSSION OF FINDINGS ON BASELINE AND PROJECTED 
ACUTE EXPENDITURE BY SERVICE 
8.2.1 Baseline expenditure, 2018 
Table 8.1 summarises the report’s findings for baseline and projected expenditure 
for the major services examined in Chapters 5 to 7. Expenditure relates to services 
provided in public acute hospitals and public psychiatric in-patient hospitals/units. 
In 2018, we estimate expenditure on in-patient discharges in acute hospitals to be 
€3,220m and expenditure on day-patient discharges to be €919m. While the 
volume of complexity-weighted day-patient activity was higher (1,038,825 
discharges) compared with in-patient activity (646,077), the unit cost of an in-
patient stay (€4,985) far exceeded that of a day patient stay (€885). The majority 
of in-patient expenditure related to emergency in-patient discharges (€2,143m). 
OPD expenditure amounted to €676.4m based on 4.0m attendances, while ED 
expenditures were €418.6m, based on 1.4m attendances. We estimate the cost of 
adult psychiatric in-patient care in public hospitals at €179m.  
 
This analysis also splits day and in-patient expenditure by the public/private status 
of discharges.82 To do this, we applied the overall average cost of hospital care for 
day patients and in-patients respectively to public and private activity profiles.83 
Based on our estimates, expenditure on public and private discharges amounted 
to €3,403m and €737m, respectively.84 Expenditure on private discharges 
represents approximately 18 per cent of expenditure in acute public hospitals. Of 
this, in-patient expenditure on private discharges accounted for €578m, including 
€344.0m on emergency in-patients and €188.0m on elective care, with the 
remainder on maternity and AMAU/ASAU-only care. 
 
8.2.2 Projected expenditure, 2018–2035 
Expenditure projections in real terms, 2018 to 2035 
Expenditure is projected to increase across all services shown in Table 8.1. The real-
terms increase in expenditure is driven by Ireland’s changing demographic profile. 
As discussed in previous analyses (Keegan et al., 2018a; Wren et al., 2017), driven 
by net migration, Ireland has historically experienced high rates of population 
growth relative to other European countries. Despite having a comparatively young 
age profile, the absolute numbers in older age cohorts have grown. These broad 
 
82  Public/private status refers to whether the patient saw the consultant on a private or public basis. It does not relate to 
the type of bed occupied nor is it an indicator of private health insurance (Healthcare Pricing Office, 2019a). 
83  As acknowledged in Chapter 5, while the hospital resources used to treat both public and private patients are largely 
similar, ideally separate public and private base costs could be applied. However, these are not calculated by the HPO 
and it was not possible to estimate them for this analysis. 
84  As context, public hospital private income in 2018 is estimated at €524m (Independent Review Group, 2019). However, 
part of this differential may reflect the application of an average base cost while not all the cost of private care may be 
covered by income. 
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trends are set to continue, meaning that the impact of demographics on future 
demand for healthcare services is likely to be important.  
 
As described in detail in Chapter 3, Covid-19 is likely to have had both short- and 
medium-term impacts on Ireland’s projected demographic profile and, by 
extension, projected demand for and expenditure on healthcare. Using the ESRI’s 
demographic model, our demographic projections have therefore been adjusted 
to this new reality (see Chapter 3). Considering findings from our favoured low and 
central population projection scenarios, between 2018 and 2035, the total 
population in Ireland is now projected to increase by between 8 and 11 per cent. 
From 2018 to 2035, the population share aged 65 years and over is projected to 
increase from 14 per cent to between 20 and 21 per cent. At the same time, the 
proportion of the population accounted for by children (0–14 years old) will 
become smaller over time as there will be relatively fewer women in the key child-
bearing age groups. In 2018, 21 per cent of the population were under the age of 
15 years, while the comparable proportion in 2035 is projected to be between 15 
and 16 per cent. Driven by assumptions on future net inward migration, the 
population aged 15–64 years is expected to increase by between 6 and 8 per cent 
by 2035. 
 
The largest increases in real expenditures are observed for day-patient and in-
patient discharges. As shown in Chapter 5, these are the services where 
expenditures per capita increase most dramatically with age, and therefore are 
most affected by projected population ageing. For these services it was also 
possible to complexity-weight expenditure profiles, which helped to further refine 
the relationship between ageing and resource use. Between 2018 and 2035, across 
our four projection scenarios (low-pressure, central, high-pressure and progress) 
real expenditure, which removes the effects of cost increases, is projected to 
increase by between 21 and 31 per cent for day patients and 25 and 38 per cent 
for in-patients. This implies projected real 2035 expenditure requirements of 
€1,109.8m to €1,201.5m for day patients and €4,029.4m to €4,445.6m for in-
patients.  
 
In contrast, ED and OPD display relatively more uniform age-related per capita 
expenditure distributions, meaning that changes to the population age structure 
have a less pronounced effect on projected expenditures. Between 2018 and 2035 
real expenditure on ED and OPD care are both projected to increase by between 
12 and 18 per cent. This equates to projected real expenditure requirements in 
2035 of between €467.5m and €496.0m for ED attendances and €758.5m and 
€798.6m for OPD attendances. Combining all service profiles in Chapter 6, we 
project real HSE gross expenditure on public acute hospitals to increase by 
between 22 and 33 per cent by 2035, reflecting 2035 gross real expenditure 
requirements of between €7,183.2m and €7,834.1m. 
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Psychiatric in-patient care (separately part of the HSE mental health budget) in 
adult HSE/HSE-funded acute hospitals/units is projected to increase by between 
16 and 25 per cent in real terms by 2035, equating to projected expenditure 
requirements of €208.8m to €223.3m in 2035. 
 
Expenditure projections in nominal terms, 2018 to 2035 
While demographic pressures drive expenditure through the projected volumes of 
services to be delivered, our analysis suggests that it is the projected cost of 
delivering these services that will be the more dominant driver of nominal 
expenditure to 2035.  
 
In projecting nominal acute expenditures, Hippocrates models pay and non-pay 
components of costs separately. Pay and non-pay (non-drug) costs in this analysis 
are modelled through the ESRI’s macro-econometric model COSMO. These costs 
are modelled based on two COSMO scenarios for economic recovery following the 
Covid-19 pandemic: a Recovery scenario and a Delayed Recovery scenario. Pay is 
modelled based on assumptions related to projected trends in government-sector 
average earnings growth (and tied to wage growth in the wider economy) over the 
projection horizon. Between 2018 and 2035 these earnings are assumed to grow 
at an average annual rate of between 2.2 and 3.5 per cent in nominal terms. Non-
pay (non-drug) costs growth reflects trends in projected inflation (based on a 
personal consumption deflator) but, across scenarios, between 0.5 and 1 
percentage point(s) higher growth per annum is modelled. Hospital drug cost 
growth for day-patient and in-patient care is projected to increase between 4.2 
and 6.2 per cent per annum, based on historic trends. 
 
Decomposition analysis of expenditure drivers conducted in Chapters 5 to 7 
highlighted pay as the single largest driver of nominal expenditure increases for 
ED, OPD, and in-patient and adult psychiatric care. This is reflective of the labour-
intensive nature of healthcare delivery; pay is the dominant contributor to the cost 
of care delivery for all services. In addition, the unit cost of day-patient care had a 
high drug cost component (24 per cent in 2018). These drugs are often innovative 
and expensive, reflecting the nature of service delivery in day-patient settings (e.g. 
chemotherapy and radiotherapy). Hospital expenditure on drugs has increased 
substantially in recent years, above other non-pay costs (Department of Public 
Expenditure and Reform, 2018) and can be expected to do so into the future, 
particularly with a large number of new oncology drugs likely to come on stream 
(Connors, 2017). 
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Reflecting these cost considerations, and the varying impact of demographics 
across services already discussed, under the three scenarios examined nominal ED 
expenditure and OPD expenditure are projected to increase by between 62 and 
109 per cent, and 63 and 108 per cent, respectively, by 2035. In contrast, day-
patient and in-patient expenditure are projected to increase by between 92 and 
161 per cent, and 86 and 150 per cent, respectively, by 2035. Combining these 
profiles in Chapter 6, we project nominal HSE gross expenditure on public acute 
hospitals to increase by between 82 and 143 per cent by 2035, reflecting 2035 
gross nominal expenditure requirements of between €10,760.6m and €14,363.3m. 
 
Psychiatric in-patient care (separately part of the HSE mental health budget) in 
adult HSE/HSE-funded acute hospitals/units is projected to increase by between 
69 and 120 per cent in nominal terms by 2035, equating to 2035 projected 
expenditure requirements of €302.7m to €395.2m. 
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Projected expenditure 2035 (€m) Percentage change 2018–2035 (%) 
2018 2018 Realb Nominal Reala Nominal 
Attendances        
ED Total 1,405,828 418.6 467.5–496.0 679.0–876.0 11.7–18.5 62.2–109.2 
OPD Total 3,965,303 676.4 758.5–798.6 1,105.2–1,404.3 12.1–18.1 63.4–107.6 
Discharges        
Day patientc 
Public 859,387 760.6 919.2–997.6 1,462.5–1,990.1 20.8–31.1 92.3–161.6 
Private 179,438 158.8 185.9–203.9 295.7–406.8 17.0–28.4 86.2–156.1 
Total 1,038,825 919.5 1,109.8–1,201.5 1,765.8–2,396.9 20.7–30.7 92.0–160.7 
        
In-patientc 
Public 530,083 2,642.3 3,302.1–3,651.1 4,905.0–6,611.3 25.0–38.2 85.6–150.2 
Private 115,995 578.2 712.8–794.5 1,058.9–1,438.7 23.3–37.4 83.1–148.8 
Total 646,077 3,220.5 4,029.4–4,445.6 5,985.3–8,050.0 25.1–38.0 85.9–150.0 
        
Electived 
Public 120,957 602.9 734.6–807.9 1,091.3–1,462.9 21.8–34.0 81.0–142.6 
Private 37,712 188.0 225.3–253.4 334.7–458.8 19.9–34.8 78.1–144.1 
Total 158,669 790.9 967.7–1,061.3 1,437.4–1,921.7 22.4–34.2 81.7–143.0 
        
Emergencye 
Public 361,005 1,799.5 2,310.7–2,593.7 3,432.4–4,696.5 28.4–44.1 90.7–161.0 
Private 69,014 344.0 436.4–499.7 648.2–904.9 26.8–45.3 88.4–163.0 
Total 430,019 2,143.5 2,764.7–3,093.4 4,106.8–5,601.4 29.0–44.3 91.6–161.3 
        
Acute gross expenditureb Total – 5,907.1 7,183.2–7,834.1 10,760.6–14,363.3 21.6–32.6 82.2–143.2 
        
Acute psychiatric in-patient Total 396,194 179.3 208.8–223.3 302.7–395.2 16.4–24.5 68.8–120.4 
 
Notes: a For day and in-patient discharges, activity is complexity-weighted; for psychiatric in-patient activity is measured in bed days. 
 b Real projections hold base costs constant at their 2018 values. 
 c These estimates are inclusive of maternity activity in public hospitals. 
 d These estimates exclude maternity activity in public hospitals. 
 e These estimates exclude maternity and AMAU/ASAU-only activity in public hospitals. 
Source:  Chapters 5 to 7. 
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Gross acute hospital expenditure, decomposition of expenditure drivers, 2018–
2035 
As described above, our analysis suggests that it is the projected cost of delivering 
future care, rather than the demographic impacts on demand, that will be the main 
driver of acute hospital expenditure increases to 2035. This is in line with previous 
Irish findings in relation to healthcare expenditure (Irish Fiscal Advisory Council, 
2018; Parliamentary Budget Office, 2019).  
 
As seen in Chapter 6 (Figure 6.3), across the scenarios examined, combined 
demographic effects are projected to add between €1,293.7m and €1,956.8m to 
total acute care expenditure growth by 2035. Within this, population ageing has a 
greater impact than population growth. This is despite modelling optimistic 
relationships between life-expectancy gain and hospital expenditure (i.e. healthy 
ageing) in our low-pressure and central scenarios, in line with international 
evidence. The main driver of projected expenditure increases, however, are pay 
costs. This reflects the labour-intensive nature of healthcare delivery; pay is the 
dominant contributor to the cost of care delivery for all services (see Chapter 5). 
Across scenarios, pay alone is projected to account for between €2,040.3m and 
€4,061.2m in additional expenditure requirements by 2035. The additional cost of 
drugs for day and in-patient care delivery account for between €474.0m and 
€909.9m. The remaining expenditure growth across the low-pressure, central and 
high-pressure scenarios reflects the impact of increases in other non-pay costs tied 
to the delivery of acute care (e.g. medical equipment and supplies, overheads, etc). 
 
Our progress scenario projects a net acute expenditure saving effect by 2035 of 
€313.4m. This suggests that, by 2035, the increased acute expenditure associated 
with clearing OPD and elective waiting-list backlogs and sustaining waiting-time 
targets into the future can be more than offset through preventing certain 
hospitalisations for conditions more appropriately treated in the community. As 
shown in Appendix E, the bulk of expenditure, excluding any associated capital 
costs, to manage waiting lists is required from 2021–2025 (€212m on average per 
year), with lower levels of recurring additional expenditure required from 2026 
onwards. 
 
Gross acute hospital expenditure, average annual growth 2018–2035 
As projected expenditure growth is a function of the length of the specified 
projection horizon, it is useful to also consider growth in terms of average annual 
change. As shown in Table 8.2, we project an overall average annual increase in 
total public acute hospital gross nominal expenditure of between 3.6 and 5.4 per 
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cent.85 Between 2013 and 2018, HSE gross expenditure on acute hospitals has 
increased at an average annual rate of 4.5 per cent (see Chapter 6). However, the 
impact of Covid-19 is likely to result in public hospital expenditure growth being 
different over the coming years than otherwise would have been the case. We 
assume an increase of 10 per cent and 15 per cent in expenditure in 2020 and 2021, 
respectively, followed by zero net growth in expenditure in 2022 as Covid-19 
supports are withdrawn. Accounting for this raises average annual growth in 
hospital expenditure to 6.0 per cent to 2025 (see Table 6.4). While this 
permanently alters projected expenditure growth to 2035, it falls within the range 
of our main scenarios.  
 
Over recent years, growth in the Irish economy, whether measured on a GDP or 
GNI* (which removes globalisation effects) basis, has outstripped overall current 
healthcare expenditure increases. Between 2014 and 2018, current healthcare 
expenditure as a proportion of GNI* (GDP) fell from 15.1 (11.5) per cent to 11.4 
(6.9) per cent (Central Statistics Office, 2018a). When considering the sustainability 
of projected nominal expenditure increases over the projection horizon, it is 
therefore important to view these increases in the context of growing national 
income which will contribute to the tax base necessary to finance future care 
needs. 
 
Moreover, when the effect of pay and non-pay cost increases are removed, we 
project a considerably lower real (or volume) average annual increase in 
expenditure growth of between 1.2 and 1.7 per cent. Adjusting for projected 
population growth over the period, projected per capita average annual real 
expenditure growth ranges between 0.6 and 0.9 per cent.  
 
TABLE 8.2 Public acute hospital gross expenditure – nominal and real average annual growth rates, and average 
annual growth rates per capita, by projection scenario 
 
 Average annual growth rates 2018–2035 (%) 
 Low Central High Progress 
Real  1.2 1.5 1.7 1.3 
Real per capita 0.7 0.9 0.6 0.7 
Nominal 3.6 4.3 5.4 4.1 
Nominal per capita  3.1 3.7 4.3 3.5 
 
Notes: Real projections hold base costs constant at their 2018 values. 
Source: Authors’ calculations. 
 
 
85  Projection exercises from other countries tend to report overall healthcare expenditure projections, making it difficult 
to compare findings from this analysis, internationally. Charlesworth and Johnson (2018), in their analysis of UK health 
spending projections report projected annual hospital spending growth of between 3.6 and 4.0 per cent between 
2018/19 and 2033/34. These projections, however, model real price effects (over and above general inflation) and are 
not directly comparable with the nominal or real projections presented in this analysis.  
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8.3 SENSITIVITY ANALYSIS 
Table 8.3 presents the projected expenditure in 2035 arising from assuming our 
central projection scenario, and examines the percentage change in expenditure if 
key assumptions are altered independently of other assumptions. 
 
This sensitivity analysis shows that sensitivity to population growth assumptions is 
greatest in services which are delivered more uniformly across the age distribution, 
such as ED and OPD care. Applying our low or high population growth projections 
affects expenditure on these services to a greater extent than day-patient or in-
patient services, where care is delivered to a greater extent to older people. This 
differing impact of the population growth assumptions arises because the major 
driver of the difference in population projections is the assumed level of migration, 
which affects numbers in younger and middle-age cohorts (see Chapter 3). 
 
The central projection scenario assumes moderate healthy ageing in line with 
international evidence on healthy ageing effects in relation to hospital expenditure 
(see Chapter 2). Consequently, assuming no health ageing effects increases 
projected 2035 expenditure relative to the central scenario, while increasingly 
stronger assumed healthy ageing effects in the form of dynamic equilibrium and 
compression of morbidity assumptions (see Section 4.2.2) reduce projected 
expenditures. Dynamic Equilibrium assumes that gains in health (proxied by 
activity rates shifts) match gains in age-specific life-expectancy change. Moderate 
Healthy Ageing, in contrast, assumes gains in health at 50 per cent gains in life 
expectancy, while Compression of Morbidity assumes gains at 150 per cent. Table 
8.3 demonstrates that services for which expenditures are more concentrated in 
older ages (i.e. day-patient and in-patient hospital care) are most sensitive to 
healthy ageing effects. For instance, assumed Dynamic Equilibrium reduces 
projected 2035 in-patient expenditure by 4.2 per cent, while Compression of 
Morbidity reduces projected 2035 expenditure by 8.4 per cent, relative to the 
central scenario. 
 
As discussed in Chapter 2, while causality is difficult to identify, inverse associations 
exist between avoidable hospitalisation, and primary care accessibility and 
resourcing. For this analysis we limited our set of avoidable hospitalisations to the 
three most resource-intensive avoidable hospitalisations, and for which evidence 
exists for appropriate treatment or prevention outside hospital, and thus have 
been considered as areas for priority primary care investment (McDarby and 
Smyth, 2019).86 Under our progress scenario, we assumed that improved 
investment and access to primary care may lead to a 33 per cent reduction in the 
rate of in-patient emergency discharges (and ED attendances) for these conditions 
 
86  Vaccine-preventable influenza and pneumonia, COPD, and urinary tract infections (including pyelonephritis). See 
Appendix A for more details. 
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by 2035. Choice of this parameter, however, was subject to considerable 
uncertainty, and (as shown in Table 8.2) expenditure projections are sensitive to 
the rate of reduction specified. For instance, if by 2035 there is a fall in the rate of 
in-patient emergency discharges by 33 per cent, this would equate to a 5.4 per cent 
reduction in in-patient expenditure, while a 50 per cent reduction in the activity 
rate would equate to an 8.2 per cent reduction in expenditure. This reflects the 
relatively large amount of resources consumed by these conditions (particularly 
vaccine-preventable influenza and pneumonia – see Appendix A). Therefore, 
policies that achieve fewer hospitalisations for these conditions (for instance, 
improved influenza vaccine uptake) could free up significant amounts of acute 
hospital resources. 
 
As described throughout this chapter, however, expenditure projections are most 
sensitive to assumed trends in the cost of care delivery, particularly pay costs. As 
part of this sensitivity analysis, we examine the extent to which pay costs may be 
offset through assumed gains in productivity – essentially assuming that the same 
projected quantity of care could be delivered but at a lower unit cost. In terms of 
productivity, we examine the effect on projected expenditures of a 1.0 and 1.5 per 
cent increase in productivity per annum, respectively. Findings presented in Table 
8.3 highlight that significant expenditure reductions could be realised with 
relatively small per annum improvements in labour productivity. The findings are 
strongest for services where pay accounts for the greatest proportions of the 
overall cost of care delivery (i.e. OPD, ED, adult in-patient psychiatric care). For 
instance, a 1 per cent per annum improvement in labour productivity could reduce 
projected ED expenditures by 11.7 per cent. This increases to a 16.8 per cent 
reduction under an assumed 1.5 per cent per annum improvement. 
 
Additionally, we consider, in the context of recent increased public expenditure 
burdens required to tackle the Covid-19 pandemic, the impact of tighter public-
sector pay policy in the coming years on projected hospital expenditure. Under one 
assumption, we consider the impact of a public pay freeze in 2021 and 2022, 
followed by a return to projected pay growth modelled under the central scenario. 
Under an alternative assumption, we consider the impact of a pay freeze in 2021 
and 2022, followed by a return to more moderate 1.5 per cent per annum pay 
growth for the remaining projection years.87,88 Implementation of the pay freeze in 
2021-2022 alone would result in relatively modest reductions in 2035 expenditure, 
between 2.1 and 3.8 per cent, relative to the central scenario. Combining this pay 
freeze with assumed projected wage growth of 1.5 per cent per annum for the 
 
87  As reported in Table 3.1, government-sector nominal average wage growth over the projection period averages 2.5 per 
cent per annum under the Recovery scenario applied under our central projections. 
88  The focus of the sensitivity exercise is to illustrate the relative effects of varying key assumptions on projected 
expenditure rather than specifying plausible scenarios. Particularly, modelling longer-term pay restraint (i.e. 1.5% per 
annum) may have wider implications for projected expenditures in terms of workforce and the economy that are not 
captured. 
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remaining projection years results in larger reductions in 2035 expenditure, of 
between 7.0 and 12.8 per cent, relative to the central scenario. 
 
TABLE 8.3 Sensitivity analysis – effect on projected expenditure for main services of varying key assumptions 
and productivity effects 
 
 Public acute hospitals 
Psychiatric 
in-patient 
 ED OPD Day patients In-patients Adult 
Projected 2035 expenditures  
based on central scenario 
746 1,062 1,995 6,332 325 
Assumption Percentage effect on 2035 expenditure of changing one assumption (%) 
Population 
Low -3.0 -2.2 -1.6 -2.0 -2.0 
High 7.1 5.3 3.7 4.4 4.8 
       
Healthy 
ageing 
None 1.5 1.7 3.2 4.2 N.A. 
DE -1.5 -1.7 -3.2 -4.2 N.A. 
CM -3.0 -3.3 -6.4 -8.4 N.A. 




0.25% by 2035 -1.2 N.A. N.A. -4.1 N.A. 
0.33% by 2035 -1.6 N.A. N.A. -5.4 N.A. 
0.50% by 2035 -2.4 N.A. N.A. -8.2 N.A. 
       
Pay 
Productivity improvement      
1.0% p.a. -11.7 -10.6 -6.6 -9.8 -12.2 
1.5% p.a. -16.8 -15.4 -9.6 -14.2 -17.6 
      
Pay freeze      
2021-2022 -3.7 -3.3 -2.1 -3.1 -3.8 
2021-2022, 1.5% p.a.  
wage growth thereafter 
-12.3 -11.2 -7.0 -10.3 -12.8 
 
Notes: Excludes maternity-related expenditures.  
We do not model varying assumptions in relation to waiting-list management, since the 2035 effect on expenditure is small 
relative to other drivers. 
Source: Authors’ calculations. 
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8.4 LIMITATIONS 
The modelling in this analysis was subject to some limitations. While detailed 
administrative data on activity and costs were available for the most acute services 
examined, gaps in activity and unit-cost information affected certain services. For 
instance, administrative age- and sex-specific data on use of public outpatient 
(OPD) care in Ireland is relatively poor. This necessitated the use of a variety of data 
sources to generate the underlying activity profiles used in this analysis (see Brick 
and Keegan (2020a) for details). Additionally, as described in Chapter 4, the lack of 
available cost data in relation to public acute psychiatric care required the 
calculation of an overall top-down unit cost of a bed day as a basis for expenditure 
projection. 
 
While this analysis examined the potential acute care expenditure implications of 
shifting certain appropriate care to the community, it did not explicitly consider 
other models of care change that may also realise future expenditure savings. This 
includes the ability to improve the model of care delivery within the acute system 
(e.g. in-patient care delivered in a day-patient setting or day-patient care delivered 
in an OPD setting) or policies in relation to improved workforce skill-mix. As shown 
in the sensitivity analysis conducted above, productivity-improving policies such as 
these could further mitigate against some of the projected acute expenditure 
growth. 
 
As described by Bojke et al. (2017), productivity is one of the key measures against 
which health policy achievements can be judged. It is often considered in claims 
about health system performance and in justifying resource allocation or in 
appealing for additional funding. Productivity effects in this analysis, however, 
were modelled as a sensitivity due to a weak evidence base in relation to health or 
hospital care productivity trends in Ireland.89 Future healthcare projection 
exercises, and policy considerations in general, would benefit from the 
construction and publication of healthcare-specific productivity indices for Ireland. 
The Office for National Statistics (ONS), for example, currently provides annual 
growth rates and indices for healthcare inputs, quality and non-quality adjusted 
output and productivity for England. This could serve as a useful template for the 
Irish system.  
 
 
89  The productivity effect is all-encompassing; while not explicitly, it could include improvements due to shifts in activity 
to other settings, e.g. from in-patient to day patient and from day patient to OPD. While beyond the scope of this 
analysis, it would be possible in a future iteration of Hippocrates to consider such changes explicitly. This would require 
a detailed analysis of trends in activity as well as substantial input from clinicians (e.g. the National Clinical Programme 
for Surgery). Such an exercise would benefit from improvements in the available OPD data, such as detailed patient-
level activity and expenditure data. 
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8.5 POLICY IMPLICATIONS, REFLECTIONS, AND CONCLUSIONS 
The main finding of this report is that due to a combination of a growing and ageing 
population and increasing costs of care delivery, expenditure on public acute and 
psychiatric in-patient services will be required to increase significantly by 2035. The 
main driver of this increased expenditure is the future expected cost of care 
delivery, particularly pay-related cost. The delivery of acute and psychiatric in-
patient care is very labour-intensive; unit costs of care derived for this analysis 
show that pay is the major component cost of care delivery across all services. 
These findings therefore have major implications for expanded staffing, workforce 
planning and training. Decades of underinvestment in acute hospitals, combined 
with a growing and ageing population, have also left the acute hospital system 
capacity constrained, resulting in large backlogs for access and long waiting times. 
Additional capital investment will also be required to meet the underlying demand 
growth and to deliver timely access to services. While this has long been 
acknowledged, the 2021 Budget has allocated additional capital spending to 
increase bed capacity in line with recommendations (PA Consulting, 2018). This 
includes funding to increase the stock of public acute hospital beds by 1,146, and 
to increase the stock of critical-care beds to 321, by the end of 2021 (Government 
of Ireland, 2020). 
 
While the outbreak of Covid-19 in 2020 resulted in a short-term shock to acute 
hospital utilisation and expenditure, the pandemic will also likely leave longer 
lasting impacts on demand for, and cost of delivering, hospital services, which are 
more relevant for modelling trends in expenditure over the medium term. In line 
with the broader macroeconomic implications of the pandemic, projected trends 
in net migration and pay and non-pay prices have been adjusted. The large recent 
increase in waiting-list numbers for hospital care – a result of cancellation of all but 
essential elective services – has also been incorporated into estimates of the 
additional expenditure required if this backlog is to be addressed over the next 
number of years. 
 
With the above in mind, this report projects that total HSE gross expenditure on 
public hospital services will increase by between 22 and 33 per cent in real terms, 
and 82 and 143 per cent in nominal terms, by 2035. In nominal terms this reflects 
an average annual increase of between 3.6 and 5.4 per cent, within the range of 
average annual increase in acute expenditure over recent years. However, 
increased expenditure in response to Covid-19 will likely drive expenditures above 
trend in the short (but not longer) term. Expenditure requirements also increase if 
a policy decision is made to address existing waiting-list backlogs. In addition to 
demographic and cost pressures, we estimate the expenditure in terms of 
additional activity required to address these backlogs (and sustain lower waiting 
times) at €212m on average per year in nominal terms between 2021 and 2025 
with an additional €58m (2026–2030) to €71m (2031–2035) on average per annum 
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required to keep waiting times below a 12-week target over the remainder of the 
projection horizon. As the system is currently operating at close to full capacity, as 
noted, additional capital investment in beds is also required. At an acute service 
level, the greatest projected expenditure pressures are observed for day and in-
patient care. These are the services where expenditure per capita increase most 
dramatically with age and are therefore most affected by projected population 
ageing. Additionally, many services provided in a day patient setting require the 
delivery of innovative and expensive drugs (e.g. oncology drugs). This has been 
identified as a further significant cost pressure in addition to pay. 
 
Findings from this analysis provide some insights into how policy may respond to 
mitigate against some of these projected expenditure pressures. As identified by 
Sláintecare (Government of Ireland, 2018b; Houses of the Oireachtas Committee 
on the Future of Healthcare, 2017), our health system remains hospital-centric and 
the prevention or treatment of many conditions could be better provided in the 
community. Taking an evidence-based approach, we focused on three such 
conditions that currently consume significant hospital resources: vaccine-
preventable influenza and pneumonia, COPD, and urinary tract infections 
(including pyelonephritis). We showed that reducing the rate of hospitalisation for 
these conditions by a third by 2035 could result in material acute expenditure 
savings. While this analysis did not consider the associated expenditure 
implications of additional staffing and other resources required to facilitate greater 
levels of care in the community, there is evidence for cost-effective community 
treatment or prevention (McDarby and Smyth, 2019). For instance, close to €300m 
was spent in 2018 in treating vaccine-preventable influenza and pneumonia in 
public acute hospitals. Yet, while seasonal influenza and pneumococcal vaccination 
are considered the primary approach to preventing morbidity and mortality 
associated with these conditions, vaccination rates for these conditions lag 
significantly behind the UK (McDarby and Smyth, 2019). Future research planned 
under the ESRI Research Programme in Healthcare Reform will provide baseline 
estimates and expenditure projections on public and private non-acute health and 
social care services. 
 
Sensitivity analysis has also shown that reasonable productivity improvements 
could offset some of the large projected increases in the unit cost of care delivery. 
Examples of how this might be achieved include improved information and 
communication technology (ICT), changes in hospital staff skill-mix, and better 
management (Wanless, 2002). An improved integration with post-acute hospital 
care could also reduce delayed discharges, allowing more hospital patients to be 
seen. Recent ESRI research has shown that hospital stays for older people are 
shorter in areas with better supply of home care and residential care services 
(Walsh et al., 2020b; Walsh et al., 2019). The flexibility of Hippocrates also allowed 
for analysis of the sensitivity of projected expenditures to assumed changes in 
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public-sector pay policy. It is also important to consider, however, that projected 
increases take place in a context of national income growth which will increase the 
ability to finance future expenditure requirements. 
 
In addition to projections of expenditure, this report has developed a more 
detailed and comprehensive analysis of public hospital age- and sex-related 
expenditure profiles than has previously been available for Ireland. These findings 
may have wider uses and applications. Already this is evidenced in that the 
expenditure profiles developed for this analysis formed the foundation for a 
Department of Health submission, for the first time, of Irish age-cost profiles to the 
European Commission. Until now, Ireland was only one of three countries unable 
to submit age-cost profiles to the Commission to inform its Ageing Reports. It was 
outside the scope of this analysis to consider the impact of plans to remove private 
activity from public hospitals; however, the presentation of estimated acute 
expenditure profiles separately for public and private activity may provide useful 
insights regarding these reforms (Independent Review Group, 2019). A detailed 
understanding of public hospital expenditure on private emergency and maternity 
activity, in particular, becomes important under such reforms as expenditure on 
this care is likely to remain within the public system, given the elective care focus 
of private hospitals (Keegan et al., 2018b). Finally, conversion of activity profiles to 
expenditure required detailing and analysis of unit costs of hospital services by pay 
and non-pay cost components. Ireland does not routinely publish on healthcare 
unit costs. These estimates may have wider applicability for policy and also for 
research in other areas such as costing or cost-effective analyses. 
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APPENDIX A 
Avoidable hospitalisations 
Appendix A Avoidable hospitalisations 
DIAGNOSIS CODES 
As discussed in Section 4.3.2, 21 avoidable hospitalisation conditions were 
identified. The International Classification of Diseases Tenth Revision, 8th edition 
diagnosis codes used to identify these conditions in HIPE are outlined in Table A.1. 
In addition, the table presents the number of weighted and complexity-weighted 
emergency in-patient (excl. maternity) discharges with these conditions in 2018 
and the proportion of the total they account for. 











N % N % N % 
Vaccine preventable        
Influenza and pneumonia 
(vaccine-preventable) 
Any DX (excl. ADX D57) of: 
J09- J11, J13-J14, J16.8, 
J18.1, J18.8-J18.9 
25,300 25.6 58,584 50.2 405,435 48.6 
Other vaccine- 
preventable conditions 
A08.0 (any), A35-A37, A80, 
B05-B06, B16.1, B16.9, 
B18.0-B18.1, B26, 
G00.0 (any), M01.4 (any) 
323 0.3 222 0.2 1,026 0.1 
Acute        
Urinary tract infections, 
including pyelonephritis 
N10-N12, N13.6, N39.0 14,804 15.0 14,068 12.0 123,519 14.8 
Convulsions and epilepsy G40, G41, R56 7,623 7.7 5,650 4.8 32,024 3.8 
Cellulitis L03-L04, L08, L08.8-L08.9, 
L88, L98.0, L98.3 
6,601 6.7 5,275 4.5 40,969 4.9 
Ear, nose and throat infections H66-H67, J02-J03, J06, J31.2 7,170 7.3 2,580 2.2 11,710 1.4 
Gangrene Any DX: R02 447 0.5 1,761 1.5 10,691 1.3 




518 0.5 1,021 0.9 5,144 0.6 
Dehydration and gastroenteritis E86, K52.2, K52.8, K52.9 932 0.9 732 0.6 5,391 0.6 
Dental conditions K02-K06, K08, K09.8, 
K09.9, K12-K13 
790 0.8 545 0.5 2,333 0.3 
Pneumonia 
(not vaccine-preventable) 
Any DX (excl. ADX D57): 
J15.3-J15.4, J15.7 
139 0.1 455 0.4 2,301 0.3 
Pelvic inflammatory disease N70, N73-N74 285 0.3 204 0.2 1,275 0.2 
Chronic        
COPD J40-J44 15,161 15.4 13,277 11.4 115,072 13.8 
Congestive cardiac failure I50, I11.0, J81 6,429 6.5 7,955 6.8 65,754 7.9 
Diabetes complications E10.0–E10.8, E11.0–E11.8, 
E13.0–E13.8, E14.0–E14.8 
3,938 4.0 5,626 4.8 35,408 4.2 
Asthma J45-J46 3,860 3.9 1,724 1.5 9,948 1.2 
Angina Excl. ADX blocks 1820-2140: 
I20, I24.0, I24.8-I24.9 
2,453 2.5 1,628 1.4 8,742 1.0 
Iron deficiency anaemia D50.1, D50.8-D50.9 1,991 2.0 1,293 1.1 8,432 1.0 
Hypertension I10, I11.9 2,508 2.5 675 0.6 5,421 0.6 
Bronchiectasis J47 471 0.5 532 0.5 4,519 0.5 
Nutritional deficiencies E40-E43, E55.0, E64.3 7 0.0 58 0.1 362 0.0 
Total avoidable hospitalisationsb 98,676 100 116,768 100 834,561 100 
 
Notes: a Principal diagnosis unless otherwise stated.  
DX: diagnosis; ADX: additional diagnosis. 
 b A discharge is counted as one if one or more of the 21 conditions are recorded. 
Source:  HIPE, 2018; Australian Institute on Health and Welfare (2020); McDarby and Smyth (2019). 
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DISCHARGE PROFILES, 2018 
The selected conditions for further analysis are vaccine-preventable influenza and 
pneumonia, COPD, and urinary tract infections (including pyelonephritis). 
Collectively they account for 54.2 per cent of unweighted and 70.7 per cent of 
complexity-weighted avoidable hospitalisations recorded in 2018.90 Figure A.1 
outlines the age-specific unweighted and complexity-weighted discharges in 2018 
for the three conditions and the sum of the three. All three conditions are most 
prevalent in older ages. Vaccine preventable influenza and pneumonia had the 
highest volume of discharges (25,300) of the three conditions in 2018 and is most 
affected by complexity weighting (58,584), particularly at older ages. 
 
FIGURE A.1 Avoidable hospitalisations – age- specific unweighted and complexity-weighted discharges, 2018 
 
All Vaccine preventable influenza and pneumonia 
  




Source: HIPE, 2018. 
  
 
90  The number of in-patient bed days recorded for those discharges aged 65+ years with vaccine preventable influenza 
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Figure A.2 shows age- and sex-specific profiles of complexity-weighted discharges 
and the discharge rate per 1,000 population. The rate per 1,000 population for all 
three conditions increases with age from approximately 50 years. There are more 
male than female discharges for both COPD and vaccine preventable influenza and 
pneumonia, with the differential particularly high at 75 years and older. For COPD 
the rate per 1,000 population for females becomes relatively stable from 70 years 
onwards, while for males it continues to increase with age. 
 
FIGURE A.2 Avoidable hospitalisations – age- and sex-specific complexity-weighted discharges and discharge 
rates per 1,000 population, 2018 
 
All Vaccine preventable influenza and pneumonia 
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EXPENDITURE PROFILES, 2018 
Total expenditure on the three selected conditions in 2018 was €411m. The 
majority, €292m, related to vaccine preventable influenza and pneumonia. Most 
of the expenditure was concentrated in older ages (50 years and older) (Figure A.3). 
 
FIGURE A.3 Avoidable hospitalisations – age- and sex-specific expenditure, 2018 
 
All Vaccine preventable influenza and pneumonia 
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APPENDIX B 
Public acute psychiatric in-patient service utilisation, 2018–2035 
Appendix B Public acute psychiatric in-patient service utilisation, 2018–2035 
To align with the highly aggregated expenditure data available for public acute 
psychiatric in-patient services, data from the HRB NPIRS was aggregated to align 
with the units included in the CSO System of Health Accounts expenditure category 
pertaining to acute adult in-patient units.91 Table B.1 lists the 29 public acute adult 
HSE and HSE-funded units included in the SHA and Hippocrates.92,93 
 
TABLE B.1 HSE and HSE-funded acute adult psychiatric in-patient units by Community Healthcare Organisation 
 
Total CHO 1 Total CHO 6 
Cavan General - Unit Cluain Mhuire  
Letterkenny General - Unit St Vincent’s University Hospital, Elm Park Unit 
Sligo Mental Health Services Newcastle Hospital 
Total CHO 2 Total CHO 7 
Mayo General Hospital - Unit St James Hospital - Unit 
Roscommon General Hospital - Unit Tallaght Hospital - Unit 
UCHG - Unit Lakeview Unit, Naas General Hospital – Unit 
Total CHO 3 Total CHO 8 
Acute Psychiatric Unit, Ennis General Hospital, Co. Clare Midlands Regional Hospital Portlaoise - DOP Unit 
Acute Psychiatric Unit 5B, University Hospital Limerick St. Loman’s Hospital, Mullingar 
Total CHO 4 Cluain Lir Care Centre, Mullingar 
Bantry General - Unit Drogheda Department of Psychiatry, Crosslanes 
Cork University Hospital - Unit Total CHO 9 
Mercy University Hospital - Unit Connolly Hospital - Unit Pine & Ash Ward 
St Stephen's Hospital St Vincent’s Fairview - Hospital 
University Hospital Kerry - Unit Mater Hospital - Unit 
Total CHO 5 Ashlin Centre – Joyce & Sheehan Units 
St Luke's Hospital Kilkenny - Unit  
Waterford General Hospital  
 
Source: HSE Mental Health Division (2019). 
  
 
91  These are defined as acute adult psychiatric in-patient units with a 24-hour medical presence and classified as approved 
centres by the Mental Health Commission under the Mental Health Act 2001. SHA category HP1.2 – Mental Health 
Hospitals, HC1.1.2 – specialised in-patient curative care, HF1.1.1 – central government schemes. 
92  The included units accounted for 80 per cent of total acute psychiatric in-patient unit expenditure and 89 per cent of 
acute psychiatric in-patient bed days in 2018. 
93  It is hoped that, when the expenditure data available for mental health services improves, additional services may be 
added to the Hippocrates Model. 
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BASELINE UTILISATION, 2018 
Figure B.1 presents the number of episodes/episode rate94 and bed days/bed day 
rate for adult psychiatric in-patient units from 2015–2018. Rates are calculated 
using ESRI population estimates for 2018 for those aged 18 years and older.95 
Episodes and bed days and their accompanying rates have decreased slightly over 
the period. 
 
FIGURE B.1 Psychiatric in-patient – episodes and bed days and episode and bed day rates per 1,000 
population, 2015–2018 
 
Episodes Bed days 
  
 
Note: Rates calculated using ESRI population calculations for 2018, 18 years and older. 
Source: HRB NPIRS, 2015–2018. 
 
Figure B.2 presents age- and sex-specific in-patient episodes and bed days, with 
accompanying rates per 1,000 population for 2018. The number of episodes is 
highest for males in the 35–39 age group while for females it is in the 40–44 age 
group. There is a large differential in the episode rate for males and females in the 
25–34 age groups; the male rate is between 1.5 and 1.75 times greater than the 
female rate. For adult bed days the distribution of the number of bed days and the 
bed day rate is quite different for males than females. The number of male bed 
days peaks at 35–39 years (24,209) while the bed day rate peaks at 30–34 years 
(143.2 per 1,000 population).96 For females the number of bed days peaks at 50–
54 years while the bed day rate does not peak until 70–74 years (142.8 per 1,000 
population). The male rate is higher than the female rate at all ages, except for the 
65–74 age groups.  
 
94  The term episodes is used rather than discharges, admissions or patients, as this analysis uses an aggregation of the 
following activity in 2018: completed episodes – discharges and deaths in 2018; active new episodes – patients 
admitted in 2018 who have not yet been discharged by 31 December 2018, and active long-stay episodes – patients 
admitted prior to 2018 that have not yet been discharged on 31 December 2018 (Brick et al., 2020a). 
95  It should be noted that there was a small number of episodes/bed days in adult units relating to children aged less than 
18 years. 
96  This is due to differing diagnoses between males and females in these age groups. There are a high number of males 
with a diagnosis of ‘F20-F29 Schizophrenia, schizotypal and delusional disorders’ which is associated with a relatively 
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FIGURE B.2 Psychiatric in-patient – age- and sex-specific in-patient episodes and bed days and episode and 




Note: Rates calculated using ESRI population calculations for 2018, 18 years and older. 
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PROJECTIONS OF DEMAND, 2018–2035 
Table B.2 presents projected bed day demand and projected demand growth for 
the three projection scenarios (see Chapter 7). Bed day demand in acute 
psychiatric in-patient units is projected to grow to 461,356 days, 470,803 days, and 
493,444 days, across our low, central and high-pressure scenarios, respectively, 
between 2018 and 2035. Larger growth is projected for females than males across 
all scenarios. 
 
TABLE B.2 Psychiatric in-patient – projected bed day demand by projection scenario, 2018 and 2035 
  
2018 2035a,b 
Activity Low Central High 
Male 213,760 244,781 (14.5) 250,338 (17.1) 263,779 (23.4) 
Female 182,434 216,575 (18.7) 220,465 (20.8) 229,665 (25.9) 
Total 396,194 461,356 (16.4) 470,803 (18.8) 493,444 (24.5) 
 
Note: a Percentage growth 2018–2035 in parentheses. 
 b We assume no healthy ageing effects for psychiatric in-patient care. 
Source:  HRB NPIRS (2018) and author calculations. 
 
Figure B.3 presents age-specific bed day projections for acute adult psychiatric in-
patient units by projection scenario. Across all scenarios, a relatively large 
proportion of the projected bed day demand growth takes place at older ages (50 
years and older). Substantial growth is also seen in the 20–29 years age groups, 
particularly in the high-pressure scenario. In the 30–49 years age groups, demand 
for in-patient bed days is projected to decrease between 2018 and 2035 in all 
scenarios. These changes reflect the underlying demographic projections across 
the scenarios. 
 





Note: We assume no healthy ageing effects for psychiatric in-patient care. 
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Appendix C Short-term expenditure adjustments – Assumptions and Analysis 
BACKGROUND 
As described throughout this report, Hippocrates has been developed as a 
medium-term projection model. It projects annual expenditure requirements 
based on known drivers of demand and cost (e.g. demographics, pay). The model 
does not forecast expenditure, which may vary from year to year due to 
unanticipated shocks, of which Covid-19 represents a striking example. As outlined 
in Chapter 1, additional resources have been, and are planned to be, provided to 
the health system in 2020 and 2021 in response to the demands placed on the 
system by Covid-19, and relatedly to expand capacity, tackle waiting lists and 
transform care delivery in line with Sláintecare. In this appendix, we consider how 
projected expenditures over the short and medium term may differ when directly 
accounting for these Covid-related expenditure shocks, which may represent a mix 
of both temporary and permanent additions to expenditure. We incorporate these 
adjustments into analysis in Chapter 6. 
 
To examine the effects these direct adjustments may have on our projections, we 
specify an additional scenario (central – adjusted) that adjusts expenditure 
requirements in 2020, 2021 and 2022 as follows: 
2020:  10% increase in public acute gross expenditure 
2021:  15% increase in public acute gross expenditure 
2022:  Gross expenditure at 2021 levels. This reflects the net effect of 
assumed removal of Covid-related supports and increased 
expenditure due to demographic and cost considerations. 
2023-2035:  A return to the central projection growth path. 
 
The assumptions in relation to 2020 and 2021 are discussed in more detail below. 
 
2020 
Since the outbreak of the Covid-19 pandemic, acute hospitals have incurred 
additional Covid-related expenditure in 2020, relating to costs such as personal 
protective equipment (PPE), infection control measures, and additional staff.97 
Additional acute funding for 2020 was included in the HSE Winter Plan (Health 
Service Executive, 2020b). However, at the time of writing it is unclear how much 
final 2020 expenditure will differ from the 2020 National Service Plan estimates 
 
97  Personal communication, HSE Finance, 23 October 2020. 
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(Health Service Executive, 2019). In this analysis we assume that these extra 
measures may contribute to a 10 per cent increase in 2020 expenditure.98 
 
2021 
In October 2020, the Government announced a total health budget of €22.1 billion 
for 2021 – an increase of €3.8 billion, or 20.7 per cent, on 2020. While difficulty 
arises in understanding how these funds will be split between acute and non-acute 
services, broad breakdowns of allocations have been published (see Table C1). In 
terms of hospital care, large capital funding allocations have been earmarked to 
increase acute and critical care bed capacity in line with the 2018 Capacity Review. 
These, however, are separate to current funding allocations.99 In terms of current 
funding, one large item with potential relevance to hospital care is the ‘improving 
access to care’ initiative (see Table C1). Overall, this is set at €318m, and includes 
€210m provided for a new ‘access to care’ fund to improve access to care for those 
significantly affected by the Covid-19 pandemic (Government of Ireland, 2020). 
Included in the health budget allocation is a Covid-19 current expenditure 
allocation of €1,751m (Government of Ireland, 2020). A yet unknown portion of 
this temporary funding will be directed towards hospital care; for example, in 
terms of additional PPE, planning for surge-related acute capacity, and infection 
prevention and control. Overall however, based on Table C.1 and associated 
commentary on these allocations (Government of Ireland, 2020), it is reasonable 
to assume that most of the 2021 health budget funds will be directed to either 
capital projects or primary and social care. In that regard, we consider it instructive 
to model a 15 per cent increase in hospital funding (expenditure) in 2021. 
 
TABLE C.1 Summary of new expenditure measures in the health service, 2021 
 
Item  Cost in 2021 (€m) 
Increasing capacity to progress implementation of the Capacity Review 2018  467 
Delivering enhanced community and social care services 425 
Disability Services 100 
Mental Health Services 38 
Implementing National Strategies and Expert Review 147 
Public Health, Well Being and the National Drug Strategy 53 
Improving access to care 318 
Introducing New Drugs 50 
e-Health 58 
COVID-19 Measures: Public Health Initiatives 1,300 
COVID-19 Measures: Additional supports 404 
 
Source: Government of Ireland (2020). 
  
 
98  Personal communication with HSE Finance (22 October 2020) suggests that this is a reasonable approximation of 2020 
gross forecasted public acute hospital expenditure.  
99  Although increased capacity should allow for more activity to take place, increasing current expenditure requirements, 
particularly given the large levels of unmet demand for care evident in the Irish hospital system.  
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FINDINGS 
Figure C.1 highlights the impact of these expenditure adjustment assumptions on 
projected public acute hospital expenditure through the projection horizon relative 
to the central projection scenario. Expenditure under the ‘adjusted’ central 
scenario in 2035 is projected at €13,669m relative to €12,050m under the central 
scenario.  As can be seen, the expenditure increases are modelled to have both a 
permanent and temporary dimension.  
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While some of the assumed expenditure increases in 2020 and 2021 permanently 
raise projected expenditure requirements, the effect of this shock is less pertinent 
over the entire projection period, with average annual growth rates, and projected 
expenditures, falling within the bounds of our main projection scenarios (see Table 
C.2). Over the period 2018–2035, we report average annual increases of 4.3, 5.1, 
and 5.4 per cent in the central, central-adjusted and high-pressure scenarios, 
respectively. 
 
TABLE C.2 Public acute hospital gross expenditure – nominal average annual growth rates by projection scenario 
and incorporating short-term assumed expenditure and budgetary adjustments 
 
 Nominal expenditure growth (average annual) 
Low Central High Progress Central - adjusted 
2013-2018* 4.5 
2018-2025 3.3 4.1 5.3 4.5 6.0 
2026-2030 3.8 4.4 5.5 4.2 4.4 
2031-2035 3.8 4.3 5.4 4.1 4.3 
2018-2035 3.6 4.3 5.4 4.1 5.1 
 
Source: 2013–2018 – HSE Management Data Reports, December; 2018–2035 – authors’ calculations. 
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Appendix D Projected expenditures – average growth rates 2018–2035 
Table D.1 below converts overall projected expenditure growth for public acute 
hospital care (reported in Chapter 5) and public acute psychiatric in-patient care 
(reported in Chapter 7), by projection scenario, into average annual growth rates 
over the period 2018 to 2035. 
 
TABLE D.1 Public acute and psychiatric in-patient gross expenditure – real and nominal average annual growth 
rates by projection scenario, 2018–2035 
 
  
Expenditure growth (average annual) 2018–2035 (%) 
Real Nominal 
Low Central High Low Central High 
Emergency Department 0.7 0.9 1.0 2.9 3.5 4.4 
Outpatients 0.7 0.9 1.0 2.9 3.4 4.4 
Day patients 1.1 1.4 1.6 3.9 4.7 5.8 
Public 1.1 1.4 1.6 3.9 4.7 5.8 
Private 0.9 1.3 1.5 3.7 4.6 5.7 
In-patients 1.3 1.7 1.9 3.7 4.4 5.5 
Public 1.3 1.7 1.9 3.7 4.4 5.5 
Private 1.2 1.6 1.9 3.6 4.4 5.5 
Psychiatric in-patient units/hospitals 0.9 1.0 1.3 3.1 3.6 4.8 
 
Notes: Real projections hold base costs constant at their 2018 values. 
Source: Authors’ calculations. 
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Appendix E Waiting list management 
Table E.1 summarises the results of our waiting list management analysis (see Brick 
and Keegan (2020b) for full details on the data, methods, results and sensitivity 
analysis). We estimate that, over the first five years, to clear the backlog of cases 
waiting for appointments/treatment and to keep pace with the trend in waiting 
lists and population change would require an additional spend, excluding any 
associated capital costs, of €1,058.4m, or €211.7m per annum. Once the backlog 
has been cleared, we estimate that over the following five years (2026–2030) an 
average of €58.4m per annum would be required to maintain waiting lists at a 12-
week level. This would increase to an average of €70.5m per annum in the 
subsequent five years (2031–2035).100 
 
TABLE E.1 Projected activity and nominal expenditure required to clear backlogs (2021–2025) and sustain 
elective waiting times at <12 weeks for OPD, day patient, and in-patient care 
 
 
Average annual additional activity and expenditure 












per year (€m) 
OPD 148,761 28.6 47,379 10.4 49,461 12.3 
Day patient 59,013 78.7 14,269 22.1 14,914 27.2 
In-patient 11,999 104.5 2,590 26.0 2,706 31.1 
Total  211.7  58.4  70.5 
 
Source: Brick and Keegan (2020b). 
 
100  As the OPD backlog is cleared it would be important to reassess future requirements as the day and in-patient waiting 
lists stabilise. 
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